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ABSTRACT
THE ASSOCIATION OF THE INFLAMMATORY POTENTIAL OF DIET WITH
INFLAMMATION AND DEPRESSION AMONG U.S. ADULTS: NHANES 2005-2010
SEPTEMBER 2020
DENIZ AZARMANESH, B.S., TABRIZ UNIVERSITY OF MEDICAL SCIENCES
M.S., UNIVERSITY OF MASSACHUSETTS AMHERST
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Professor Elena T. Carbone

Depression affects 8% of adults in America. Women are twice as likely as men to
experience depression. The economic burden in the U.S. is $83 billion in direct (e.g.,
pharmaceutical) and indirect costs (e.g., absenteeism from work). The etiology of
depression includes non-modifiable (e.g., genetics) and modifiable risk factors (e.g.,
diet). Depression is concurrent with an increase in inflammatory biomarkers, such as creactive protein (CRP). Emerging research suggests that a pro-inflammatory diet may
increase odds of experiencing depression. The Dietary Inflammatory Index (DII) assesses
the inflammatory potential of diet.
According to our narrative review of the current literature in Chapter 1, the
association of the DII and depression is stronger among women than it is in men. While
many studies have found significant associations between the DII and depression, no
study to date has evaluated the mediation role of inflammation on this association. The
vi

association of the DII with various types of depression (e.g., somatic, cognitive) has not
been studied. Previous research has not contrasted the association of DII and depression
among pre- and post-menopausal women. The aim of this dissertation was to examine the
association of the DII with different types of depression, study the mediation role of
inflammation in these associations, and compare the results among pre- and postmenopausal women. For our analyses, we used the National Health and Nutrition
Examination Survey.
In Chapter 2, we evaluated the mediation role of CRP on the association of the
DII and different types of depression. Our results suggest that a pro-inflammatory diet is
significantly associated with higher odds of major depression. The mediation role of CRP
on this association was significant but not biologically meaningful.
In Chapter 3, we compared the association of the DII and depression among preand post-menopausal women. The association of a pro-inflammatory depression with
higher odds of major depression was stronger among pre-menopausal women.
In conclusion, CRP does not strongly mediate the association between the DII and
depression. The association of DII and depression is stronger in women, especially premenopausal women. Future studies need to replicate these results in longitudinal studies,
using various inflammatory biomarkers.
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CHAPTER 1
DOES THE DIETARY INFLAMMATORY INDEX (DII) PREDICT
DEPRESSION DIFFERENTLY AMONG MEN COMPARED TO WOMEN? A
NARRATIVE REVIEW
1.1

Abstract
Depression affects 8% of adults in America and 264 million people worldwide.

Women are twice as likely as men to experience depression in their lifetime. Depression
is a chronic disease correlated with both systemic inflammation and diet. A diet
assessment tool, called the Dietary Inflammatory Index (DII), assesses the inflammatory
potential of diet. The DII has been associated with depression, with a stronger association
observed among women. No previous review has assessed the differences among men
and women to explain the differences in findings for DII and depression. In this narrative
review, we explored the biological and environmental differences among men and
women to find the potential factors which lead to differences in the correlation of DII and
depression among the two populations. Higher inflammatory biomarkers are seen in
women compared to men, which may partially explain the stronger associations of DII
and depression. Finding the risk factors for inflammation and depression in women will
help us better target for prevention and treatment of depression in this population.
Further, DII may not be an accurate assessment tool in the evaluation of inflammatory
potential of diet among men. Taking into account gender differences in the evaluation of
diet may help stimulate research in finding better dietary assessment tools, tailored to
each gender group.

1

1.2

Introduction
According to CDC, depression affects 8.1% adults in America over the age of 20

(CDC, 2018) and 264 million people worldwide (Salama & Mullany, 2017; WHO 2020).
Women in America are twice as likely as men to experience depression, as evidenced by
a report by the CDC, where the prevalence of depression was 10.4% among women and
5.5% in men. Depression is a chronic disease that is associated with major morbidities,
such as cardiovascular disease (CVD), diabetes, and cancer (e.g., breast, lymphoma,
gastrointestinal) (Lucas et al., 2014; Sanches-Villegas et al., 2015; Spiegel & GieseDavis, 2003), as well as global disability (Akbaraly et al., 2016), and mortality (Wirth,
2017). Systemic inflammation has also been associated with CVD, diabetes, and cancer
(Cavicchia et al., 2009; Shivappa et al., 2014; Tabung et al., 2016) and progress of
diseases (Na et al., 2017). Inflammation may be a contributor to the development of
depression (Adjibade et al., 2017), due to its role in neurological diseases
(Kunnumakkara et al., 2018). Modifiable risk factors, such as diet, have been identified in
the development of depression (Phillips et al., 2017). One of the pathways through which
diet affects depression is through systemic inflammation (Phillips et al., 2017). A newly
developed diet assessment tool, the Dietary Inflammatory Index (DII) (Shivappa et al.,
2014), has been used to assess the inflammatory potential of diet and study its
associations with depression.
Identifying factors that attenuate or help prevent depression is of utmost
importance to help lower the burden it has on societies. According to the World Health
Organization, depression is a leading cause of disability worldwide (WHO 2020). The
2

economic burden of MDD increased by 21.5% from 2005 to 2010, increasing from
$173.2 billion to $210.5 billion per year (Greenberg et al., 2015). In 2000, the economic
burden of depression was $83 billion in the United States (Greenberg et al., 2015), which
shows the consistent growth of its burden on the society. In 2010, for every dollar spent
on its direct costs, $1.90 was spent on the indirect costs of MDD (e.g., lost income, extra
social security payments) (Schoefield et al., 2019) (APA).
Diet can contribute to the prevention of depression. This review summarizes the
findings on the associations of DII and depression since the development of DII in 2014.
Furthermore, to the best of our knowledge, no other narrative review has been published
to date examining how DII predicts depression differently among men and women. We
first reviewed the physiological findings on inflammation, depression and diet. Then, we
summarized the findings on DII and depression. Finally, we discussed the potential
biological mechanisms that may explain differences in findings among men and women.
We evaluated the existing epidemiologic evidence, and proposed potential opportunities
for future research to address the gap in our findings.
1.3

Current Status of Knowledge

1.3.1 Inflammation
Inflammation is a normal and essential part of the body’s defense mechanism
against pathogens and injuries (Innes & Calder, 2018). Aside from the effect of
pathogens themselves, the prolonged exposure to an inflammatory response is damaging
to tissues. Negative feedback mechanisms, such as anti-inflammatory cytokines, help
control the timing of inflammation and inhibit pro-inflammatory signaling (Innes &

3

Calder, 2018). The loss of these regulatory processes leads to chronic systemic
inflammation (Innes & Calder, 2018). Systemic inflammation is characterized by
increased pro-inflammatory cytokines and chemokines in circulation (Sanchez-Villegas,
2015; Shivappa et al., 2014) in response to various non-modifiable factors (e.g., genetics,
hormones, aging) (Julia et al., 2017), and modifiable and environmental factors (e.g.,
anxiety, smoking, hypertension, and diet) (Adjibade et al., 2017; Shivappa et al., 2014;
Almeida-de-Souza et al., 2017). Chronic inflammation is associated with cancer (e.g.,
breast, colon, liver, bladder, lung, stomach), arthritis, CVD, diabetes, and neurological
diseases. Higher levels of Interleukin (IL) -6, c-reactive protein (CRP) (Akbaraly et al.,
2016; Cavicchia et al., 2009; Derry et al., 2015; Khansari et al., 2009; Neurath & Finotto,
2011), and tumor necrosis factor-alpha [TNF-a] (Adjibade, 2017; Derry et al., 2015;
Phillips et al., 2017), and IL-1B (Derry et al., 2015) have been associated with
depression.
1.3.2 Role of Inflammation in Depression
Various genetic and environmental factors, such as stressful life events, or
response to illnesses and medication use are the etiologic factors in the development of
depression (Ekmekcioglu, 2012). Metabolic and inflammatory conditions, including
lower insulin sensitivity, higher homocysteine levels, and higher stress hormones (e.g.,
cortisol) and endothelial dysfunction are potential factors leading to depression (Shivappa
et al., 2016). Individuals suffering from depression often have high pro-inflammatory
cytokine levels, such as CRP, TNF-a, IL-1B, and IL-6 in both their blood and
cerebrovascular fluid, when no other medical condition was present (Ekmekcioglu, 2012;
Makhija & Karunakaran, 2013; Shivappa et al., 2016). Antidepressant use has resulted in
4

lowering of these cytokines (Ekmekcioglu, 2012; Lindqvist et al., 2017; Strawbridge et
al., 2015). These findings suggest that a bidirectional association exists between
inflammation and depression.
Different biochemical pathways have been suggested to link inflammation to
depression. Pro-inflammatory cytokines affect mood and mental health by changing the
metabolism of neurotransmitters (e.g., serotonin [5-HT]), dopamine, noradrenaline,
glutamate), basal ganglia function, neuroendocrine system, or synaptic plasticity
(Adjibade et al., 2017; Derry et al., 2015; Miller et al., 2009). The changes in the nervous
system by pro-inflammatory cytokines are the basis for the monoamine hypothesis that
identifies central synaptic deficiency of 5-HT and/or norepinephrine as the cause of
depression (Makhija & Karunakaran, 2013). Cytokines stimulate and increases 5-HT
reuptake from synapses. Increased amounts of IL-6, IL-1, and TNF-a in cerebrospinal
fluid also activate the mitogen-activated protein kinase (MAPK) pathway, which
upregulate the reuptake of neurotransmitters, such as 5-HT, dopamine, and
norepinephrine in the hippocampus (Makhija & Karunakaran, 2013). Pro-inflammatory
cytokines affect the maintenance of 5-HT production by causing an imbalance in the
kynurenine (KYN) pathway, which is also the main pathway for the amino acid
Tryptophan’s (TRP) degradation (Allison et al., 2014). The KYN pathway includes a
series of enzymatic reactions that lead to the breakdown of TRP into metabolites called
kynurenines (Allison et al., 2014). Lower TRP levels in the body and lower availability
of brain-derived neurotrophic factor are some of the mechanisms through which
inflammation is associated with depression (Sanchez-Villegas et al., 2015). Aside from
TRP’s role as a precursor for 5-HT production in the brain, TRP metabolites, such as
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quinolinic acid (QUIN) and kynurenic acid (KYNA), are also involved in the
development of depression symptoms and cognitive impairment (Allison et al., 2014).
Previous research has shown various immune responses to depression, such as
chronic low-grade inflammation, activation of compensatory anti-inflammatory reflex
system, and high circulatory pro-inflammatory cytokine levels (e.g., CRP, IL-6, IL-1B,
and TNF-a) (Berk et al., 2013; Cepeda et al., 2016; Derry et al., 2015). These immune
responses explains the endocrine changes due to depression (Adler et al., 2008).
Oxidative and nitrosative stress (O&NS), and the autoimmune responses against these
types of stress increase with depression (Berk et al., 2013). Pro-inflammatory cytokines,
such as IL-1 and TNF-a, stimulate the neuroprogression of depression via free radical
production and the O&NS pathway (Makhija & Karunakaran, 2013). Depression is
typically concurrent with depleted antioxidant levels, such as TRP, tyrosine, albumin,
zinc, vitamin E, and glutathione, which exacerbate O&NS activity. This in turn, leads to
an increased cellular damage and autoimmune response (Makhija & Karunakaran, 2013).
One of the mechanisms through which pro-inflammatory cytokines can lead to
depression is through changes in the metabolism, synthesis, and reuptake of
neurotransmitters involved in mood health, such as 5-HT, norepinephrine, glutamate, and
dopamine (Adjibade et al., 2017; Ekmekcioglu, 2012). External stressors decrease the
production of neurotrophic factors, including the brain-derived neurotrophic factors
(BDNF), a neurotransmitter that promotes neuronal growth, survival, maturation, and
synaptic plasticity in the hippocampus (Makhija & Karunakaran, 2013). Low serum
BDNF has been observed in depressed individuals and typically correlates with severity
of disease (Makhija & Karunakaran, 2013). The endothelial dysfunction caused by pro-
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inflammatory cytokines impedes the expression of BDNF and reduce its levels, which is
also observed in depression (Lucas et al., 2014; Shivappa et al., 2016). Endothelial
dysfunction may be due to changes in mRNA production and activation of enzymes like
indoleamine 2,3-dioxygenase (IDO). IDO and tryptophan 2,3-dioxygenase (TDO) are
rate-limiting enzymes that control the degradation of TRP to kynurenines (KYNs)
(Allison et al., 2014). The function of IDO and TDO is regulated by various factors, such
as steroids and cytokines (Allison et al., 2014). Pro-inflammatory cytokines activated
IDO, which in turn increases the degradation of TRP and subsequently decreases 5-HT
levels (Catena-Dell’Osso et al., 2013). Further, metabolites from the degradation of TRP,
such as KYNs, can disrupt the production of 5-HT from TRP (Adjibade et al., 2017;
Ekmekcioglu, 2012; Makhija & Karunakaran, 2013). KYNs can also form kynurenic acid
that is a potential inhibitor of dopamine release (Ekmekcioglu, 2012). Dopamine, like
serotonin, is involved in mood regulation (Ekmekcioglu, 2012), and its inhibition can
result in the development of depression.
Cytokines can also stimulate the HPA-axis and lead to the release of stress
hormones, which then leads to depressive symptoms by the action of corticotropin
releasing hormone and cortisol (Ekmekcioglu, 2012; Makhija & Karunakaran, 2013).
Additionally, when there are leaky parts in the brain-blood barrier, pro-inflammatory
cytokines damage the central nervous system through various pathways, such as
decreasing neurogenesis and dysregulating glial/neuronal interactions (Adjibade et al.,
2017; Ekmekcioglu, 2012).
1.3.3 Inflammatory Potential of Diet

7

Diets can affect depression by stimulating changes of neurotransmitters, oxidative
stress, and the HPA axis (Wirth et al., 2017). Diets that induce inflammation, such as the
Western diet, are also associated with neuro-inflammation (Wirth et al., 2017).
Inflammatory potential of diet can be a modifier in the medical conditions related to
systemic inflammation and depression, such as CVD and diabetes. Western diets,
characterized as being high in red meat, processed food, refined grains, fried foods, and
sweets, are associated with increased chronic disease risk. Conversely, the Mediterranean
diet (e.g., high in lean meat, whole grains, fruits, vegetables, and moderate alcohol
intake) is associated with decreased chronic disease risk (Cavicchia et al., 2009; Lucas et
al., 2014; Phillips et al., 2017; Shivappa et al., 2014). The Western diet is correlated with
pro-inflammatory biomarkers (e.g., CRP, TNF-a, IL-6) and the Mediterranean diet is
correlated with anti-inflammatory biomarkers (e.g., IL-10) (Cavicchia et al., 2009; Na et
al., 2017; Tabung et al., 2016; Shivappa et al., 2014; Wirth et al., 2017). Proinflammatory diets are correlated with depression (Akbaraly et al., 2016; SanchesVillegas et al., 2015; Shivappa et al., 2016; Wirth et al., 2017). Healthy diets (e.g., high
scores on the Alternative Healthy Eating Index, the Mediterranean diet, or the Norwegian
diet) are correlated with lower odds of depression (Adjibade et al., 2017; Akbaraly et al.,
2016; Phillips et al., 2017; Shivappa et al., 2016; Wirth et al., 2017).
Unhealthy diets are characterized as being high in energy, having high glycemic
indices, saturated and trans fat, and being low in beneficial foods such as omega-3 fatty
acids and fiber (Ekmekcioglu, 2012). Unhealthy diets are high in calories and may lead to
obesity, hyperlipidemia, and diabetes. The obesity caused by these diets may lead to
depression through an increase in pro-inflammatory cytokine levels. Previous studies
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linking inflammation and depression have suggested comorbidities, such as obesity,
hyperlepitenemia or insulin resistance (IR) as the possible links between inflammation
and depression (Shivappa et al., 2016). The development of depression in obese
individuals may be due to the systemic inflammation that occurs among them. Increased
production of cytokines in fat cells, especially in abdominal obesity, alongside leptin and
increased activity and dysfunction of HPA, and oxidative stress lead to inflammation in
obese individuals (Berk et al., 2013). This partially explains the presence of increased
inflammation in individuals with depressive symptoms (Shivappa et al., 2016). High
levels of cortisol is related to depression, possibly by decreasing the 5-HT available in the
synaptic cleft (Adler et al., 2008).
Previous studies have suggested that high glycemic index of food and high
saturated and trans fat intake by themselves can rise pro-inflammatory cytokine (e.g.,
CRP, IL-6) levels, which is a risk factor for development of depression (Ekmekcioglu,
2012). Omega-3 fatty acid, docosahexaenoic acid (DHA), and eicosapentaenoic acid
(EPA), have been inversely associated with depression (Ekmekcioglu, 2012). Overall,
diets high in processed meats, fried foods, and sweets are significantly associated with
higher CRP and IL-6 levels (Ekmekcioglu, 2012).
The administration of anti-inflammatory compounds by themselves, such as
omega-3 polyunsaturated fatty acids (PUFA), are effective in treating depressed patients
(Catena-Dell’Osso et al., 2013). These anti-inflammatory compounds also reduce the
production of cytokines, such as IL-1 and TNF-a (Catena-Dell’Osso et al., 2013). Whole
grains and fiber and other dietary components high in beta-glucans and phytochemicals
promote immune function and protect against oxidative stress; thus, preventing
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inflammation and depression (Berk et al., 2013). Diets high in glycemic load are related
to higher CRP levels, while foods containing omega-3 fatty acids, such as nuts and
seafood, reduce the production of pro-inflammatory cytokines (Berk et al., 2013). Studies
with animals fed diets high in saturated fatty acids have shown increased levels of
neuroinflammation (Berk et al., 2013). This increase in inflammation may be explained
by the health of the gut microbiota; while the decrease in inflammation by high fiber
intake appear to be due to the increased short-chain fatty acids produced by the
fermentation of dietary fiber in the gut (Berk et al., 2013).
Some studies have found prospective associations between healthy diets and 30%
reduction in the risk of development of depression (Ekmekcioglu, 2012). While other
studies have linked higher depression risk to high intakes of processed foods, meat and
meat products, refined grains, and processed pastries (Ekmekcioglu, 2012). A crosssectional study among peri-menopausal women (i.e., 45-54 y) reported a 54% increase in
odds of reporting depressive symptoms with higher fast-food intake (Ekmekcioglu,
2012). The hypothesis is that healthy, Mediterranean-style diets have anti-inflammatory
properties and help build a healthier vascular system, which leads to lower risk of
developing depression (Adjibade et al., 2017).
Several studies have shown a positive association between DII scores and chronic
cardiometabolic conditions, such as diabetes, cancer, and CVD (Adjibade et al., 2017;
Sanchez-Villegas et al., 2015; Wirth et al., 2017). Patients suffering from chronic
diseases like cancer are more likely to develop depression (Adjibade et al., 2017).
Therefore, development of chronic diseases due to high DII may be a pathway between
DII and depression.
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1.3.4 Dietary Inflammatory Index (DII)
Many studies have focused on single nutrients in assessing their association with
inflammation or chronic diseases. Another key limitation of previous dietary quality
indices is the fact that their assessment is based on recommendations of intake (Shivappa
et al., 2015). To address this limitation, new analyses have been developed to assess
overall dietary patterns. This new approach is relevant because nutrients have synergistic
or antagonistic effects when consumed together (Barbaresko et al., 2013; Almeida-deSouza et al., 2017) and bioactive compounds in diet act as pro- or anti-inflammatory
agents (Adjibade et al., 2017). Using indices that examine overall dietary pattern help us
better understand diet-disease associations. These new dietary indices are best suited to
assess associations of overall diet with chronic diseases (Hu et al., 2002; Jacques et al.,
2001; Tabung et al., 2016).
Dietary components such as fiber, vitamin E, zinc, and omega-3 fatty acids are
inversely associated with systemic inflammation, as assessed by inflammatory
biomarkers (e.g., CRP) (Cavicchia et al., 2009), while dietary items, such as total fat and
saturated fatty acids have pro-inflammatory capacities (Almeida-de-Souza et al., 2017).
The DII was developed to assess the effect of all pro- and anti-inflammatory dietary
components in conjunction with each other and come up with the overall inflammatory
potential of diets. The authors used close to 2000 peer-reviewed articles published
between 1950 and 2010, which have assessed the association of dietary components on
six inflammatory biomarkers (i.e., IL-1B, IL-4, IL-6, IL-10, TNF-a, and CRP) (Cavicchia
et al., 2009; Shivappa et al., 2014).
DII Calculation
11

The DII is comprised of 45 items (36 nutrients and nine foods), including
macronutrients, micronutrients, and flavonoids. The inflammatory potential for each DII
food item is scored based on the effect it has on the six inflammatory biomarkers
mentioned above: increase (+1), decrease (-1), and no effect (0). The DII can be
calculated using both FFQ and 24-hour dietary recall data. The DII is a scale, ranging
from -8.87 (maximally anti-inflammatory) to +7.98 (maximally pro-inflammatory)
(Shivappa et al., 2014; Wirth et al., 2017). Each individual’s intake is subtracted from the
standard world means then divided by its standard deviation (Shivappa et al., 2014) to
create a z-score (mean=0, standard deviation=1) (Akbaraly et al., 2016). The standard
world mean and its standard deviations are the range of intakes of food derived from 11
nutritional databases from different parts of the world (Wirth et al., 2014). The z-score is
then transformed to a percentile to minimize right skewing, which is common in dietary
data. The percentile is then centered (i.e., to create normal distribution of data) by
doubling the value and subtracting one from the result. Then, the centered value is
multiplied by the literature-derived inflammatory effect score of the corresponding DII
food item to calculate the food item-specific DII score for each participant. The food
item-specific scores for each food item of DII is then summed to create the overall DII
score for each participant. The higher the DII score, the more pro-inflammatory the diet
is, and the more negative the score, the more anti-inflammatory the participant’s diet is.
For example, an individual’s intake is 2079 calories. We will create the z-score by
subtracting the standard world mean for energy intake (i.e., 2056) and then dividing it by
the standard deviation for energy (i.e., 338). Our z-score will be 0.06. The z-score is then
transformed to a percentile, yielding a score of 0.56. This number is centered by doubling
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it and then subtracting value of one from the doubled number: 0.12. This centered
number is then multiplied by the inflammatory effect score for energy intake (i.e., 0.18)
to create the DII score for energy: 0.02. The same step is replicated for all the other food
items included in the DII to create an overall score of DII for the individual.
The DII has been validated using six different inflammatory biomarkers with diet
being assessed using 24-hour dietary recall interviews and seven-day dietary recalls
(Shivappa et al., 2014). The DII has been associated with various inflammatory
biomarkers, such as CRP, IL-6, and tumor necrosis factor-a R2 (TNFa-R2) (Shivappa et
al., 2014; Shivappa et al., 2015; Shivappa et al., 2017; Wirth et al., 2017). Higher DII
scores (i.e., more pro-inflammatory) are inversely associated with adherence to the
Mediterranean diet (Ruiz-Canela et al., 2015). Higher DII scores (i.e., more proinflammatory) have been positively associated with different types of cancer (Shivappa et
al., 2014), CVD (Garcia-Arellano et al., 2015) and obesity (Ruiz-Canela et al., 2015), as
well as mortality (Shivappa et al., 2015), depression in women (Sanchez-Villegas et al.,
2015; Shivappa et al., 2016; Akbaraly et al., 2016; Lucas et al., 2014), and lower
cognitive functioning, such as short-term and working memory, as assessed by
neuropsychological evaluation (Adjibade et al., 2017; Kesse-Guyot et al., 2017).
1.3.5 Findings on DII and Depression
We found 11 epidemiological studies relevant to our topic: five were prospective
studies (Sanchez-Villegas et al., 2015; Akbaraly et al., 2016; Shivappa et al., 2016;
Adjibade et al., 2017; Shivappa et al., 2018a) and six were cross-sectional (Bergmans &
Malecki, 2017; Phillips et al., 2017; Wirth et al., 2017; Jorgensen et al, 2018; Shivappa et
al., 2018b; Salari-Moghaddam, 2019).
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A. Cross-Sectional Studies
Wirth et al., 2017 used the National Health and Nutrition Examination Survey
(NHANES) 2005-2012 database and their analysis included 18,875 adults. The
population was categorized into quartiles of DII for analysis. Comparing the highest
quartile to the lowest, the odds of having depressive symptoms was 30% higher (95% CI
1.00-1.68) in the fourth quartile, among women only in the fully adjusted model. In a
study by Bergmans & Malecki (2017), who used data from 11,592 adults (i.e., >20 years
of age) from the NHANES 2007-2012 database, DII was categorized into quintiles and its
association with the 9-item Patient Health Questionnaire (PHQ-9) diagnosed depression
was assessed. Comparing the highest to the lowest quintile, they found an OR of 2.26
(95% CI 1.60-3.20, P < 0.0001) for depression in the fully adjusted model. However,
their results were not modified when interaction terms with sex were entered in the
model. In the most recent cross-sectional study by Jorgensen et al. (2018), the NHANES
2007-2012 database and a population of 11,624 adults (i.e., >18 years of age) were used
for analysis. Their results showed higher odds of depression for participants in the third
quartile of DII (OR = 1.41, 95% CI 1.04-1.92) and in the fourth quartiles of DII (OR =
1.74, 95% CI 1.25-2.42), in the fully adjusted model. In their population, those with
depression were more likely to be younger and women. They did not report their results
stratified by sex. Phillips et al. (2017) used the data on 2,047 adults between the ages of
50 and 69 years. Diet was assessed using a self-administered FFQ and energy-adjusted
DII scores (E-DII) were calculated. In their multivariate logistic regression model,
participants in the third tertile compared to the first tertile (i.e., referent group) had a 60%
higher odds of being depressed (95% CI 1.04-2.47, P = 0.03). However, after additional
adjustments for antidepressant use and history of depression, the association was no
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longer significant (P=0.22). After stratifying by sex, their results remained significant
only among women (OR = 2.29, 95% CI 1.49-3.51, P < 0.001). These results remained
significant after controlling for antidepressant use and history of depression among
women (OR = 2.23, 95% CI 1.15-4.36, P = 0.02). In a cross-sectional study by Shivappa
et al. (2018b), they assessed the association of the DII with depression. They categorized
DII into tertiles and used the Depression, Anxiety, and Stress Scale (DASS) to assess
depressive symptoms. Their population consisted of 300 Iranian female adolescents.
They defined moderate depressive symptoms as DASS score of 10 and above, on a range
of 0-21. They found that in the fully-adjusted model, individuals in the third tertile of DII
had higher depression scores (B = 1.67; 95% CI 0.04-3.31; P-trend = 0.07) and higher
odds of having moderate depressive symptoms (OR = 3.96; 95% CI 1.12-13.97; P-trend
= 0.03). Salari-Moghaddam and colleagues (2019) assessed the association of DII with
psychological profile among 3,363 adult Iranians (58.3% female). They used a Dishbased 106-item Semi-quantitative FFQ to assess the food intake of participants. They had
29 food-items available on the list of items for DII. To assess psychological disorders,
including depression, they used the Iranian validated version of Hospital Anxiety and
Depression Scale (HADS), with the depression score range of 0-21. In the multivariableadjusted model, their results showed that compared to those in the lowest quintile of DII,
participants in the highest quintile had higher depression scores (6.56 ± 0.16 vs. 5.48 ±
0.16; P < 0.001). In their sex-stratified model, they looked at the risk of depression across
quintiles of DII. They found significant positive results in the multivariable-adjusted
model among women (OR = 1.92, 95% CI 1.24-2.98; P-trend = 0.002), but not among
men (OR = 1.68, 95% CI 0.93-3.04; P-trend = 0.01).
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B. Prospective Studies
Adjibade and colleagues (2017) assessed the association of the DII with incident
depressive symptoms (DepS) among 3,523 depression free adults. No significant
association between DII and incidence of DepS was found in the fully adjusted model
(OR Quartile 4 vs. Quartile 1 = 0.73, 95% CI 0.39-1.34, P=0.63, and OR continuous DII
= 0.96, 95% CI 0.86-1.09, P=0.56). In the sex-stratified analysis marginally significant
results were found among men (OR Quartile 4 vs. Quartile 1 = 2.32, 95% CI 1.01-5.35,
P=0.06). Akbaraly and colleagues (2016) examined the association of DII with recurrent
DepS, using data from 4,246 middle-aged adults. Using logistic regression in their fully
adjusted model a significant association between DII and recurrent DepS was found
among women only. For each one increment increase in standard deviation (SD) of DII, a
66% increase in odds of recurrent DepS were observed (95% CI 1.30-2.12). However, the
same association did not exist among men (OR=1.12, 95% CI 0.92-1.36). When
categorizing DII in tertiles, the odds of having recurrent DepS over a five-year follow-up
period was higher in the highest tertile compared to the lowest tertile (OR=2.83, 95% CI
1.48-5.42) among women only, in the fully adjusted model. No such association existed
among men. Additional adjustments for IL-6 and CRP levels did not attenuate the results.
In another prospective study examining the association between the DII and incidence of
depression, after a median 8.5 years of follow-up Sanchez-Villegas and colleagues (2015)
found a hazards ratio (HR) of 1.47 (95% CI 1.17-1.85, P=0.01) for incidence of
depression comparing DII of the highest quintile to the lowest among 15,093 individuals.
When results were stratified by 55 years of age, an increased HR of 2.70 (95% CI 1.225.97) emerged among participants above the age of 55. However, the authors did not
differentiate the results between men and women. Shivappa et al. (2016) looked at the
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prospective association of the DII with the risk of depression among 6,438 middle-aged
women followed up for 12 years. Comparing the lowest quartile of DII (i.e., most antiinflammatory) to the highest quartile, they found a relative risk of 0.81 (i.e., 20% lower
risk) of developing depression (95% CI 0.69-0.96, P=0.03), in the fully adjusted model.
In one of the most recent prospective studies, the same authors (Shivappa et al., 2018a)
assessed the same association using the Osteoarthritis Initiative database in America
among 3,648 individuals with an eight-year follow-up. Comparing the highest to the
lowest quartile of DII, they found a significantly higher incident of DepS (HR=1.24, 95%
CI 1.01-1.53, P=0.04), in the fully adjusted model. Looking at DII as a continuous
variable, an increase in one SD of DII did not result in an increased risk of depressive
symptoms at follow-up (HR=1.02, 95% CI 0.96-1.09, P=0.52).
Aside from Adjibade et al. (2017) and Wirth et al. (2017), who used 24-hour dietary
recalls, the remainder of the studies used FFQ’s as their dietary assessment tools.
C. Meta-Analyses
A meta-analysis by Wang et al. (2018) evaluated the association of the DII with
depression. They included four prospective (Sanchez-Villegas et al., 2015; Adjibade et
al., 2017; Shivappa et al., 2017; Shivappa et al., 2018) and two cross-sectional (Phillips et
al., 2017; Wirth et al., 2017) studies in their analysis, which resulted in 49,584
observations. They found that the overall risk of depression was 23% higher when
comparing the highest to the lowest quantile of DII (95% CI 1.12-1.35). Among
prospective studies, the risk ratio (RR) was 1.25 (95% CI 1.12-1.40) and among crosssectional studies it was 1.16 (95% CI 0.96-1.41). When they stratified their results by
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gender, they found that the risk of depression was 25% higher for women (95% CI 1.091.42) and 15% higher in men (95% CI 0.83-1.59). But results were not significant in men.
In a different study, Lassale and colleagues (2019) performed a systematic review
and meta-analysis of observational studies on the association of different dietary indices
and risk of depression. In their analysis of the studies on the DII, they performed metaanalysis of five cohort studies (Sanchez-Villegas et al., 2015; Akbaraly et al., 2016;
Shivappa et al., 2016; Adjibade et al., 2017; Shivappa et al., 2018a) and four crosssectional studies (Bergmans et al., 2017; Phillips et al., 2017; Shivappa et al., 2018b;
Wirth et al., 2017). Comparing the least inflammatory diets to the most inflammatory,
they found that there was an inverse association with depression in both cohort studies
(overall HR = 0.76; 95% CI 0.63-0.92) and in cross-sectional studies (overall HR = 0.64;
95% CI 0.45-0.91). They found heterogeneity in the results in all studies that they
attributed to the differences in estimates between men and women. Some studies had
found only significant inverse associations among women and not men (Akbaraly et al.,
2016; Phillips et al., 2017; Wirth et al., 2017); while one study had found significant
inverse associations among men and not women (Adjibade et al., 2017).
1.4

Differences in Men and Women
All the studies found significant associations between higher DII scores (i.e.,

more pro-inflammatory) and higher likelihood of developing depression or having
depressive symptoms. Four studies found significant results among both men and women
(Sanchez-Villegas et al., 2015; Bergmans & Malecki, 2017; Jorgensen et al., 2018;
Shivappa et al., 2018); however, Bergmans & Malecki (2017) in their analysis of the
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association of DII quintiles and odds of depression using NHANES 2007-2012 noted that
the said association was not affected by sex, when assessing the interactions. Two studies
included only women in their analysis (Shivappa et al., 2016; Shivappa et al., 2018b).
The mean age in the first study was 52 y, where the authors found that those with the
most anti-inflammatory diet (i.e., 4th quartile) had 19% lower risk of developing
depression (95% CI 0.69-0.96; P-trend = 0.03). In the second study that included 15-18
year-old adolescent females, the researchers found 296% higher odds of having moderate
depressive symptoms (95% CI 1.12-13.97; P-trend = 0.03) when comparing the third
tertile of DII to first tertile. In other studies the associations were either only significant
among female participants (Akbaraly et al., 2016; Wirth et al., 2017; Salari-Moghaddam
et al., 2019) or were significant in all participants but remained significant only in women
after stratifying by sex (Phillips et al., 2017). Additional adjustments for IL-6 and CRP
levels in the study by Akbaraly et al. (2016) did not attenuate the results, which may
indicate that the association of DII and depressive symptoms is independent from
inflammation. In a prospective cohort of 3,523 middle-aged participants, Adjibade et al.
(2017) identified 172 cases of incident depressive symptoms over 12.6 years of followup. They did not find any associations between DII and incident depression in the full
sample or among women. However, men in the highest quartile of DII had higher risk of
incident depression, which was only marginally significant (OR=2.32, P=0.06).
Data have been inconsistent regarding the association of DII with depression, with
one study finding a borderline significant association in men only (Adjibade et al., 2017),
and another in women only (Akbaraly et al., 2016). This may be due to various reasons,
including higher prevalence of depression among women, with 21.3% of women and

19

12.9% of men experiencing major depressive disorders in their lifetimes (Derry et al.,
2015). This difference among men and women is potentially due to events that may lead
to hormonal changes (e.g., premenstrual symptoms, postpartum), more cases of falsepositives among women, or difference in responsiveness to dietary changes (Derry et al.,
2015; Adjibade et al., 2017). In an intervention study conducted among middle-aged
adults (i.e., 50-70 y) reported that testosterone reduces the expression of IL-1B and TNFa among men but does not affect CRP and IL-6 levels; while, among women, estrogen
changed CRP levels but did not affect IL-6, IL-B1, or TNF-a (Corcoran et al., 2010).
Therefore, the association of hormonal changes and depression among women may be
independent of the effect of hormones on inflammation. Overall, estrogen has a
protective effect against inflammation (Derry et al., 2015). Therefore, it is important to
stratify results by menopausal status to assess whether the differences in the association
of DII and depression among men and women is due to the estrogen decline after
menopause.
A high DII score, which is related to poor diet quality (Bawaked et al., 2017),
may be a proxy for other lifestyle factors that might be the cause of depression in women,
such as low physical activity levels or poor social support. In the study by Adjibade et al.
(2017), pro-inflammatory diets were associated with depression among less physically
active individuals as compared to those who were more active (Adjibade et al., 2017).
This can be explained by the anti-inflammatory properties of physical activity and its
ability to lower pro-inflammatory cytokines (e.g., CRP, IL-6, TNF-a) and increase antiinflammatory cytokines (e.g., IL-10, IL-12, IL-4) in the blood circulation (Adjibade et al.,
2017). Based on these findings the authors suggest that the protective effect of an anti-
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inflammatory diet on depression emerges only when other unhealthy lifestyle behaviors
are present, such as low physical activity levels or smoking (Adjibade et al., 2017).
Women tend to have more risk factors for inflammation, such as physical inactivity,
obesity, and childhood adversity (Choi et al., 2013; Donoho et al., 2013; Moieni et al.,
2015; Derry et al., 2015). These factors can lead to depression, which may partially
explain the findings of this review that the DII is more strongly associated with
depression among women than it is men.
Women are more likely to experience higher levels of inflammation and
subsequently depression (Derry et al., 2015). A study by Lakoski et al. (2006) that
included 6,814 men and women participants (aged 45-84 y) reported higher median CRP
among women compared with men (2.56 vs. 1.43 mg/L; P <0.0001), even after excluding
acute inflammation (i.e., CRP>10 mg/L) and controlling for estrogen-use (1.85 vs. 1.33
mg/L; P <0.0001). Another study (Khera et al., 2005) also found significantly higher
CRP levels among women compared to men (median, 3.3 vs. 1.8 mg/L; P <0.001).
Inflammatory potential of diet may be one of the environmental factors that lead to high
levels of inflammation among women. DII was created by finding the correlations
between food items and inflammation. Therefore, it may be an indirect indicator for
inflammation levels. As mentioned previously, inflammation and depression are related
(Ekmekcioglu, 2012). The association between DII and depression may be an indirect
indicator for the association of inflammation and depression.
Women tend to have lower caloric intakes than men (Leblanc et al., 2015). Lower
intake of energy is associated with higher DII scores (i.e., more pro-inflammatory), which
may be due to the fact that the more energy an individual consumes, the most likely it is

21

that they will have sufficient intake of beneficial nutrients. Most studies have not found
any associations between DII and depression among men. Men tend to have high energy
intake levels and higher energy levels are typically associated with lower (i.e., more antiinflammatory) DII scores. A study by Hakkarainen and colleagues (2004), found that
men with higher energy intakes were more likely to experience anxiety or depressed
mood. They also found that higher intakes of omega-3 and omega-6 fatty acids were
associated with anxiety and depressed mood. These findings indicate that diet may not
have as strong an association with depression in men than it does in women. This may
partially explain why no associations were found among DII and depression as men.
Based on an analysis of NHANES 2003-2004, men had higher intakes of protein
compared to women (Fulgoni, 2008). Shivappa and colleagues (2014) found a similar
trend in their results. Julia et al. (2017) reported high alternate-DII (ADII) scores with
higher protein intakes. ADII, unlike DII, does not include the variables for which the
subparts are included. For example, energy intake is not included, because macronutrients
are included. Thus, the higher protein intake in men may also be a contributor to their
high DII scores. The elevated DII scores with higher protein intake may be due to an
increased red meat and animal-based protein consumption, which are typically high in
total and saturated fat. A recent meta-analysis of observational studies found moderately
higher risk of depression with meat consumption (Zhang et al., 2017). One study has
shown higher intakes of vitamin/mineral supplement among women compared to men
(Shivappa et al., 2014), which may be a contributor to lower DII scores in women.
Adjibade et al. (2017) found significant associations between DII and risk of
incident depression among current and former smokers compared with never smokers.
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Toxins, such as free radicals, in cigarette smoke can lead to chronic inflammation and
higher levels of CRP and other pro-inflammatory cytokines in smokers, which in turn can
lead to depression (Adjibade et al., 2017). Based on reports by the National Institute of
Health (NIH) on drug abuse, men are more likely to use tobacco products compared with
women (NIH). The remainder of studies included in this review have not assessed their
results by smoking status and have not evaluated the interaction between smoking and
gender in the association of DII and depression.
Pro-inflammatory diets may contribute to weight gain and obesity (Lucas et al.,
2014). Increases in adipose tissue, which is a source of pro-inflammatory cytokines, may
lead to systemic inflammation (Lucas et al., 2014). Obesity has been associated with high
cortisol levels and high HPA axis reactivity to stress and mood disorders (SanchezVillegas et al., 2015). Further, the HPA axis functions less efficiently in obese individuals
and IL-6 responses become sensitized in response to stress stimuli in obesity, which
suggests a modified response to psychological stress (Sanchez-Villegas et al., 2015).
Therefore, obesity has been identified as a possible pathway linking pro-inflammatory
diets to depression (Lucas et al., 2014). As women tend to have more body fat compared
to men (Karastergiou et al., 2012), this may be a pathway linking higher DII levels with
depression in women more than it does in men.
One of the possible explanations for the difference in findings for DII and
depression between men and women might be the difference in the association of
inflammation and depression in these two groups. However, most studies have found that
this association is stronger in men than women. A study by Vetter and colleagues (2013)
assessed the gender differences in the association of depression and CRP. They included
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382 obese individuals in their analysis from a weight loss intervention trial. They used
PHQ-8 to assess depression and defined a score of 10 and above as major depression.
They found significant associations between major depression and log-transformed CRP
in both the crude model (P <0.01) and the multivariable adjusted model (P = 0.04). They
further entered an interaction term between gender and depression. They found that the
correlation between symptoms consistent with major depression and CRP remained
significant among men (B = 0.28; 95% CI 0.72-0.49; P <0.01) but not women (B = 0.05;
95% CI -0.05-0.16; P = 0.32). Their results for the relation between PHQ-8 score and
CRP was similar, with a correlation coefficient of 0.02 (95% CI 0.003-0.04; P = 0.02) in
men and 0.004 (95% CI -0.006-0.014; P = 0.42) in women. A different study by Tayefi
and colleagues (2017), looked at the association of depression and CRP among 9,759
(60% female) middle-aged participants (mean age = 48 y) of a cohort in Iran. They used
the Beck Depression Inventory to assess depression and categorized participants into four
groups based on their depressive scores: no or minimal, low, moderate, and severe. They
found significant correlations between CRP and odds of severe depression among men
(OR = 1.04; 95% CI 1.02-1.05; P <0.001) but not women (OR = 1.00; 95% CI 0.99-1.01;
P >0.05). Three more studies found similar results. Ford and Erlinger (2004) used the
data from the Third NHANES (N = 6,914) and found a significant correlation between
major depression and increased CRP levels among men but not women. A study by
Toker and colleagues (2005) found a significant positive association between CRP and
depression among men (B = 1.08; P <0.05) but not among women (B = 0.34; P >0.05).
Similar results were found among a large population of Finnish adults (aged >30 y)
(Elovainio et al., 2004). One study found contrasting results, where depression was
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associated with CRP among women only (Ma et al., 2010). The strong evidence for the
strong association of CRP and depression among men suggests that either the CRP levels
in men are independent of diet, or that the DII is not a strong measure of the
inflammatory potential of diet. None of the studies on the association of DII and
depression have looked at the mediation effect of inflammation.
In a longitudinal study by Chocano-Bedoya and colleagues (2014), where
researchers followed individuals for 6-18 years, they found no associations between
markers of inflammation (i.e., CRP, IL-6, TNF-a) and incident depression. This suggests
that depression might be leading to increases in inflammation and not vice versa. With
this assumption we should discuss the findings of the studies on DII and depression as
correlational. It is possible that the inflammatory potential of diet and its subsequent
increase in inflammation are not the pathway to depression in some cases. Reverse
causality may be present, where depression leads to poor dietary choices. Previous
studies have shown that those with depression have higher consumption of unhealthy
foods (e.g., fat, sugar) and lower consumption of healthy foods (e.g., fruits, vegetables)
(Whitaker et al., 2014; Payne et al., 2012; Jacka et al., 2015). A study by Jacka and
colleagues (2015) showed that current depression is associated with lower healthy dietary
patterns (B = -0.12; P = 0.03) and is not associated with Western (i.e., unhealthy) dietary
pattern (B = 0.01; P = 0.86). However, they found associations between past history of
depression and lower Western dietary pattern (B = -0.12; P <0.001) but not with a healthy
dietary pattern (B = 0.05; P = 0.07). Their findings suggest that current depression is
related to unhealthy diets but past depression is linked to healthy dietary patterns. It is

25

important to distinguish between past and current depression in future analyses of DII
and depression.
Sleep disturbances have been associated with the development of psychiatric
disorders and mood disturbances in various studies (Berk et al., 2013). For example,
insomnia has been prospectively associated with the development of depression (Berk et
al., 2013). Women tend to have more trouble sleeping at night and severe symptoms of
depression compared with men (Boccabella & Malouf, 2017). Sleep deprivation is
associated with neuroendocrine and neurobiological abnormalities seen in other mood
disorders, such as depression (Berk et al., 2013). It is also associated with alteration in
immune functioning that leads to alteration in pro-inflammatory cytokine levels (e.g.,
CRP, TNF-a, IL-6) (Berk et al., 2013). Cytokines can alter mood, as shown in animal
models. For instance, elimination of IL-6 and TNF-a genes in rats has led to
antidepressant-like behavior in these animals (Berk et al., 2013). Treatment of sleep
disturbances and depression lower IL-6 levels, which further suggests a possible pathway
connecting the two conditions through inhibition of neurogenesis in sleep disruption
(Berk et al., 2013). In the study by Lucas et al. (2014), which used the NHS database, the
subjects were all nurses. Previous research has shown poor diet quality among night shift
workers (Peplonska et al., 2019). As most nurses work night shifts, these results may not
be generalized to other populations. Additionally, sleep disturbances is a possible
confounder in the association of the DII and depression found in this population, as the
authors did not control for sleep in their analyses. Further, they did not control for central
obesity in their analysis. Central adiposity is associated with higher systemic
inflammation (Elks et al., 2010) and risk of chronic diseases (Li et al., 2012).
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Work by Ruiz-Canela and colleagues (2015) revealed a positive association
between high DII scores and higher central and abdominal obesity. The average age of
this population was about 62 years, indicating a majority of post-menopausal women.
Previous studies (Carr, 2003; Donato et al., 2006) have shown an increased waist
circumference and central obesity among post-menopausal women, as well as increase in
CRP levels (Vetter et al., 2013). Post-menopausal women and pre-menopausal women
who have undergone ovariectomy have higher levels of CRP compared to premenopausal
women (Abu-Taha et al., 2009; Tayefi et al., 2017). The changes in dietary intake and
CRP levels among menopausal women may exacerbate the findings for DII and
depression. Many of the studies we included in this review did not differentiate between
post-menopausal and pre-menopausal women, and many did not control for hormone
replacement therapy or procedures that may have led to early menopause, such as
ovariectomy.
1.5

Conclusions
Like many other factors, such as stress/anxiety, obesity, physical inactivity,

smoking, and sleep disturbances that exert their effects in the development of depression
through inflammation, pro-inflammatory diet is also hypothesized to be associated with
depression through its effect on systemic inflammation (Sanchez-Villegas et al., 2015;
Adjibade et al., 2017). However, the findings have been inconsistent on inflammation
linking DII to depression and other studies have reported no change in the association of
DII and depression, when controlled for circulating cytokines, such as CRP and IL-6
(Akbarly et al., 2016; Phillips et al., 2017).
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Overall, adherence to an anti-inflammatory diet is reported to be protective
against depression. However, this review shows that the DII may not be able to predict
depression in men, as well as it does in women. It is also possible that the physiology of
depression development is not related to diet among men. The age of the participants in
almost all these studies was above 35 years, with the average mean of 50 years. One of
the cohorts enrolled participants with an age range of 18-101 (Sanchez-Villegas et al.,
2015). However, the number of participants in the cohort comprised of only about 6%
men and 15% women below the age of 25 (Segui-Gomez et al., 2006). Further studies are
needed to assess these associations among younger populations.
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Table 0.1 Extended Data on the Studies Included in this Review on the Association of the DII and Depression, Continued onto Next Page

Author, Year,
Country

Study Design,
Length of FU

Participants
N
Age

Adjibade et al.
(2017), France

Prospective

3,523

SU.VI.MAX
(Supplementation
en Vitamines et
Mineraux
Antioxydants)

35-60 y
(mean
age at
baseline
49.5 y)

Sex
(%male)
42.3%

Exclusion
Criteria

Exposure
Assessment

Outcome
Assessment

Adjustments

DepS,or
treatment w/
antidepressants
at baseline,
missing CES-D
FU data, no DII
value

DII (36 of 45
items available),
using 24-hour
dietary records

DepS incidence:
CES-D 20-item
>=17 for men

Age, sex, intervention group
during trial phase, education
level, marital status, BMI, PA,
socio-professional status,
energy intake w/o alcohol,
number of 24-hr recalls,
interval between 2 CES-D
measurements, smoking
status, cancer or CVD events
during FU

Antidepressant
use in phases 3
or 5, no complete
dietary data or
covariates at
phase 7 or data
on DepS at
phases 7 and 9

DII (27 of 45
items available),
using FFQ

-

DII (28 of 45
items available),
using 24-hour
dietary recalls

CES-D 20-item
>=23 for women
Quartiles

12.6 y

Akbaraly et al.
(2016),
England

Prospective

4,246

Whitehall II
5y

Bergmans and
Malecki
(2017), USA

Cross-sectional

11,592

35-55 y
(mean
age at
baseline
60.5 y)

>20 y

74.8%

48.0%

NHANES 20072012
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Recurrent DepS:
CES-D >=16 or
antidepressant
use both at
baseline and FU

Age, ethnicity, total energy
intake, SES, marital status,
PA, smoking, alcohol, CHD,
T2DM, HTN, use of lipidlowering medications, central
obesity, cognitive impairment,
occupational grade

Depression:
PHQ-9 >=10

Age, gender, race/ethnicity,
poverty income ratio category,
employment, health insurance
status, educational status,
BMI, marital status, PA,

Tertiles

smoking, sedentary time, total
energy intake, vitamin
supplement use, menopause,
any comorbidities (CVD,
HTN, dyslipidemia,
respiratory illness, cancer)

Quintiles

Jorgensen et al.
(2018), USA

Cross-sectional

11,624

NHANES 20072012

Phillips et al.
(2017), Ireland

Cross-sectional

2,047

The Cork and
Kerry Diabetes
and Heart
Disease Study
(Phase II)

>=18 y
(mean
45.3 y)

50-69 y
(mean
59.7 y)

41.9%

49.2%

CVD (history of
heart attack,
angina, stroke,
CHD), missing
data on CVD risk
factors, diet,
depression

DII (28 of 45
items available),
using 24-hour
dietary recalls

Missing FFQ

Energy
adjusted-DII (26
of 45 items
available), using
FFQ

Depression:
PHQ-9 >=10

Age, race/ethnicity, education,
BMI, sex, PA, annual
household income,
cholesterol-lowering
medication, history of cancer,
smoking, supplement use in
the past 30 days, energy
intake

DepS:

Age, gender, BMI, smoking
and alcohol consumption, PA,
antidepressant use, history of
depression

Quartiles

CES-D 20-item
>=16

Tertiles
SalariMoghaddam et
al., (2019), Iran

Cross-sectional
The Study on the
Epidemiology of
Psychological,
Alimentary

3,363

Mean
36.3 y

41.7%

Total daily
energy intakes
outside the range
of 800-4200
kcal/d

30

DII (29 of 45
items available),
using a Willettformat dishbased 106-item
semi-

Depression:
Hospital
Anxiety and
Depression
Scale (HADS)

Age, sex, total energy intake,
marital status, education,
family size, home ownership,
antidepressant use, vitamin
supplement use, smoking,

Health and
Nutrition
(SEPAHAN)

SanchezVillegas et al.
(2015), Spain

Prospective

15,093

Seguimiento
Universidad de
Navarra (SUN)
cohort study

Mean at
baseline
38.3 y

41.3%

8.5 y

Shivappa et al.
(2016),
Australia

Prospective
Australian
Longitudinal
Study on
Women’s Health
12 y

6,438

50-55 y
(Mean
age at
baseline
52.0 y)

0

quantitative
FFQ (DS-FFQ)

and General
Health
Questionnaire
(GHQ)

physical activity, presence of
chronic conditions, BMI

>=1 not
completed FU
questionnaire,
energy intake
>4000 or <800 in
men or >3500 or
<500 kcal/d in
women, antidepressant use or
depression
diagnosis before
baseline, w/o
date of diagnosis
of depression
incidence

DII (28 of 45
items available),
using FFQ

Depression
incidence:

Age, sex, BMI, cumulative
average for DII (at baseline
and after 10 years of FU),
energy intake, prevalence of
disease, smoking, PA during
leisure time, use of vitamin
supplement, presence of CVD,
T2DM, HTN, dyslipidemia at
baseline

History of DepS
(CES-D >=10)
before baseline,
missing data on
baseline diet
intake or DepS
dur FU, or
missing data on
relevant
confounders

DII (26 of 45
items available),
using FFQ
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Quintiles

Self-reported
physiciandiagnosed
depression,
and/or habitual
use of antidepressants

Depression
incidence:
CES-D 10-item
>=10

Quartiles

Energy intake, smoking, BMI,
highest education completed,
marital status, PA, menopause
status, night sweats, personal
illness or injury, depression
diagnosis or treatment

Shivappa et al.
(2018)a, USA

Prospective

3,648

Mean
60.6 y

43.2%

Osteoarthritis
Initiative (OAI)
8y

Shivappa et al.,
(2018)b, Iran

Wirth et al.
(2017), USA

Cross-sectional

Cross-sectional
NHANES 20052012

300

18,875

15-18 y

Mean 47
y

0

49%

Missing baseline
data for CES-D,
having DepS at
baseline, missing
data for DII, total
energy
consumption
>4200 or <800
for men and
>3800 or <500
kcal/d for
women

DII (24 of 45
items available),
using FFQ

Major depression
and anxiety
disorder, use of
anti-depressant
or sedative
medication,
following a
special diet

DII (31 of 45
items available),
using a 168item FFQ

Lack of dietary
information, lack
of PHQ-9,
caloric intake
<100 kcal

DII (27 of 45
items available),
using 24-hour
dietary recalls

CES-D 20-item
>16

Quartiles

Depression:
Depression,
Anxiety, and
Stress Scale
(DASS)

Age, sex, race, BMI,
education, smoking habits,
yearly income, Physical
Activity Scale for Elderly
score, Charlson comorbidity
index, CES-D at baseline,
statins use, and NSAIDs or
cortisone use

Physical activity, BMI,
presence of chronic disease,
smoking, salary, marital status

Tertiles

Quartiles
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DepS incidence:

Depression:
PHQ-9 >=10

Age, race, marital status, WC,
perceived health, education,
current infection status,
smoking, family history of
smoking, past cancer
diagnosis, average nightly
sleep duration

BMI: body mass index; CES-D: Center for Epidemiologic Studies-Depression Scale; CHD: coronary heart disease; CRP: C-reactive protein; CVD: cardiovascular disease; DepS:
depressive symptoms; DII: Dietary Inflammatory Index; FFQ: food frequency questionnaire; FU: follow-up; HDL: high density lipoprotein; HTN: hypertension; IL-6: interleukin6; MHI-5: Mental Health Index score 5; NHANES: National Health and Nutrition Examination Survey; PA: physical activity; SES: socio-economic status; PHQ-9: 9-item Patient
Health Questionnaire; T2DM: type 2 diabetes mellitus; TNF-a: tumor necrosis factor alpha; TNFR2: tumor necrosis factor alpha receptor 2; w/: with; WC: waist circumference;
w/o: without

33

CHAPTER 2
2

2.1

MEDIATING EFFECT OF INFLAMMATION ON THE ASSOCIATION OF
DIETARY INFLAMMATORY INDEX AND DEPRESSION
Abstract

Depression affects 8% of adults in America and is one of the leading causes of disability
in Western countries. The Dietary Inflammatory Index (DII) has previously been
associated with inflammation and depression in separate analyses. However, no study to
date has looked at the potential mediating effect of inflammation on the association of
DII and depression. We used the cross-sectional National Health and Nutrition
Examination Survey (NHANES) 2005-2010 database to assess these associations. Our
analysis included 10,022 participants aged 20 years and older. Inflammation was assessed
by C-Reactive Protein (CRP) levels. Contrasting the highest to lowest DII quartiles, the
total effect of DII on depression was 1.21 units (95% CI 0.99-1.44, P<0.001) of which
0.08 units were explained by the mediating effect of CRP (95% CI 0.05-0.11, P<0.001) in
the age- and sex-adjusted model. After further adjusting for the remainder of our
covariates (race/ethnicity, BMI, waist circumference, marital status, education, smoking,
poverty-to-income ratio, and physical activity), CRP explained 0.02 units (95% CI 0.310.78, P=0.005) out of 0.55 (95% CI 0.006-0.03, P<0.001). No mediation association was
found in the sex-stratified models. Further studies are needed to assess the associations
with various inflammatory biomarkers in larger and more diverse populations.
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2.2

Introduction
Depression, characterized by changes in mood, and cognitive and physical

symptoms, affects about 8% of adults aged 20 and older in America (CDC, 2018).
According to the World Health Organization, major depressive disorder (MDD) is the
leading cause of disability worldwide (WHO 2012). The global economic burden of
MDD rose 21.5% from 2005 to 2010, increasing from $173.2 billion to $210.5 billion per
year (Greenberg et al., 2015). In 2000, the economic burden of depression was $83
billion in the United States (Greenberg et al., 2015). In 2010, for every dollar spent on its
direct costs, $1.90 was spent on the indirect costs of MDD (e.g., lost income, extra social
security payments) (Schoefield et al., 2019) (APA). Depression is a chronic disease
associated with major comorbidities, such as cardiovascular disease (CVD), diabetes, and
cancer (Lucas et al., 2014; Sanches-Villegas et al., 2015), as well as global disability
(Akbaraly et al., 2016), and mortality (Wirth, 2017). Depression is also a
psychoneuroimmunological disorder (Cepeda et al., 2016) associated with chronic
inflammation and cell-mediated immune activation (Leonard & Maes, 2012). Higher
levels of inflammatory markers, such as C-Reactive Protein (CRP), Tumor Necrosis
Factor-alpha (TNF-a), Interleukin (IL)-1, and IL-6, have been observed in the serum and
cerebrospinal fluid of individuals with MDD, where no other medical condition was
present (Makhija & Karunakaran, 2013).
Previous research has shown increased risk/incidence of depression in association
with the Western diet and decreased risk/incidence of depression with the Mediterranean
diet (Cavicchia et al., 2009; Lucas et al., 2014; Phillips et al., 2017; Shivappa et al., 2014;
Tabung et al., 2015). Adherence to Western dietary patterns has been linked to higher
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levels of pro-inflammatory biomarkers (e.g., CRP, TNF-a, IL-6) and adherence to the
Mediterranean diet pattern to higher levels anti-inflammatory (e.g., IL-10) biomarkers
(Cavicchia et al., 2009; Na et al., 2017; Tabung et al., 2016; Shivappa et al., 2014; Wirth
et al., 2017). The Dietary Inflammatory Index (DII) was developed to assess the
inflammatory potential of diets in relation to inflammation and chronic diseases. This
index evaluates the correlations of all pro- and anti-inflammatory dietary components
with inflammatory markers in conjunction with each other. Data have been inconsistent
regarding DII and depression. Higher DII scores (i.e., more pro-inflammatory) have been
positively linked to depression among women in some studies (Sanchez-Villegas et al.,
2015; Shivappa et al., 2016; Akbaraly et al., 2016; Lucas et al., 2014), whereas other
studies have found marginally significant findings in men only (Adjibade et al., 2017).
Overall, previous studies have shown separate correlations between DII with
inflammation and depression. To the best of our knowledge, no study has examined the
mediation role of inflammatory biomarkers on the association of DII and depression,
including results from NHANES. Part of our aim was to confirm whether the association
between the DII and depression is explained by markers of inflammation, such as CRP.
Most studies to date have focused on older adults. This may be due to the fact that CRP is
mainly studied in the context of cardiovascular disease (CVD) (Copeland et al., 2012).
This older population provides an opportunity to study chronic or recurrent depression
and a higher dose of depression that may accrue with age over a lifetime (Copeland et al.,
2012). Many studies have incorporated populations with diseases in their studies (Na et
al., 2017); more studies are needed to examine the association of DII and inflammation in
healthy and younger populations.
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Depression can manifest itself with sickness symptoms, such as fatigue, pain,
appetite changes, and sleep disturbance (Derry et al., 2015; Hickman et al., 2014). These
are referred to as somatic symptoms of depression which can also be symptoms of
systemic inflammation (Derry et al., 2015). Somatic and non-somatic symptoms have
different effects on the course of diseases. For example, the presence of somatic
symptoms, such as sleep disturbances, may exacerbate inflammation by further
increasing CRP and IL-6 levels, compared with those without sleep disturbances (Derry
et al., 2015). Somatic symptoms are overall correlated with higher levels of CRP, IL-6,
and TNF-a (Duivis et al, 2013). A different study found sP-selectin, an inflammatory
marker, a predictor for somatic symptoms and pain among depressed individuals (Bai et
al., 2014). Among heart failure patients, somatic and affective depression symptoms have
been associated with increases in different cytokines (Kupper et al., 2012). The increase
in pro-inflammatory cytokines may also worsen depressive symptoms. Assessing the risk
factors and the etiology for the different symptoms of depression will help identify the
biological factors related to specific symptoms, which may be due to different underlying
clinical conditions (Faraj, 2017; NCHS). For instance, white cell count predicted somatic
depression among patients with acute coronary heart disease, who had no history of
depression (Steptoe et al., 2013). Overall, somatic depressive symptoms are more
prevalent among women (NCHS). Higher somatic symptoms over the past two years
significantly predicted an increase in TNF-a among women with depression (Dannehl et
al., 2014). The association of DII with somatic and cognitive symptoms of depression has
not been studied before. As discussed above, somatic symptoms are related to higher pro-
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inflammatory cytokines. The mediation effect of inflammation on the association of DII
and somatic symptoms have not been previously studied.
The main aims of this study were to: 1) assess the relation of DII with depression
and its subtypes in a large population of men and women; and 2) determine the extent to
which observed associations are mediated by a single marker of inflammation (CRP). We
used the National Health and Nutrition Examination Survey (NHANES) 2005-2010
database.
2.3

Subjects and Methods
NHANES is a nationally representative cross-sectional study, which collects data

from new participants every two years. We chose three cycles of data collected between
2005 and 2010, where data were available on diet and CRP, and included the Patient
Health Questionnaire (PHQ)-9. There were 31,034 observations available in the
NHANES 2005-2010 database. We excluded those who had missing age data (N=2,035)
and restricted our analysis to adults (i.e.,  20 years, as defined by NHANES)
[N=20,625]. We excluded participants who were pregnant (N=462), as this population
has different dietary intake patterns, as well as different inflammation and depression
levels compared to the general population. We further excluded those who had CRP
levels above 10 mg/L (N=1,486), as this is an indicator of acute inflammation or
medication use (Akbaraly et al., 2016).
2.3.1 Assessment of Exposure: Diet
Of the 20,163 remaining observations, we restricted our analysis to those who had
data on two days of dietary intake and excluded 3,135 who either had one day of dietary
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data or no dietary data. Participants’ dietary intake was assessed using two 24-hour
dietary recalls (24DR), which have been previously validated. Karvetii and Knuts (1985)
compared one-day 24-hour recall with observed food intake. They reported the productmoment correlation coefficient between the recall and observed for intake between 0.58
and 0.74, with women having more accurate results than men. In a study by Yuan and
colleagues (2017), self-administered 24-hour recall’s performance in assessing dietary
intake was similar to 7-day dietary record (7DDRs), adjusting for within-person
variation. A study published by USDA (Rhodes et al., 2003), using biomarker data
assessed the validity USDA’s Automated Multiple Pass Method (AMPM), which is used
for collecting 24-hr dietary recalls in NHANES. They reported over 80% of their
participants were acceptable reporters (i.e., those within 95% confidence limits). Overall,
24-hour recalls have validity on a group level and large groups of subjects, but not on the
individual level (Beer-Borst & Amado, 1995; Karvetti & Knuts, 1985; Posner et al.,
1982). This instrument can be used to validate estimates of dietary intake, when less
detailed assessment tools, such as Food Frequency Questionnaires (FFQs), are used as the
main dietary assessment tool (NCI, 2020). The NCI’s 24-hour dietary recall validation
report notes underestimation of true intake by 3-34%, and underreporting of protein 1128%. Aside from protein, there are limited reports for the other DII components, due to
lack of recovery biomarkers (i.e., directly related to intake and not subject to
homeostasis) for these components.
The inflammatory potential of the diet was assessed using the DII. This dietary
assessment tool was created using nearly 2000 articles published from 1950 to 2010 that
assessed the association of dietary components on six inflammatory biomarkers (i.e., IL-
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1B, IL-4, IL-6, IL-10, TNF-a, and CRP). The articles were assigned a score based on
study design. The DII is comprised of 45 items (36 nutrients and nine foods), including
macronutrients, micronutrients, and flavonoids. Construct validity of the DII was
established using the SEASONS study and CRP as the validator. The association of DII
and inflammation has been assessed in 18 studies to date, where many found positive
associations between DII with CRP (Shivappa et al., 2014; Wirth et al., 2014; Xu et al.,
2014; Kizil et al., 2016; Boden et al., 2017; Na et al., 2017; Shivappa et al., 2017; Tabung
et al., 2017; Shivappa et al., 2018), IL-6 (Shivappa et al., 2015; Boden et al., 2017;
Tabung et al., 2016; Almeida-de-Souza et al., 2017; Tabung et al., 2017), IL-4 (ZamoraRos et al., 2015), TNF-a (Tabung et al., 2016; Tabung et al., 2017), and overall
inflammatory score (Almeida-de-Souza et al., 2017). Shivappa et al. (2017) found
significant negative associations between DII and IL-1, an anti-inflammatory biomarker,
and negative associations with INF-y that did not reach significance in the analysis.
However, several researchers found no associations between DII with CRP (Shivappa et
al., 2015; Kizil et al., 2016; Tabung et al., 2016; Almeida-de-Souza et al., 2017; Shin et
al., 2017) or with IL-6, IL-8, and PPARG (Zamora-Ros et al., 2015). It should be noted
that most of these studies have been with older populations.
To calculate the DII scores, we created a z-score for each food item. For this, we
subtracted the standard world means, provided by the creators of the DII, from our study
participants’ intakes. Then, we divided the result by the world means’ standard deviation,
also provided by the creators of DII, to create the z-score (Shivappa et al., 2014). The
standard world mean and the standard deviations are the range of intakes of food derived
from 11 nutritional databases from different parts of the world (Wirth et al., 2014). These
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means allow us to compare the individuals’ intakes from our database to be compared
relative to range of intakes by diverse populations (Shivappa et al., 2014). The z-score
was then transformed to a percentile to minimize right skewing, which is common in
dietary data. We centered the percentile by doubling the value and subtracting 1 from the
result to reduce the odds of skewing. Then, we multiplied it by the inflammatory effect
score of the corresponding food item to calculate the food item-specific DII score for
each participant. The food item-specific scores for each food item of DII were summed to
create an overall DII score for each participant. The higher the DII score, the more proinflammatory the diet is, and the more negative the score, the more anti-inflammatory the
participant’s diet is.
Using the 24-hour recall of NHANES dataset, 27 of the 45 DII diet components
were available in our analysis to calculate the DII score (Table 2.1). These dietary
components included: energy, carbohydrate, protein, total fat, alcohol, caffeine, fiber,
cholesterol, saturated fat, monounsaturated fatty acid (MUFA), polyunsaturated fatty acid
(PUFA), omega-3, omega-6, iron, magnesium, zinc, selenium, niacin, thiamin, riboflavin,
folic acid, beta-carotene, and vitamins B12, B6, A, C, and E. Vitamin D intake was only
available for 2007-2008 and 2009-2010 cycles. We performed a sub-analysis with these
cycles, where the DII included vitamin D values as well. However, results of the subanalysis did not differ from the analysis of all cycles (i.e., 2005-2010); therefore, we only
reported analysis from all cycles.
We categorized the DII scores into quartiles (Q1, Q2, Q3, Q4), which allowed us
to compare extreme levels of inflammatory potential of the diet and minimize nondifferential misclassifications of exposure.
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2.3.2 Assessment of Outcome: Depression
NHANES used the PHQ-9 to assess depressive symptoms. We had PHQ-9 data
available on 10,966 participants. PHQ-9 is an instrument used for diagnoses of depressive
disorders in primary care (Kroenke et al., 2001). It has nine items that are based on the
criteria of the fourth edition of the Diagnostic and Statistical Manual of Mental Diseases
(DSM-IV) for diagnosis of major depressive disorder (CSAT 2008; Kroenke et al., 2001).
PHQ-9 has been validated in two different studies, on a total of 6,000 patients in 15
different health clinics (Spitzer et al., 1999; Spitzer et al., 2000). It has a diagnostic
validity comparable to the clinician-administered PRIME-MD (Kroenke & Spitzer,
2006), which is the first instrument developed for use in primary care that diagnoses
specific mental disorders using the DSM-IV diagnostic criteria (Spitzer et al., 1999).
PHQ-9 has been validated and a score of 10 has a sensitivity of 88% and a specificity of
88% for diagnosing moderate-to-severe depression (Kroenke et al., 2001).
Responses to all nine items are coded on a four-point scale (Not at all = 0, Several
days = 1, More than half the days = 2, Nearly every day = 3). The score for all 9 items are
totaled to make the PHQ-9 Score with the minimum and maximum total scores of 0 and
27, respectively, and with higher scores representing more severe symptoms. We
considered major depression as present if five or more items were identified for at least
“more than half the days” in the past two weeks, with one of the symptoms being
depressed mood or anhedonia (i.e., absence of enjoyment, motivation, and interest)
(Cooper et al., 2018; Kroenke et al., 2001). If the final item of PHQ-9 (i.e., suicidality)
was present at all, even for “several days,” it was counted in the diagnosis as part of the
five items. The score was also used in categorizing the severity of depression: 0-4 = no
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depression, 5-9 = mild depression, 10-14 = moderate depression, 15-19 = moderately
severe, and 20-27 = severe depression. We combined the first two and the last three
categories to dichotomize PHQ-9 scores into no-to-mild and moderate-to-severe
depression, using cut-points of <10, and  10, respectively. The somatic sub-score was
calculated by summing the PHQ-9 items on sleep disturbance, fatigue, appetite changes,
and psychomotor retardation/agitation (Case & Stewart, 2014). The cognitive-affective
sub-score was calculated by summing the remaining five items on the PHQ-9, including
anhedonia, depressed mood, low self-esteem, concentration problems, and suicidal
ideation (Case & Stewart, 2014).
2.3.3 Assessment of Outcome: Inflammation
The NHANES data provide participants’ CRP levels as a measure of the body’s
response to inflammation. CRP data were available for all adult participants included in
our study. Blood samples were collected in the NHANES Mobile Examination Center
after at least a 9-hour fast. Blood specimens after collection were processed and sent to
the University of Washington in Seattle to be processed. CRP was quantified by latexenhanced nephelometry. For the quantification of CRP, particles consisting of a
polystyrene core and a hydrophilic shell were used to link anti-CRP antibodies
covalently. A dilute solution of test sample was mixed with latex particles coated with
mouse monoclonal anti-CRP antibodies. CRP present in the test sample forms an antigen
antibody complex with the latex particles. CRP concentrations were calculated using a
calibration curve. The lower detection limit for CRP is 0.2 ng/ml. If the values were
below the limit of detection, the value for that value would be the detection limit divided
by the square root of two (https://wwwn.cdc.gov/Nchs/NHANES/200943

2010/CRP_F.htm). We used CRP in our study both as a continuous variable in the
mediation analysis, and a dichotomous variable in other analyses based on previous
studies that consider CRP levels above 3 mg/L indicative of high-risk for chronic disease
(Shivappa et al., 2015).
2.3.4 Assessment of Covariates
Our continuous variables were age, poverty-to-income ratio (PIR), and physical
activity (PA). Our categorical variables included sex, race, BMI, waist circumference,
marital status, education, diabetes, and smoking. Among the remaining participants, after
excluding those with missing data on depression and diet (N=10,966), there was no
missing data on sex, race, or waist circumference, We excluded 65 who had missing data
on BMI, 381 on marital status, and 9 on diabetes. We further excluded 376 missing on
smoking and nine on education After excluding the missing data for these covariates,
10,022 observations remained for analysis. However, 711 on PIR and 1,060 on PA
remained missing. To avoid further exclusions and losing statistical power, we addressed
the missing data on PA and PIR by creating quartiles for each of these variables, with an
additional fifth category for the missing.
2.3.5 Statistical Analysis
We used histograms to assess the normality of distribution of exposure and
outcome variable, and scatter plots to assess the linearity of association between
covariates and our exposure and outcomes. Pairwise correlations and variance inflation
factor were used to test for possible collinearity between variables. For the distribution of
subject characteristics, t tests were used for continuous covariate across categories of DII,
CRP, and depression. For the categorical covariates, we used Chi2 test for our
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dichotomous outcomes (i.e., CRP and depression) and one-way ANOVA to assess
distribution across DII quartiles.
Linear regression models were used for continuous outcomes: CRP, total
depression score, and somatic and affective depression. Logistic regression was used for
dichotomous outcomes: CRP (cutoff at 3 mg/L), major depression, and depression
severity (i.e., no-to-mild and moderate-to-severe). Predicted probability test was
conducted to assess the probability of our dichotomous outcomes (i.e., CRP, major
depression, moderate-to-severe depression) at different levels of DII. After assessing the
direct effect of DII on depression, we further explored the indirect (i.e., mediating) effect
of inflammation on the association of DII and depression. This analysis assessed how
much of the relationship between DII and depression was explained by the intervening
effect of CRP and other inflammatory biomarkers. Structural equation modeling (SEM)
was used to perform the mediation analysis. Inflammatory biomarkers and depression
scores were entered in our analysis models as continuous variables and DII was used as a
continuous and categorical (i.e., quartiles) variable in separate models.
We built three regression models for each outcome: Model 1 was age and sex
adjusted; for Model 2 we used the likelihood ratio test to identify the most parsimonious
model; and Model 3, was our fully-adjusted model that included age, sex, race/ethnicity,
BMI, waist circumference, marital status, education, diabetes, smoking, poverty-toincome ratio, and physical activity. In this paper, we only report the results for Model 1
and Model 3 in the text, as the results for Model 2 did not substantially differ from Model
3.
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CRP is a biomarker used in predicting future CVD events (Jorgensen et al., 2018).
CVD may increase depression risk and it is suggested that CVD and depression have a
bidirectional association (Jorgensen et al., 2018). We examined the multiplicative
interaction of CVD and DII in our regression models, as well as stratifying our results by
CVD status. We also entered the multiplicative interaction of inflammatory conditions
(i.e., asthma, arthritis) and DII in the models.
All statistical analysis tests were conducted using the STATA Statistical Software
(StataCorp. 2017. Stata Statistical Software: Release 16. College Station, TX: StataCorp
LLC). P-value less than 0.05 was considered as statistically significant.
2.4
2.4.1

Results
Population Characteristics
After restricting our results to non-pregnant adults and excluding those who had

missing or incomplete information on diet, CRP, PHQ-9, and any of our covariates, we
had 10,022 participants in our analyses. The mean DII score for our population was -0.39
(SD 1.84), which indicates a slightly pro-inflammatory diet. The range of DII score in
Q1, Q2, Q3, and Q4 was -5.25 to -1.77, -1.76 to -0.44, -0.43 to 0.99, and 1.00 to 4.49,
respectively. The mean CRP score was 2.44 mg/L (SD 2.26), where the range was 0.1 9.9 mg/L, and the mean total depression score was 3.03 (SD 4.12), where the score
ranged between 0 and 27. The range for somatic depression was 0-12 and the mean 1.82
(SD 2.29), and for cognitive-affective depression the range was 0-15 and mean was 1.21
(SD 2.21). Participants in Q4 of DII compared to Q1 had higher BMI and waist
circumference, were less educated, and were less physically active. Further, they were
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more likely to be female, non-White, single or divorced, current or past smoker, and have
pre-diabetes or diabetes (Table 2.2).
2.4.2

Inflammation
In Model 1, continuous CRP levels was higher in Q2, Q3, and Q4 compared to

Q1, our referent (Q4 vs. Q1 𝛽: 0.57; 95% CI: 0.45, 0.70; P-trend = 0.001); in Model 2
and Model 3 the coefficients were attenuated but remained significant (Q4 vs. Q1 𝛽:
0.22; 95% CI: 0.10, 0.35; P-trend = 0.001; and 𝛽: 0.21; 95% CI: 0.08-0.33; P-trend =
0.002, respectively). In the sex stratified models, the associations were significant in
Model 1 for both men and women (Q4 vs. Q1 𝛽: 0.46; 95% CI, 0.29, 0.63, P-trend
<0.001; and 𝛽: 0.74; 95% CI: 0.54, 0.93; P-trend < 0.001). However, while the
association remained significant for women (Q4 vs. Q1 𝛽: 0.28; 95% CI: 0.09, 0.47; Ptrend = 0.007), it was no longer significant among men in the fully adjusted model (Q4
vs. Q1 𝛽: 0.14; 95% CI: -0.03, 0.30; P-trend = 0.170) (Table 2.3).
When CRP was entered in the models as a dichotomous outcome, we found
significant associations in Model 1 (Q4 vs. Q1 OR = 1.55; 95% CI, 1.36, 1.76; P-trend
<0.001). We found similar results in our sex-stratified models (Q4 vs. Q1 OR = 1.50;
95% CI, 1.24, 1.80; P-trend <0.001; and OR = 1.62; 95% CI, 1.34, 1.94; P-trend <0.001,
for men and women, respectively). No significant association was found in Model 2 or
the fully adjusted models (Table 2.4).
2.4.3 Depression
First, we assessed depression as a continuous outcome. Comparing DII Q4 to Q1
in the fully adjusted models, the associations were only significant in the total population
47

(B = 0.47, 95% CI 0.24-0.70, P <0.001) and among women (B = 0.72, 95% CI 0.34-1.10,
P<0.001) but not among men (Table 2.5). Similar results were found for somatic
depression, where beta was 0.21 (95% CI 0.08-0.34, P = 0.001) for the total population
and 0.34 (95% CI 0.13-0.55, P = 0.001) for women (Table 2.6). The same pattern was
found for cognitive-affective depression with beta being 0.26 (95% CI 0.13-0.38, P =
0.001) in the total population and 0.37 (95% CI 0.17-0.58, P <0.001) in women (Table
2.7).
The odds of probable major depression was positive and significant among all
groups (Table 2.8). In the age and sex adjusted model for the whole population, the odds
of having major depression compared to Q1 for Q2, Q3, and Q4 was 2.2, 2.8, and 4.2 (Ptrend <0.001), respectively. However, in the fully-adjusted model, the ORs attenuated
with adjustment for covariates and the ORs for Q2, Q3, and Q4 were 1.8, 2.0, and 2.4 (Ptrend <0.001), respectively. Sex-stratified results suggest stronger associations in women
and a dose-response, which is not present in men. Among men, the odds of having major
depression compared to Q1, in Q2, Q3, and Q4 in the age-adjusted model was 2.2, 2.5,
and 3.1 (P-trend <0.001), respectively, and in the fully-adjusted model was 1.7 for all (Ptrend = 0.042). Among women, the odds of having major depression compared to Q1, in
Q2, Q3, and Q4 in the age-adjusted model was 2.4, 3.5, and 5.5 (P-trend <0.001) and in
the fully-adjusted model was 2.0, 2.5, and 3.3 (P-trend <0.001), respectively. The results
in Model 2 were similar to the fully-adjusted model (Table 2.8). Similar results were seen
for the odds of having moderate-to-severe depression, but the OR was slightly smaller
(Table 2.9).
2.4.4 Predicted Probabilities
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We assessed predicted probability, contrasting the lowest (i.e., -5) and highest
(i.e., +4) levels of DII. The probability of having major depression went from 1.3% to
12% in the total sample, 1.4% to 9% in men, and 1.3% to 15% in women in the ageadjusted model (Figure 2.1). In the fully adjusted model, it went from 2.2% to 8% in the
total sample, 2.3% to 5.3% in men, and 2.2% to 10.5% in women (Figure 2.2).
We further evaluated the predicted probability of having moderate-to-severe
depression when comparing DII of -5 to +4. The probability went from 2.8% to 18.1% in
the total sample, 2.7% to 13.6% in men, and 3% to 22.3% in women in the unadjusted
model (Figure 2.3). In the fully adjusted model, it went from 4.6% to 12.3% in the total
sample, 4.3% to 8.5% in men, and 5% to 16.1% in women (Figure 2.4).
2.4.5 Mediation Analysis
In our mediation analysis, comparing Q4 of DII to Q1, the total effect on the
increase in total depression score was 1.21 (95% 0.99-1.44, P-trend <0.001) in the age
and sex adjusted model, of which only 0.08 (95% CI 0.05-0.11, P-trend <0.001) was
explained by the indirect effect of CRP (Table 2.10). In the fully adjusted model, the
results for Q2 and Q3 were similar, with only 0.01 points of indirect effect of CRP
explaining the 0.20 change in depression (95% CI, 0.001, 0.02; P-trend = 0.005). As in
Q4, out of 0.20 change in total depression, only 0.02 (95% CI 0.006-0.03, P-trend =
0.005) of the total effect (B=0.55, 95% CI 0.31-0.78, P-trend <0.001) was explained by
the indirect effect of CRP. In terms of ratio, only 3% of total change was attributed to the
indirect (i.e., mediation) effect of CRP. No significant indirect effects of CRP were in our
sex-stratified models (Table 2.10). Looking at somatic depression as outcome, comparing
DII Q4 to Q1, 0.01 units (95% CI 0.005-0.02, P-trend = 0.002) out of 0.25 (95% CI 0.1249

0.38, P-trend <0.001) was explained by the indirect effect of CRP, which accounts for 4%
of total change in somatic depression. Results were not significant in the fully-adjusted,
sex-stratified models (Table 2.11). For cognitive depression, 0.007 (95% CI 0.0004-0.01,
P-trend = 0.036) out of 0.29 (95% CI 0.16-0.41, P-trend <0.001) were explained by CRP,
respectively, accounting for 6% of total change in cognitive depression. Similar to total
and somatic depression, results were not significant in sex-stratified models (Table 2.12).
2.4.6 Sensitivity Analysis
We entered the interaction term of CRP and BMI in the model, which had a
significant role on the association of DII and CRP.
We further examined the multiplicative interaction of CVD and DII in our
regression models. We did not find the interaction term significant. After stratifying
models by CVD status (i.e., have CVD [n = 716], do not have CVD [n = 9,306]), we did
not find any significant associations between the DII and different types of depression
among those who had CVD. The predicted probability of major depression or severe
depression was not different among those with CVD compared with those who did not
have CVD. We did not find any difference in the coefficients and the standard errors
when comparing the models with the interaction term with those without it.
When we entered the multiplicative interaction of inflammatory conditions (i.e.,
asthma, arthritis) and DII in the models, the interaction term was significant in models
with CRP and depression as outcomes. When stratified results by having inflammatory
conditions, the odds of having high CRP levels (>3 mg/dl) was 6% higher (P = 0.005) in
those with the inflammatory condition and only 1% higher (P = 0.317) in those without
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the condition. We compared participant who had inflammatory conditions to those who
did not. Our results showed that the beta coefficient for overall continuous depression, as
well as affective depression, was higher among those with inflammatory conditions
compared to those without. However, DII had significant associations with somatic
depression only among those with inflammatory conditions.
2.5

Discussion
In this cross-sectional study, we found significant associations between the DII

and different types of depression. CRP did not explain the association between DII and
any type of depression. To date, 13 epidemiological studies -- seven prospective (Lucas
et al., 2014; Sanchez-Villegas et al., 2015; Akbaraly et al., 2016; Shivappa et al., 2016;
Adjibade et al., 2017; Shivappa et al., 2018a; Vermeulen et al., 2018) and six crosssectional (Bergmans & Malecki, 2017; Phillips et al., 2017; Wirth et al., 2017; Jorgensen
et al, 2018; Shivappa et al., 2018b; Salari-Moghaddam et al., 2019) -- have assessed the
association between inflammatory potential of the diet and depression. It is noteworthy
that Lucas et al. (2014) and Vermeulen et al. (2018) used reduced rank regression to
identify dietary patterns associated with inflammatory biomarker levels, instead of the
DII. All the studies found significant associations between higher DII scores and higher
likelihood of developing depression or having depressive symptoms. However,
Vermeulen and colleagues (2018) compared the lowest to the highest quartile of dietary
pattern and found an inverse association between an inflammatory dietary pattern (i.e.,
high in pasta, sugar-sweetened beverages, processed meat, chocolates and sweets) and the
odds of depression occurrence (OR = 0.56, 95% CI, 0.40 – 0.94). With the exception of
five studies (Sanchez-Villegas et al., 2015; Bergmans & Malecki, 2017; Jorgensen et al.,
51

2018; Vermeulen et al., 2018) that found significant results in the whole population
including both men and women, most associations were either only significant among
females (Akbaraly et al., 2016; Wirth et al., 2017) or were significant in all participants,
but remained significant only in women after stratifying by sex (Phillips et al., 2017).
Two studies’ populations only consisted of women (Shivappa et al., 2016; Shivappa et
al., 2018b). One study’s results were not modified by the interaction term with sex
(Bergmans & Malecki, 2017) and one study did not stratify their results by sex
(Jorgensen et al., 2018). Similar to most of these findings, our results on the association
of DII and depression remained significant only among women after stratifying by sex. In
contrast to all other studies and our results, Adjibade et al. (2017) found marginally
significant associations between DII and incidence of depressive symptoms only among
men and not among women. The authors attributed this observation potentially to the
higher cases of false-positives among women. They further surmised that diet may have a
smaller role in the development of depression among women than it does in men, and that
depression in women may be due to hormonal fluctuations rather than diet. The mean and
the standard deviation of age for women in this study was 47.6  6.4, which is close to
the age of menopausal transition when many women become vulnerable to developing
depression (Kahn et al., 2001).
Pro-inflammatory diets may lead to the leaky gut and bacterial translocation,
which may eventually lead to depression (Slyepchenko et al., 2016; Shivappa et al.,
2018). Recently, bacterial translocation due to “leaky gut” has been suggested as a
possible role in the development of inflammation and subsequently depression (Berk et
al., 2013). The plasma levels of IgA and/or IgM are increased in depression compared to
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healthy subjects, in response to lipopolysaccharides (LPS), which is part of the bacterial
wall of gram negative bacteria that are found in the normal gut flora (Berk et al., 2013;
Makhija & Karunakaran, 2013). LPS can activate molecules, such as nuclear factor (NF)kB, which leads to activation of production of pro-inflammatory cytokines (e.g., TNFa,
IL-1, COX-2) (Berk et al., 2013). The same pathway may increase the production of
oxidative stress factors, such as nitric oxide (Berk et al., 2013). Bacterial translocation is
thought to be a primary cause in the onset of depression, because it can increase
inflammation. The resulted inflammation can further exacerbate depression, leading to a
vicious cycle (Berk et al., 2013).
Cytokines can also stimulate the hypothalamic pituitary adrenal (HPA)-axis and
lead to the release of stress hormones, through which corticotropin releasing hormone
and cortisol may induce depression symptoms (Ekmekcioglu, 2012). Further, when there
are leaky parts in the blood-brain barrier, pro-inflammatory cytokines can damage the
central nervous system through various pathways, such as decreasing neurogenesis and
dysregulating glial/neuronal interactions (Adjibade et al., 2017; Ekmekcioglu, 2012).
Diets are thought to affect depression via changes on neurotransmitters, oxidative stress,
and the HPA axis (Wirth et al., 2017). Diets that induce inflammation, such as the
Western diet, have also been associated with neuro-inflammation (Wirth et al., 2017).
Previous research has shown depression accompanied with oxidative and
nitrosative stress, as well as an increase in inflammatory biomarkers (Berk et al., 2013).
The mechanism through which diet quality and mental disorders are associated has been
suggested to be through the effect of dietary components on inflammation (Berk et al.,
2013). Different prospective studies among both women and men, such as the Nurses’

53

Health Study or the Health Professionals Follow-up Study (HPFS), have shown higher
levels of CRP and IL-6 with the consumption of the Western diet, characterized as being
high in red and processed meat and refined carbohydrates. However, a Mediterranean diet
high in fruit, vegetables, and whole grains was associated with reduced levels of CRP and
IL-6, with the latter only seen among women (Berk et al., 2013). After stratifying our
results by sex, we did not find any significant associations between the DII and CRP
among men. Although the DII is an indicator of a healthy diet high in fiber and omega-3
fatty acids, similar to the Mediterranean diet, the different scoring system of DII may
partially explain the difference in findings. For example, not only does DII incorporate
food items (e.g., fiber) and macronutrients (e.g., fat), it also includes micronutrients and
energy intake. Further, our analysis was cross-sectional and looked at diet and CRP at a
point in time. However, findings from HPFS look at the prospective effect of diet and its
change over time on CRP levels.
In separate models (not reported) of the regression analysis assessing the
correlation of the DII with depression, we adjusted the models by CRP levels in addition
to other covariates. The association of DII with depression remained unchanged and
significant, similar to previous studies (Akbaraly et al., 2016; Sanchez-Villegas et al.,
2015; Phillips et al., 2017; Shivappa et al., 2016). This further confirms our findings for
the mediation of CRP that were not biologically meaningful and suggest that the DII is
independently related to depression. This is despite our results showing a significant
correlation between CRP levels and depression in the fully adjusted models. Longitudinal
studies are therefore needed to look at the lifetime or long-term effects of inflammatory
potential of diet on chronic inflammation and depression, as these conditions typically
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take years to develop. Previous studies have also reported changes in cytokine levels
among the depressed, but suggested that the link between DII and depression was
independent of the difference in cytokine levels (Shivappa et al., 2018). A randomized
controlled trial has shown a decrease in depressive symptoms with the consumption of
the Mediterranean diet (Jacka et al., 2017; Shivappa et al., 2018). One of the possible
explanations for the association of diet and depression, regardless of inflammatory
profile, may be that healthier diets can act as proxy measures for an overall healthy
lifestyle. Another possible explanation for why we did not find biologically meaningful
mediation effects is that we do not know if the correlation between inflammation and
depression is causative (Belmaker and Agam, 2008; Dantzer et al., 1999; Lucas et al.,
2014). Based on a meta-analysis, the association of inflammation and depression may be
bidirectional (Howren et al., 2009; Lucas et al., 2014).
Our findings from the sensitivity analysis we performed showed that DII was
significantly associated with somatic depression only among those who had inflammatory
conditions. One possible explanation is the overlap of the symptoms of somatic
depression and inflammatory conditions, such as fatigue. This may have led to the
symptoms of inflammatory conditions mistaken for somatic depression. It is also possible
that an inflammatory diet may exacerbate somatic symptoms only in those with an
inflammatory condition.
We did not find any differences in the association of DII and depression when we
stratified our results by CVD status. A possible reason for our null findings is the small
sample size of the sub-group with CVD. It is also possible that individuals with CVD are
on an altered diet due to their health condition that is not representative of the diet they
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had been following throughout their lives that may have been more inflammatory and
possibly led to the development of depression. In the future, it would be helpful to use
prospective studies and test the association of lifetime dietary intakes of individuals with
incident CVD and depression.
A key strength of our study is that it included a large sample size. This was the
first study to examine the mediating effect of CRP on the association of DII and
depression. Further, it was the first time to our knowledge that the sub-categories of
depression (i.e., somatic) were assessed in relation to DII. The 24-hour Dietary Recalls
are the “gold standard” for dietary data collection and a validated PHQ-9 questionnaire
was used to assess depression.
Our study had several limitations. It had a cross-sectional design; thus, we were
not able to infer temporality between the associations of DII with CRP or depression. We
also had several missing items on the DII; however, the number of items we had was
similar to previous studies. We did not have data on clinically diagnosed depression. We
were not able to control for antidepressant or anti-inflammatory medication use in our
models, or to perform sensitivity analysis based on medication use, because of the
complicated formatting of data available on medication use in NHANES. Nondifferential
misclassification of the DII and depression was possible. However, due to the use of
validated questionnaires, as well as looking across extreme categories of DII (i.e.,
quartiles) or depression (i.e., major depression, moderate-to-severe depression, clinically
diagnosed depression), the likelihood of occurrence of misclassifications is minimal.
Another possible issue is selection bias and the difference between our excluded and
included populations. Those who were excluded were less likely to be White, married or
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with partner, or have higher education. Comparing the crude analysis of DII with having
high CRP among included and excluded samples, for each unit increase in the DII the
odds of having high CRP increased by 2% in the included and 12% in the excluded. Our
selection criteria may have biased our results towards the null when looking at CRP as
our outcome. No differences were observed in the results for the crude association of DII
with depression.
2.6

Future Directions
More studies are needed to examine the association of different types of

depression and inflammatory biomarkers using a more diverse population. Using
longitudinal datasets to look at the effect of lifetime change in the DII on its association
with inflammation and depression is also warranted. Our study did not confirm that the
association of DII and depression is via CRP-associated immune function. One possible
explanation is that the DII is not a strong dietary assessment tool in evaluating the
inflammatory potential of diets, which would reflect the inflammatory biomarker levels.
It is not clear what other pathway may mediate the correlation between DII and
depression. DII may be an indicator of an overall healthy diet or other healthy habits that
may be related to depression (e.g., physical activity, social support). As mentioned above,
due to the cross-sectional design of our study, it is possible that depression may lead to
unhealthy behaviors, such as unhealthy dietary habits. Diet may be related to depression
via other pathways, such as the neuroendocrine pathways affecting neurotransmitters,
neurohormones, and the HPA axis. For example, the surplus of metabolites, such as
QUIN, due to excessive breakdown of tryptophan can lead to over-activity of the HPAaxis, which has been shown to influence the development of major depression (Adler et
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al., 2008; Allison et al., 2014). More studies are needed to confirm these hypotheses.
Overall, lifetime consumption of an anti-inflammatory diet may be protective against the
development of depression among adults.
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Table 2.1 Food parameters included in the dietary inflammatory index, inflammatory effect scores, and global intake
values, Shivappa et al. (2014)a, Continued onto Next Page
Food Parameter

Overall Inflammatory Effect Score

Global Daily Mean Intake

SD

-0.278

13.98

3.72

Vitamin B12 (ug)

0.106

5.15

2.7

Vitamin B6 (mg)

-0.365

1.47

0.74

Beta-Carotene (ug)

-0.584

3718

1720

Caffeine (g)

-0.11

8.05

6.67

Carbohydrate (g)

0.097

272.2

40

Cholesterol (mg)

0.11

279.4

51.2

Energy (kcal)

0.18

2056

338

0.298

71.4

19.4

-0.663

18.8

4.9

Folic acid (ug)

-0.19

273

70.7

Iron (mg)

0.032

13.35

3.71

Magnesium (mg)

-0.484

310.1

139.4

MUFA (g)

-0.009

27

6.1

Niacin (mg)

-0.246

25.9

11.77

n-3 Fatty acids (g)

-0.436

1.06

1.06

n-6 Fatty acids (g)

-0.159

10.8

7.5

Protein (g)

0.021

79.4

13.9

PUFA (g)

-0.337

13.88

3.76

Riboflavin (mg)

-0.068

1.7

0.79

Saturated fat (g)

0.373

28.6

8

Selenium (ug)

-0.191

67

25.1

Thiamin (mg)

-0.098

1.7

0.66

Vitamin A (RE)

-0.401

983.9

518.6

Available in NHANES and Included in Analysis
Alcohol (g)

Total fat (g)
Fiber (g)
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Vitamin C (mg)

-0.424

118.2

43.46

Vitamin D (ug) b

-0.446

6.26

2.21

Vitamin E (mg)

-0.419

8.73

1.49

Zinc (mg)

-0.313

9.84

2.19

Eugenol (mg)

-0.140

0.01

0.08

Garlic (g)

-0.412

4.35

2.90

Ginger (g)

-0.453

59.0

63.2

Green/black tea (g)

-0.536

1.69

1.53

Flavan-3-ol (mg)

-0.415

95.8

85.9

Flavones (mg)

-0.616

1.55

0.07

Flavonols (mg)

-0.467

17.7

6.79

-0.25

11.7

3.82

Anthocyanidins (mg)

-0.131

18.05

21.14

Isoflavones (mg)

-0.593

1.20

0.20

Onion (g)

-0.301

35.9

18.4

Pepper (g)

-0.131

10.00

7.07

Saffron (g)

-0.140

0.37

1.78

Thyme/oregano (mg)

-0.102

0.33

0.99

0.229

3.15

3.75

Turmeric (mg)

-0.785

533.6

754.3

Rosemary (mg)

-0.013

1.00

15.00

Not Available in NHANES and Not Included in Analysis

Flavonones (mg)

Trans fat (g)

a.
b.

Shivappa, N., Steck, S. E., Hurley, T. G., Hussey, J. R., & Hébert, J. R. (2014). Designing and developing a
literature-derived, population-based dietary inflammatory index. Public health nutrition, 17(8), 1689-1696.
Vitamin D only available in 2009 and 2010 NHANES cycles
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Table 2.2 Subject characteristics by Dietary Inflammatory Index (DII) quartiles, among 10,022 Participants from the
National Health and Nutrition Evaluation Study 2005-2010, Continued onto Next Page
DII Quartiles
n (%)
Q1

Q2

Q3

Q4

2,510 (25.01%)

2,509 (25.0%)

2,509 (25.0%)

2,509 (25.0%)

Subject Characteristics

Mean (SD)

Mean (SD)

Mean (SD)

Mean (SD)

Age (y)

49.9 (16.2)

48.9 (16.3)

48.8 (16.8)

48.7 (17.4)

Physical Activity (MET-minutes)*

980 (1522)

825 (1676)

606 (1329)

540 (1178)

Poverty-to-Income Ratio *

3.2 (1.6)

2.8 (1.6)

2.5 (1.5)

2.1 (1.4)

Dietary Inflammatory Index Scores

-2.7 (0.6)

-1.1 (0.3)

0.2 (0.4)

2.0 (0.8)

n (%)

n (%)

n (%)

n (%)

1,670 (66.5)

1,392 (55.5)

1,136 (45.3)

908 (36.2)

Female

839 (33.4)

1,113 (44.4)

1,369 (54.6)

1,595 (63.7)

White

1,510 (60.1)

1,284 (51.2)

1,155 (46.1)

1,116 (44.6)

Hispanic

544 (21.6)

721 (28.7)

722 (28.8)

709 (28.3)

Black

338 (13.4)

400 (15.9)

531 (21.2)

594 (23.7)

Multiracial

117 (4.6)

100 (4.0)

97 (3.8)

84 (3.3)

Never smoker

1,342 (53.5)

1,376 (54.9)

1,364 (54.4)

1,202 (48.0)

Ever smoker

1,167 (46.5)

1,129 (45.0)

1,141 (45.5)

1,301 (51.9)

1,723 (68.6)

1,667 (66.5)

1,585 (63.2)

1,432 (57.2)

Divorced/Widowed/Separated

410 (16.3)

472 (18.8)

508 (20.2)

600 (23.9)

Single (Never married)

376 (15.0)

366 (14.6)

412 (16.4)

471 (18.8)

31 (1.2)

29 (1.1)

32 (1.2)

59 (2.3)

783 (31.2)

682 (27.2)

666 (26.6)

653 (26.1)

Subject Characteristics
Sex
Male

Race

Smoking

Marital Status
Married/Partner

BMI
Underweight
Normal Weight
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Overweight

947 (37.7)

926 (36.9)

877 (35.0)

830 (33.1)

Obese

748 (29.8)

868 (34.6)

930 (37.1)

961 (38.4)

Low Risk

1,278 (50.9)

1,077 (43.0)

999 (39.8)

935 (37.3)

High Risk

1,231 (49.0)

1,428 (57.0)

1,506 (60.1)

1,568 (62.6)

Below HS

393 (15.6)

572 (22.8)

725 (28.9)

943 (37.6)

HS Degree

507 (20.2)

563 (22.4)

637 (25.4)

670 (26.7)

Some College/AA

716 (28.5)

772 (30.8)

705 (28.1)

642 (25.6)

College Grad & Higher

893 (35.6)

598 (23.8)

438 (17.5)

248 (9.9)

1

394 (15.7)

525 (20.9)

611 (24.4)

827 (33.0)

2

486 (19.3)

534 (21.3)

620 (24.7)

669 (26.7)

3

584 (23.2)

628 (25.0)

601 (24.0)

519 (20.7)

4

889 (35.4)

649 (25.9)

484 (19.3)

313 (12.5)

5 (Missing)

156 (6.2)

169 (6.7)

189 (7.5)

175 (7.0)

1

674 (26.8)

857 (34.2)

1,009 (40.2)

1,103 (44.0)

2

255 (10.1)

277 (11.0)

284 (11.3)

267 (10.6)

3

611 (24.3)

528 (21.0)

462 (18.4)

420 (16.7)

4

792 (31.5)

597 (23.8)

460 (18.3)

389 (15.5)

5 (Missing)

177 (7.0)

246 (9.8)

290 (11.5)

324 (12.9)

2,275 (90.6)

2,192 (87.5)

2,168 (86.5)

2,141 (85.5)

234 (9.3)

313 (12.5)

337 (13.4)

362 (14.4)

WC

Education Level

Quartiles of PIR

Quartiles of PA

Diabetes
Not Present
Borderline/ Diabetic

P values from ANOVA and chi-square tests <0.05 for all comparisons, except for age (P=0.063)
* N for Physical Activity=8,985
* N for Poverty-to-Income Ratio= 9,333
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Table 2.3 Estimated Beta Coefficient and Standard Errors for the Association of Dietary Inflammatory Index
Quartiles * and Continuous CRP Levels (mg/L), among 10,022 Participants from the National Health and Nutrition
Evaluation Study 2005-2010, Continued onto Next Page
Model 1a

Model 2b

Beta (SE)

95% CI

Beta (SE)

95% CI

Quartile 1

Referent

-

Referent

-

Quartile 2

0.30 (0.06)

0.18-0.43

0.13 (0.06)

Quartile 3

0.39 (0.06)

0.27-0.52

Quartile 4

0.58 (0.06)

0.45-0.71

Model 3c
Beta (SE)

95% CI

All (N=10,022)

P-trend

Referent

-

0.02-0.25

0.12 (0.06)

0.01-0.24

0.12 (0.06)

0.008-0.24

0.11 (0.06)

-0.003-0.23

0.22 (0.06)

0.10-0.35

0.21 (0.06)

0.08-0.33

<0.001

0.001

0.002

Male (N=5,106)
Quartile 1

Referent

-

Referent

-

Quartile 2

0.19 (0.07)

Quartile 3
Quartile 4

0.04-0.34

0.07 (0.07)

0.27 (0.08)

0.11-0.43

0.46 (0.08)

0.29-0.63

P-trend

Referent

-

-0.07-0.21

0.06 (0.07)

-0.08-0.20

0.03 (0.07)

-0.12-0.18

0.02 (0.07)

-0.13-0.17

0.14 (0.08)

-0.02-0.31

0.14 (0.08)

-0.03-0.30

<0.001

0.134

0.170

Female (N=4,916)
Quartile 1

Referent

-

Quartile 2

0.50 (0.10)

Quartile 3
Quartile 4
P-trend

Referent

-

Referent

-

0.29-0.71

0.20 (0.09)

0.01-0.40

0.19 (0.09)

0.001-0.39

0.57 (0.10)

0.37-0.77

0.22 (0.09)

0.03-0.41

0.21 (0.09)

0.02-0.39

0.74 (0.10)

0.54-0.93

0.30 (0.09)

0.12-0.49

0.28 (0.09)

0.09-0.47

<0.001

0.003

0.007

* The range of DII quartiles: Q1= -5.25 to -1.77, Q2 = -1.76 to -0.44, Q3 = -0.43 to 0.99, and Q4 = 1.00 to 4.49

a.

Model 1: Adjusted for age and sex (not controlled for sex in stratified models)
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b.

c.

Model 2: Adjusted for age, sex, race (White, Hispanic, Black, Multiracial), BMI (underweight, normal
weight, overweight, obese), WC (low risk, high risk), marital status (Married/Partner,
Divorced/Widowed/Separated, Never married), smoking (never smoker, ever smoker), PIR (quartiles), PA
(quartiles)
Model 3: Adjusted for age, sex, race (White, Hispanic, Black, Multiracial), BMI (underweight, normal
weight, overweight, obese), WC (low risk, high risk), marital status (Married/Partner,
Divorced/Widowed/Separated, Never married), education (Below high school, high school degree, some
college/AA, college grad and higher), diabetes (None diabetic, borderline/diabetic), smoking (never
smoker, ever smoker), PIR (quartiles), PA (quartiles)

Table 2.4 Estimated Odds Ratio for the Association of Dietary Inflammatory Index Quartiles and Risk of High CRP
Levels (>3 mg/L)*, among 10,022 Participants from the National Health and Nutrition Evaluation Study 2005-2010,
Continued onto Next Page
Model 1a

Model 2b

Odds
Ratio

95% CI

Odds
Ratio

Quartile 1

1

-

1

Quartile 2

1.25

1.10-1.42

Quartile 3

1.38

Quartile 4

1.55

95% CI

Model 3c
Odds
Ratio

95% CI

-

1

-

1.08

0.95-1.24

1.07

0.94-1.23

1.22-1.57

1.10

0.96-1.26

1.09

0.95-1.25

1.36-1.76

1.15

0.99-1.32

1.13

0.98-1.30

All (N=10,022)

P-trend

<0.001

0.062

0.086

Male (N=5,106)
Quartile 1

1

-

1

-

1

-

Quartile 2

1.22

1.03-1.45

1.11

0.93-1.32

1.10

0.92-1.32

Quartile 3

1.24

1.04-1.49

0.99

0.82-1.20

0.99

0.82-1.20

Quartile 4

1.50

1.24-1.80

1.13

0.93-1.38

1.13

0.92-1.38

P-trend

<0.001

0.371

0.404

Female (N=4,916)
Quartile 1

1

-

1
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-

1

-

Quartile 2

1.30

1.07-1.59

1.02

0.82-1.27

1.00

0.81-1.25

Quartile 3

1.52

1.26-1.84

1.15

0.94-1.42

1.13

0.92-1.39

Quartile 4

1.62

1.34-1.94

1.14

0.92-1.40

1.11

0.90-1.37

P-trend

<0.001

0.134

0.201

* Those with CRP above 10 mg/L have been excluded.
a. Model 1: Adjusted for age and sex (not controlled for sex in stratified models)
b. Model 2: Adjusted for age, sex, race (White, Hispanic, Black, Multiracial), BMI (underweight, normal weight,
overweight, obese), WC (low risk, high risk), smoking (never smoker, ever smoker), PIR (quartiles), PA
(quartiles)
c. Model 3: Adjusted for age, sex, race (White, Hispanic, Black, Multiracial), BMI (underweight, normal weight,
overweight, obese), WC (low risk, high risk), marital status (Married/Partner, Divorced/Widowed/Separated,
Never married), education (Below high school, high school degree, some college/AA, college grad and higher),
diabetes (None diabetic, borderline/diabetic), smoking (never smoker, ever smoker), PIR (quartiles), PA
(quartiles)
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Table 2.5 Estimated Beta and Standard Errors for the Effects of Dietary Inflammatory Index Quartiles and
Depression Symptom Score*, among 10,022 Participants from the National Health and Nutrition Evaluation Study
2005-2010, Continued onto Next Page
Model 1a

Model 2b

Model 3c

Beta (SE)

95% CI

Beta (SE)

95% CI

Quartile 1

Referent

-

Referent

Quartile 2

0.44 (0.11)

0.21-0.66

Quartile 3

0.61 (0.11)

0.38-0.84

0.16 (0.11)

-0.06-0.39

Quartile 4

1.21 (0.11)

0.98-1.44

0.47 (0.11)

0.24-0.70

Beta (SE)

95% CI

All (N=10,022)

P-trend

0.19 (0.11)

<0.001

-

Referent

-

Referent

-

-0.02-0.41

<0.001

Male (N=5,106)
Quartile 1

Referent

-

Referent

-

Quartile 2

0.38 (0.13)

0.12-0.64

0.19 (0.13)

-0.06-0.45

Quartile 3

0.46 (0.14)

0.19-0.74

0.13 (0.14)

-0.14-0.40

Quartile 4

0.79 (0.15)

0.49-1.08

0.22 (0.15)

-0.08-0.52

P-trend

<0.001

0.184

Female (N=4,916)
Quartile 1

Referent

-

Quartile 2

0.59 (0.20)

Quartile 3
Quartile 4
P-trend

a.
b.

Referent

-

0.20-0.99

0.27 (0.19)

-0.10-0.66

0.87 (0.19)

0.49-1.25

0.29 (0.19)

-0.08-0.67

1.63 (0.19)

1.26-2.00

0.72 (0.19)

0.34-1.10

<0.001

Referent

-

<0.001

* Range of Score: 0-27
Model 1: Adjusted for age and sex (not controlled for sex in stratified models)
Model 2: Adjusted for age, sex, race (White, Hispanic, Black, Multiracial), BMI (underweight, normal
weight, overweight, obese), WC (low risk, high risk), marital status (Married/Partner,
Divorced/Widowed/Separated, Never married), education (Below high school, high school degree, some
college/AA, college grad and higher), smoking (never smoker, ever smoker), PIR (quartiles), PA (quartiles)
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c.

Model 3 did not differ from Model 2.

Table 2.6 Estimated Beta and Standard Errors for the Effects of Dietary Inflammatory Index Quartiles and Score for
Somatic Symptoms of Depression *, among 10,022 Participants from the National Health and Nutrition Evaluation
Study 2005-2010, Continued onto Next Page
Model 1a

Model 2b

Model 3

Beta (SE)

95% CI

Beta (SE)

95% CI

Quartile 1

Referent

-

Referent

Quartile 2

0.23 (0.06)

0.11-0.36

Quartile 3

0.28 (0.06)

0.15-0.40

0.06 (0.06)

-0.06-0.19

Quartile 4

0.57 (0.06)

0.44-0.70

0.21 (0.06)

0.08-0.34

Beta (SE)

95% CI

All (N=10,022)

P-trend

0.11 (0.06)

<0.001

-

Referent

-

Referent

-

-0.004-0.24

0.005

Male (N=5,106)
Quartile 1

Referent

-

Referent

-

Quartile 2

0.20 (0.07)

0.05-0.35

0.12 (0.07)

-0.02-0.26

Quartile 3

0.20 (0.08)

0.04-0.35

0.04 (0.08)

-0.11-0.20

Quartile 4

0.35 (0.08)

0.18-0.51

0.08 (0.08)

-0.09-0.25

P-trend

<0.001

0.470

Female (N=4,916)
Quartile 1

Referent

-

Referent

-

Quartile 2

0.32 (0.11)

0.10-0.54

0.16 (0.10)

-0.05-0.37

Quartile 3

0.42 (0.10)

0.21-0.63

0.13 (0.10)

-0.07-0.34

Quartile 4

0.80 (0.10)

0.59-1.00

0.34 (0.10)

0.13-0.55

P-trend

<0.001

0.001

* Range of Score: 0-12
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Referent

-

a.
b.

Model 1: Adjusted for age and sex (not controlled for sex in stratified models)
Model 2: Adjusted for age, sex, race (White, Hispanic, Black, Multiracial), BMI (underweight, normal
weight, overweight, obese), WC (low risk, high risk), marital status (Married/Partner,
Divorced/Widowed/Separated, Never married), education (Below high school, high school degree, some
college/AA, college grad and higher), smoking (never smoker, ever smoker), PIR (quartiles), PA (quartiles)

Table 2.7 Estimated Beta and Standard Errors for the Effects of Dietary Inflammatory Index Quartiles and Score for
Cognitive Symptoms of Depression *, among 10,022 Participants from the National Health and Nutrition Evaluation
Study 2005-2010, Continued onto Next Page
Model 1a

Model 2b

Beta (SE)

95% CI

Beta (SE)

Quartile 1

Referent

-

Referent

Quartile 2

0.20 (0.06)

0.08-0.32

Quartile 3

0.32 (0.06)

0.20-0.45

Quartile 4

0.63 (0.06)

0.51-0.76

Model 3
95% CI

Beta (SE)

95% CI

All (N=10,022)

P-trend

Referent

-

-0.04-0.19

0.07 (0.06)

-0.04-0.19

0.09 (0.06)

-0.02-0.22

0.10 (0.06)

-0.02-0.22

0.26 (0.06)

0.13-0.38

0.26 (0.06)

0.13-0.38

0.07 (0.06)

<0.001

-

<0.001

<0.001

Male (N=5,106)
Quartile 1

Referent

-

Referent

-

Quartile 2

0.17 (0.07)

Quartile 3
Quartile 4

0.03-0.31

0.06 (0.07)

0.27 (0.07)

0.12-0.41

0.44 (0.08)

0.28-0.60

P-trend

Referent

-

-0.07-0.20

0.07 (0.07)

-0.06-0.21

0.08 (0.07)

-0.06-0.23

0.08 (0.07)

-0.06-0.23

0.13 (0.08)

-0.02-0.30

0.14 (0.08)

-0.02-0.30

<0.001

0.097

0.093

Female (N=4,916)
Quartile 1

Referent

-

Referent

-

Quartile 2

0.27 (0.10)

Quartile 3
Quartile 4

0.06-0.49

0.12 (0.10)

-0.08-0.33

0.12 (0.10)

-0.09-0.32

0.44 (0.10)

0.24-0.65

0.16 (0.10)

-0.04-0.36

0.15 (0.10)

-0.04-0.36

0.83 (0.10)

0.63-1.03

0.37 (0.10)

0.17-0.58

0.37 (0.10)

0.17-0.58
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Referent

-

P-trend

a.
b.

c.

<0.001

<0.001

<0.001

* Range of Score: 0-15
Model 1: Adjusted for age and sex (not controlled for sex in stratified models)
Model 2: Adjusted for age, sex, race (White, Hispanic, Black, Multiracial), BMI (underweight, normal
weight, overweight, obese), WC (low risk, high risk), marital status (Married/Partner,
Divorced/Widowed/Separated, Never married), education (Below high school, high school degree, some
college/AA, college grad and higher), smoking (never smoker, ever smoker), PIR (quartiles), PA (quartiles)
Model 3: Adjusted for age, sex, BMI (underweight, normal weight, overweight, obese), marital status
(Married/Partner, Divorced/Widowed/Separated, Never married), education (Below high school, high
school degree, some college/AA, college grad and higher), smoking (never smoker, ever smoker), PIR
(quartiles), PA (quartiles)

Table 2.8 Estimated Odds Ratio for the Association of Dietary Inflammatory Index Quartiles and Risk of Probably
Major Depression, among 10,022 Participants from the National Health and Nutrition Evaluation Study 2005-2010,
Continued onto Next Page
Model 1a
Odds
Ratio

95% CI

Quartile 1

1

-

Quartile 2

2.2

Quartile 3
Quartile 4

Model 2b
Odds
Ratio

Model 3c

95% CI

Odds
Ratio

95% CI

All (N=10,022)
1

-

1.5-3.2

1.8

2.8

2.0-4.0

4.2

3.0-5.8

P-trend

1

-

1.3-2.6

1.8

1.3-2.6

2.0

1.4-2.9

2.0

1.4-2.9

2.5

1.7-3.5

2.4

1.7-3.4

<0.001

<0.001

<0.001

Male (N=5,106)
Quartile 1

1

-

Quartile 2

2.2

Quartile 3
Quartile 4
P-trend

1

-

1

-

1.4-3.5

1.7

1.1-2.7

1.7

1.1-2.8

2.5

1.6-3.9

1.7

1.0-2.8

1.7

1.1-2.8

3.1

1.9-4.9

1.7

1.1-2.8

1.7

1.0-2.8

<0.001

0.042

Female (N=4,916)

69

0.051

Quartile 1

1

-

1

-

Quartile 2

2.4

Quartile 3
Quartile 4

1.3-4.4

2.0

3.5

2.0-6.1

5.5

3.2-9.5

P-trend

a.
b.

c.

1

-

1.1-3.7

2.0

1.1-3.7

2.5

1.4-4.5

2.5

1.4-4.4

3.4

1.9-5.9

3.3

1.9-5.8

<0.001

<0.001

<0.001

Model 1: Adjusted for age and sex (not controlled for sex in stratified models)
Model 2: Adjusted for age, sex, WC (low risk, high risk), marital status (Married/Partner,
Divorced/Widowed/Separated, Never married), education (Below high school, high school degree, some
college/AA, college grad and higher), smoking (never smoker, ever smoker), PIR (quartiles), PA (quartiles)
Model 3: Adjusted for age, sex, race (White, Hispanic, Black, Multiracial), BMI (underweight, normal
weight, overweight, obese), WC (low risk, high risk), marital status (Married/Partner,
Divorced/Widowed/Separated, Never married), education (Below high school, high school degree, some
college/AA, college grad and higher), smoking (never smoker, ever smoker), PIR (quartiles), PA (quartiles)

Table 2.9 Estimated Odds Ratio for the Association of Dietary Inflammatory Index Quartiles and Risk of Probably
Moderate or Severe Depression, among 10,022 Participants from the National Health and Nutrition Evaluation
Study 2005-2010, Continued onto Next Page
Model 1a
Crude
OR

95% CI

Quartile 1

1

-

Quartile 2

1.7

Quartile 3
Quartile 4

Model 2b
Adjusted
OR

Model 3c

95% CI

Adjusted
OR

95% CI

All (N=10,022)
1

-

1.3-2.2

1.4

2.1

1.7-2.7

3.1

2.4-3.9

P-trend

1

-

1.1-1.8

1.4

1.1-1.8

1.5

1.2-2.0

1.5

1.2-2.0

1.8

1.4-2.4

1.8

1.4-2.4

<0.001

<0.001

<0.001

Male (N=5,106)
Quartile 1

1

-

1

-

Quartile 2

1.5

Quartile 3

1.8

1.0-2.1

1.2

1.3-2.5

1.3
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1

-

0.8-1.7

1.23

0.8-1.7

0.1-1.8

1.29

0.9-1.8

Quartile 4

2.4

1.7-3.4

P-trend

1.4

<0.001

1.0-2.0

1.43

1.0-2.0

0.032

0.047

Female (N=4,916)
Quartile 1

1

-

Quartile 2

2.1

Quartile 3
Quartile 4
P-trend

a.
b.

c.

1

-

1

-

1.4-3.2

1.7

1.1-2.7

1.7

1.1-2.6

2.8

1.9-4.1

2.0

1.3-3.0

2.0

1.3-3.0

4.0

2.8-5.9

2.5

1.7-3.6

2.4

1.7-3.6

<0.001

<0.001

<0.001

Model 1: Adjusted for age and sex (not controlled for sex in stratified models)
Model 2: Adjusted for age, sex, BMI (underweight, normal weight, overweight, obese), WC (low risk, high
risk), marital status (Married/Partner, Divorced/Widowed/Separated, Never married), education (Below
high school, high school degree, some college/AA, college grad and higher), smoking (never smoker, ever
smoker), PIR (quartiles), PA (quartiles)
Model 3: Adjusted for age, sex, race (White, Hispanic, Black, Multiracial), BMI (underweight, normal
weight, overweight, obese), WC (low risk, high risk), marital status (Married/Partner,
Divorced/Widowed/Separated, Never married), education (Below high school, high school degree, some
college/AA, college grad and higher), smoking (never smoker, ever smoker), PIR (quartiles), PA (quartiles)
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Table 2.10 Mediation Results Examining CRP as a Mediator of the Relationship between Dietary Inflammatory Index (DII) Quartiles and Depression
Symptom Score Using Structural Equation Modeling (SEM), among Participants from the National Health and Nutrition Evaluation Survey 2005-2010,
Continued onto Next Page
DII
Quartiles

Total effect
coefficient (SE)

95% CI

Direct effect
coefficient (SE)

95% CI

Indirect effect
coefficient (SE)
[CRP]

95% CI

Indirect/Total
Effect

All (N=10,022)
Adjusted for age and sex
1 (referent)
2

0.44 (0.09)

0.24-0.63

0.39 (0.09)

0.20-0.59

0.04 (0.01)

0.02-0.06

0.09

3

0.61 (0.10)

0.41-0.82

0.55 (0.10)

0.35-0.76

0.05 (0.01)

0.03-0.08

0.08

4

1.21 (0.11)

0.99-1.44

1.13 (0.11)

0.90-1.36

0.08 (0.01)

0.05-0.11

0.06

P-trend

<0.001

<0.001

<0.001

Fully Adjusted *
1 (referent)
2

0.20 (0.09)

0.01-0.39

0.19 (0.09)

0.006-0.38

0.01 (0.005)

0.001-0.02

0.05

3

0.20 (0.10)

-0.002-0.40

0.18 (0.10)

-0.01-0.39

0.01 (0.005)

0.001-0.02

0.05

4

0.55 (0.11)

0.31-0.78

0.52 (0.11)

0.29-0.76

0.02 (0.007)

0.006-0.03

0.03

P-trend

<0.001

<0.001

Male (N=5,106)
Adjusted for age
1 (referent)
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0.005

2

0.39 (0.12)

0.14-0.63

0.36 (0.12)

0.11-0.60

0.03 (0.01)

0.005-0.05

0.07

3

0.47 (0.13)

0.21-0.74

0.43 (0.13)

0.16-0.70

0.04 (0.01)

0.01-0.07

0.08

4

0.80 (0.16)

0.48-1.12

0.73 (0.16)

0.41-1.05

0.07 (0.02)

0.03-0.11

0.08

P-trend

<0.001

<0.001

<0.001

Fully Adjusted *
1 (referent)
2

0.21 (0.12)

-0.02-0.45

0.20 (0.12)

-0.03-0.44

0.01 (0.009)

-0.007-0.02

0.04

3

0.18 (0.13)

-0.08-0.45

0.18 (0.13)

-0.08-0.44

0.008 (0.01)

-0.01-0.02

0.04

4

0.31 (0.16)

-0.008-0.64

0.29 (0.16)

-0.03-0.61

0.02 (0.01)

-0.0001-0.04

0.06

P-trend

0.058

0.078

0.064

Female (N=4,916)
Adjusted for age
1 (referent)
2

0.60 (0.16)

0.28-0.92

0.53 (0.16)

0.21-0.85

0.06 (0.02)

0.02-0.10

0.1

3

0.87 (0.16)

0.55-1.19

0.80 (0.16)

0.48-1.11

0.07 (0.02)

0.03-0.11

0.08

4

1.63 (0.17)

1.30-1.96

1.53 (0.17)

1.20-1.86

0.09 (0.02)

0.04-0.14

0.05

P-trend

<0.001

<0.001

<0.001

Fully Adjusted *
1 (referent)
2

0.27 (0.15)

-0.03-0.58

0.27 (0.15)

-0.04-0.57

73

0.007 (0.007)

-0.007-0.02

0.02

3

0.31 (0.15)

-0.0003-0.62

0.30 (0.16)

-0.009-0.61

0.008 (0.008)

-0.007-0.02

0.02

4

0.75 (0.17)

0.42-1.09

0.74 (0.17)

0.40-1.08

0.01 (0.01)

-0.01-0.03

0.01

P-trend

<0.001

<0.001

0.311

* Adjusted for age, sex, CRP, race (White, Hispanic, Black, Multiracial), BMI (underweight, normal weight, overweight, obese), WC (low risk,
high risk), marital status (Married/Partner, Divorced/Widowed/Separated, Never married), education (Below high school, high school degree,
some college/AA, college grad and higher), smoking (never smoker, ever smoker), PIR (quartiles), PA (quartiles)

Table 2.11 Mediation Results Examining CRP as a Mediator of the Relationship between Dietary Inflammatory Index (DII) Quartiles and Score for
Somatic Symptoms of Depression Using Structural Equation Modeling (SEM), among Participants from the National Health and Nutrition Examination
Survey 2005-2010, Continued onto Next Page
DII
Quartiles

Total effect
coefficient (SE)

95% CI

Direct effect
coefficient (SE)

95% CI

Indirect effect
coefficient (SE)
[CRP]

95% CI

Indirect/Total
Effect

All (N=10,022)
Adjusted for age
1 (referent)
2

0.24 (0.05)

0.12-0.35

0.21 (0.05)

0.10-0.32

0.02 (0.006)

0.01-0.04

0.08

3

0.28 (0.06)

0.17-0.40

0.25 (0.06)

0.13-0.36

0.03 (0.006)

0.02-0.04

0.10

4

0.58 (0.06)

0.45-0.70

0.53 (0.06)

0.40-0.65

0.05 (0.008)

0.03-0.06

0.08

P-trend

<0.001

<0.001

Fully Adjusted *
1 (referent)
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<0.001

2

0.12 (0.05)

0.01-0.23

0.19 (0.09)

0.006-0.38

0.008 (0.003)

0.001-0.01

0.06

3

0.08 (0.06)

-0.03-0.20

0.18 (0.10)

-0.01-0.39

0.008 (0.003)

0.001-0.01

0.10

4

0.25 (0.06)

0.12-0.38

0.52 (0.11)

0.29-0.76

0.01 (0.004)

0.005-0.02

0.04

P-trend

0.001

0.002

0.001

Male (N=5,106)
Adjusted for age
1 (referent)
2

0.21 (0.07)

0.07-0.35

0.19 (0.07)

0.05-0.33

0.02 (0.008)

0.003-0.03

0.09

3

0.20 (0.07)

0.05-0.35

0.17 (0.07)

0.02-0.32

0.02 (0.009)

0.01-0.04

0.10

4

0.36 (0.09)

0.18-0.54

0.31 (0.09)

0.13-0.49

0.05 (0.01)

0.02-0.07

0.13

P-trend

<0.001

<0.001

0.001

Fully Adjusted *
1 (referent)
2

0.12 (0.07)

-0.01-0.26

0.11 (0.07)

-0.02-0.25

0.007 (0.006)

-0.005-0.02

0.06

3

0.06 (0.07)

-0.08-0.22

0.06 (0.07)

-0.09-0.21

0.005 (0.006)

-0.007-0.02

0.08

4

0.12 (0.09)

-0.05-0.31

0.11 (0.09)

-0.07-0.29

0.01 (0.008)

0.0005-0.03

0.08

P-trend

0.225

0.292

Female (N=4,916)
Adjusted for age
1 (referent)
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0.055

2

0.32 (0.09)

0.13-0.51

0.28 (0.09)

0.09-0.47

0.03 (0.01)

0.01-0.05

0.09

3

0.43 (0.09)

0.24-0.61

0.38 (0.09)

0.20-0.57

0.04 (0.01)

0.02-0.06

0.09

4

0.80 (0.09)

0.61-0.98

0.74 (0.09)

0.56-0.93

0.05 (0.01)

0.02-0.08

0.06

P-trend

<0.001

<0.001

<0.001

Fully Adjusted *
1 (referent)
2

0.16 (0.09)

-0.02-0.34

0.15 (0.09)

-0.02-0.34

0.004 (0.004)

-0.003-0.01

0.02

3

0.15 (0.09)

-0.02-0.33

0.14 (0.09)

-0.03-0.32

0.005 (0.004)

-0.003-0.01

0.03

4

0.37 (0.09)

0.18-0.56

0.36 (0.09)

0.17-0.56

0.006 (0.006)

-0.004-0.01

0.01

P-trend

<0.001

<0.001

0.251

Table 2.12 Mediation Results Examining CRP as a Mediator of the Relationship between Dietary Inflammatory Index (DII) Quartiles and Score for
Cognitive Symptoms of Depression Using Structural Equation Modeling (SEM), among 10,022 Participants from the National Health and Nutrition
Examination Survey 2005-2010, Continued onto Next Page
DII
Quartiles

Total effect
coefficient (SE)

95% CI

Direct effect
coefficient (SE)

95% CI

Indirect effect
coefficient (SE)
[CRP]

95% CI

Indirect/Total
Effect

All (N=10,022)
Adjusted for age
1 (referent)
2

0.20 (0.05)

0.09-0.30

0.18 (0.05)

0.07-0.28
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0.01 (0.004)

0.007-0.02

0.05

3

0.31 (0.05)

0.20-0.43

0.29 (0.05)

0.18-0.40

0.02 (0.005)

0.01-0.03

0.06

4

0.62 (0.06)

0.50-0.75

0.59 (0.06)

0.47-0.72

0.03 (0.007)

0.01-0.04

0.04

P-trend

<0.001

<0.001

<0.001

Fully Adjusted *
1 (referent)
2

0.08 (0.05)

-0.01-0.18

0.08 (0.05)

-0.02-0.18

0.004 (0.002)

-0.0004-0.008

0.05

3

0.11 (0.05)

0.005-0.22

0.11 (0.05)

0.001-0.22

0.01 (0.002)

-0.0003-0.009

0.09

4

0.29 (0.06)

0.16-0.41

0.28 (0.06)

0.16-0.41

0.02 (0.003)

0.0004-0.01

0.06

P-trend

<0.001

<0.001

0.038

Male (N=5,106)
Adjusted for age
1 (referent)
2

0.18 (0.06)

0.05-0.31

0.16 (0.06)

0.03-0.30

0.01 (0.005)

0.0009-0.02

0.05

3

0.27 (0.07)

0.12-0.41

0.25 (0.07)

0.11-0.40

0.01 (0.006)

0.003-0.02

0.03

4

0.44 (0.09)

0.27-0.62

0.42 (0.09)

0.24-0.59

0.02 (0.009)

0.01-0.04

0.04

P-trend

<0.001

<0.001

0.002

Fully Adjusted *
1 (referent)
2

0.08 (0.06)

-0.04-0.21

0.08 (0.06)

-0.04-0.21

0.003 (0.003)

-0.002-0.01

0.03

3

0.12 (0.07)

-0.02-0.26

0.11 (0.07)

-0.02-0.26

0.002 (0.003)

-0.003-0.01

0.01
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4

0.19 (0.09)

P-trend

0.01-0.36

0.18 (0.09)

0.005-0.36

0.026

0.008 (0.004)

0.032

-0.001-0.01

0.04

0.108

Female (N=4,916)
Adjusted for age
1 (referent)
2

0.28 (0.08)

0.10-0.45

0.25 (0.08)

0.08-0.42

0.02 (0.009)

0.009-0.04

0.07

3

0.44 (0.08)

0.27-0.61

0.41 (0.08)

0.24-0.58

0.03 (0.01)

0.01-0.05

0.06

4

0.83 (0.09)

0.65-1.01

0.79 (0.09)

0.61-0.97

0.04 (0.01)

0.01-0.06

0.04

P-trend

<0.001

<0.001

0.001

Fully Adjusted *
1 (referent)
2

0.11 (0.08)

-0.05-0.28

0.11 (0.08)

-0.05-0.27

0.002 (0.003)

-0.004-0.01

0.02

3

0.15 (0.08)

-0.01-0.32

0.15 (0.08)

-0.01-0.32

0.003 (0.004)

-0.005-0.01

0.02

4

0.38 (0.09)

0.19-0.56

0.37 (0.09)

0.19-0.56

0.004 (0.005)

-0.007-0.01

0.01

P-trend

<0.001

<0.001

0.470

* Adjusted for age, sex, CRP, race (White, Hispanic, Black, Multiracial), BMI (underweight, normal weight, overweight, obese), WC (low risk,
high risk), marital status (Married/Partner, Divorced/Widowed/Separated, Never married), education (Below high school, high school degree,
some college/AA, college grad and higher), smoking (never smoker, ever smoker), PIR (quartiles), PA (quartiles)
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Figure 2.1 Predicted Probability of Major Depression among 10,022 Participants of NHANES 2005-2010,
Age- and Sex-Adjusted in All, and Age-Adjusted among Males and Females.
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Figure 2.2 Predicted Probability of Major Depression among 10,022 Participants of NHANES 2005-2010,
Multivariable-Adjusted.
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Adjusted for age, sex, race (White, Hispanic, Black, Multiracial), BMI (underweight, normal weight,
overweight, obese), WC (low risk, high risk), marital status (Married/Partner,
Divorced/Widowed/Separated, Never married), education (Below high school, high school degree, some
college/AA, college grad and higher), smoking (never smoker, ever smoker), PIR (quartiles), PA (quartiles)
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Figure 2.3 Predicted Probability of Moderate-to-Severe Depression among 10,022 Participants of
NHANES 2005-2010, Age- and Sex-Adjusted in All, and Age-Adjusted among Males and Females.
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Figure 2.4 Predicted Probability of Moderate-to-Severe Depression among 10,022 Participants of
NHANES 2005-2010, Multivariable-Adjusted.
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Adjusted for age, sex, race (White, Hispanic, Black, Multiracial), BMI (underweight, normal weight,
overweight, obese), WC (low risk, high risk), marital status (Married/Partner,
Divorced/Widowed/Separated, Never married), education (Below high school, high school degree, some
college/AA, college grad and higher), smoking (never smoker, ever smoker), PIR (quartiles), PA (quartiles)
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CHAPTER 3
3

3.1

ASSOCIATION OF THE DIETARY INFLAMMATORY INDEX (DII)
WITH INFLAMMATION AND DEPRESSIVE SYMPTOMS AMONG PREAND POST-MENOPAUSAL WOMEN: FINDINGS FROM THE
NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY
(NHANES) 2005-2010.
Abstract

During their lifetime, 20% of US women experience depression. Previous studies have
indicated that a high Dietary Inflammatory Index (DII) is associated with high CRP
levels and depression. No previous study has compared the association of DII with
inflammation and depression among pre- and post-menopausal women. We compared the
association of DII with inflammation and depression among pre- and post-menopausal
women. We further assessed the mediation effect of CRP on the association of DII and
depression. We used data on 2,512 pre-menopausal and 2,392 post-menopausal women
from the NHANES 2005-2010 database. The association of DII with CRP as continuous
measures was only significant among post-menopausal women. The odds of experiencing
major depression among pre-menopausal women was higher for all quartiles compared to
the referent group (i.e., DII Q1), with an OR of 3.2, 5.0, and 6.3 for Q2, Q3, and Q4,
respectively (P <0.05). Among post-menopausal women, only Q4 had 110% higher odds
of experiencing major depression compared to Q1 (P = 0.027). This suggests that lifestyle
habits, such as diet, may have a stronger influence on mental health among premenopausal women than post-menopausal women. This could be due to hormonal
fluctuations in the latter group. The wide confidence interval on the association of DII
with depression in pre-menopausal women may be an indication that our models were
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underpowered to detect modest associations. We did not find any significant differences
in effect sizes between pre- and post-menopausal women. No mediation effect of CRP
was found between DII and any of our depression outcome measures. Future studies need
to assess the effect of lifetime diet on systemic inflammation and depressive symptoms.
Future studies in different populations are needed to confirm our findings.
3.2

Introduction
During 2013-2016, 10.4% of women in the U.S. experienced depression versus

5.5% men (CDC, 2018). During their lifetime, 20% of US women experience depression
(Kessler et al., 2003). Depression among women may be due to various reasons, such as
higher likelihood of experiencing relationship distress, low social support, childhood
adversity, obesity, and physical inactivity (Derry et al., 2015). All of these issues are
potential risk factors for systemic inflammation and higher pro-inflammatory cytokine
levels (Derry et al., 2015). Menopause is associated with various changes, including an
increase in inflammation (Christensen & Pike, 2015) and depression (Cohen et al., 2006).
Results for differences in various inflammatory biomarkers by menopausal status have
been inconsistent. A cross-sectional study by Sites and colleagues (2002), which included
45 pre-menopausal and 44 post-menopausal women, found tumor necrosis factor (TNF)alpha levels significantly higher among post-menopausal women compared to premenopausal women. The same study did not find significant differences in C-reactive
protein (CRP) and interleukin (IL)-6 levels. A cross-sectional study by Malutan and
colleagues (2014) attempted to assess the differences in proinflammatory and antiinflammatory cytokines by menopausal status. Their study included 175 women divided
into 5 groups: 1) fertile, 2) pre- and peri-menopausal, 3) post-menopausal, 4) surgically
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induced menopausal, and 5) women with chronic inflammatory pathology. In their
analyses, post-menopausal women had elevated levels of IL-1B, IL-8, and TNF-a as
compared to pre-menopausal women. In menopausal transition, women are more likely to
experience somatic symptoms, such as insomnia, due to serotonergic and non-adrenergic
fluctuations (Borkoles et al., 2015). These symptoms, alongside psychosocial and
behavioral factors, such as lack of social support and stressful events, make perimenopausal women susceptible to depressive symptoms (Borkoles et al., 2015). Using
the Study of Women’s Health Across the Nation (SWAN), Bromberger and colleagues
(2011) included 221 women aged 42-52 who were pre-menopausal at study entry and in
total they included 1,698 person years of observation in their analyses: 535 premenopause, 782 peri-menopause, and 381 post-menopause. Overall, number of major
depressive episodes observed were 31 in pre-menopause, 71 in peri-menopause, and 44 in
post-menopause. They reported higher odds of depression among peri- and postmenopausal women compared to pre-menopausal women (OR=2.20 and 3.57,
respectively). Other studies from the SWAN database, further showed higher likelihood
of presence of depressive symptoms and depressive disorder in early menopausal
transition (OR=1.30), late menopausal transition (OR= 1.71) and post-menopause (OR=
1.57) compared with pre-menopausal women (Cohen et al., 2006). In a study by Cohen et
al. (2006), among 460 pre-menopausal women, aged 36-45, with no history of
depression, those who entered peri-menopause were twice as likely to develop depression
compared with women who remained pre-menopausal.
Modifiable risk factors, such as diet, have been associated with mental disorders
(Quirk et al., 2013). Dietary components such as fiber, vitamin E, zinc, and omega-3 fatty
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acids have been shown to be inversely associated with systemic inflammation, as
assessed by inflammatory biomarkers (e.g., CRP) (Cavicchia et al., 2009; Tabung et al.,
2015). Conversely total fat and saturated fatty acids have been shown to have proinflammatory capacities (Almeida-de-Souza et al., 2017). To assess the effect of all proand anti-inflammatory dietary components in conjunction with each other, the Dietary
Inflammatory Index (DII) was developed. The DII allows us to look at overall dietary
patterns and may help us better understand diet-disease associations (Barbaresko et al.,
2013; Almeida-de-Souza et al., 2017). The DII has been positively associated with
inflammatory biomarkers, such as CRP (i.e., the more inflammatory the diet, the higher
the inflammation) (Tabung et al., 2015; Shivappa et al., 2014; Shivappa et al., 2015;
Shivappa et al., 2017; Vahid et al., 2017; Wirth et al., 2017; Wood et al., 2015). Higher
DII scores (i.e., more pro-inflammatory) have been positively associated with various
health conditions, such as depression in women (Sanchez-Villegas et al., 2015; Shivappa
et al., 2016; Akbaraly et al., 2016; Lucas et al., 2014).
Data have been inconsistent however, regarding the association of DII with
depression. Some studies have found an association in men only (Adjibade et al., 2017),
and others in women only (Akbaraly et al., 2016). This may be due to the higher overall
prevalence of depression among women, more cases of false-positives among women, or
difference in responsiveness to dietary changes (Adjibade et al., 2017). Previous studies
have shown individuals with high DII scores have more significant increases in CRP
levels compared with those with lower DII scores (Na et al., 2018). Menopause is also
associated with an increase in CRP levels (Yanes & Reckelhoff, 2011) and depressive
symptoms (Borkoles et al., 2015), as well as changes in dietary habits (Matthews et al.,
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2014), which may affect the inflammatory potential of the diet. No previous study has
compared the association of DII with inflammation and depression among pre- and postmenopausal women.
We used the National Health and Nutrition Examination Survey (NHANES)
database to assess the associations of DII with inflammation and depression among preand post-menopausal women. We hypothesized that the association of DII with
inflammation and depression would be significantly stronger among post-menopausal
women as compared to pre-menopausal. Because rates of inflammation and depressive
symptoms tend to be higher among post-menopausal women, and women tend to change
their dietary intake after menopause. We also tested the mediating role of inflammation,
as assessed by CRP levels, on the association of the DII and depression in both
population groups. As post-menopausal women have reportedly higher CRP levels
compared to pre-menopausal women, we expect the association of DII and depression
among post-menopausal women to be explained by the presence of inflammation.
3.3

Subjects and Methods
We used three cycles of the NHANES cross-sectional database, collected between

2005 and 2010. We excluded participants below the age of 20, which is the cutoff
recommended by NHANES for inclusion of adult participants. Participants with a CRP
value greater than 10 mg/L were excluded, as this is more likely to be an indicator of
acute infection or inflammation (Akbaraly et al., 2016). Pregnant women were excluded,
because women often make dietary changes during their pregnancy (Forbes et al., 2018).
Inflammation and depression levels change during pregnancy (Mor et al., 2011; Racicot
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et al., 2014; Ryan et al., 2005). Those with missing depression values, missing dietary
intake or only one day of dietary intake reported, as well as missing covariates (i.e., BMI,
waist circumference, marital status, education, diabetes, race, smoking) were also
excluded. There were a large number of missing values for poverty-to-income ratio (PIR)
and physical activity (PA). To avoid further reducing our sample size, we included these
as categorical variables in our regression models, with four categories based on the
quartiles of the values and the fifth category including those with missing values. Our
final sample therefore included 4,908 pre- and post-menopausal women.
3.3.1

Assessment of Menopausal Status
To determine menopausal status, we used two questions from the NHANES

Reproductive Health Questionnaire: 1) Have you had at least one menstrual period in the
past 12 months?, and 2) What is the reason that you have not had a period in the past 12
months? Participants were considered post-menopausal if the answer to the first question
was “No” and the answer to the second question was “Menopause/Hysterectomy”
(N=2,396). Participants were considered pre-menopausal if the answer to the first
question was “Yes”, or if the answer to the first question was “No” and the answer to the
second question was “Pregnancy”, “Breast feeding”, “Medical conditions/treatments”,
and/or “Other”, and they were below the age of 55 y (N=2,512).
3.3.2 Assessment of Exposure: Diet
In NHANES 2005-2010, participants’ dietary intake was assessed using two 24hour dietary recalls (24DR), which have been previously validated. Karvetii and Knuts
(1985) compared one-day 24-hour recall with observed food intake. They reported the
product-moment correlation coefficient between the recall and observed for intake
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between 0.58 and 0.74, with women having more accurate results than men. In a study by
Yuan and colleagues (2017), self-administered 24-hour recall’s performance in assessing
dietary intake was similar to 7-day dietary record (7DDRs), adjusting for within-person
variation. A study published by USDA (Rhodes et al., 2003), using biomarker data
assessed the validity USDA’s Automated Multiple Pass Method (AMPM), which is used
for collecting 24-hr dietary recalls in NHANES. They reported over 80% of their
participants were acceptable reporters (i.e., those within 95% confidence limits). Overall,
24-hour recalls have validity on a group level and large groups of subjects, but not on the
individual level (Beer-Borst & Amado, 1995; Karvetti & Knuts, 1985; Posner et al.,
1982). This instrument can be used to validate estimates of dietary intake, when less
detailed assessment tools, such as Food Frequency Questionnaires (FFQs), are used as the
main dietary assessment tool (NCI, 2020). The NCI’s 24-hour dietary recall validation
report notes underestimation of true intake by 3-34%, and underreporting of protein 1128%. Aside from protein, there are limited reports for the other DII components, due to
lack of recovery biomarkers (i.e., directly related to intake and not subject to
homeostasis) for these components.
The inflammatory potential of the diet was assessed using the DII. This
assessment tool was created using nearly 2000 articles published between 1950 and 2010
examining the association of dietary components on six inflammatory biomarkers (i.e.,
IL-1B, IL-4, IL-6, IL-10, TNF-a, and CRP). The DII is comprised of 45 items (36
nutrients and nine foods), including macronutrients, micronutrients, and flavonoids.
Construct validity of the DII was established using the SEASONS study and CRP as the
validator. To calculate the DII scores, we created a z-score for each food item. For this,
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we subtracted the standard world means, provided by the creators of the DII, from our
study participants’ intakes. Then, we divided the result by the world means’ standard
deviation, also provided by the creators of DII, to create a z-score (Shivappa et al., 2014).
The standard world mean and the standard deviations are the range of intakes of food
derived from 11 nutritional databases from different parts of the world (Wirth et al.,
2014). These means allow us to compare the individuals’ intakes from our database to be
compared relative to range of intakes by diverse populations (Shivappa et al., 2014). The
z-score was then transformed to a percentile to minimize right skewing, which is
common in dietary data. We centered the percentile by doubling the value and subtracting
1 from the result to reduce the odds of skewing. The result was multiplied by the
literature-derived inflammatory effect score of the corresponding DII food item to
calculate the food item-specific DII score for each participant. The food item-specific
scores for each food item of DII were summed to create the overall DII score for each
participant. The higher the DII score, the more pro-inflammatory the individual’s diet is,
and the more negative the score, the more anti-inflammatory their diet is. Using the 24hour recall of NHANES database, 27 of the 45 DII food items were be available in our
analysis to calculate the DII score (Table 3.1). These food items were: energy,
carbohydrate, protein, total fat, alcohol, caffeine, fiber, cholesterol, saturated fat,
monounsaturated fatty acid (MUFA), polyunsaturated fatty acid (PUFA), omega-3,
omega-6, iron, magnesium, zinc, selenium, niacin, thiamin, riboflavin, folic acid, betacarotene, and vitamins B12, B6, A, C, and E. Vitamin D intake was only available for
2007-2008 and 2009-2010 cycles. We performed a sub-analysis with these cycles, where
the DII included 28 items, including vitamin D values. However, since we did not notice
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any substantial differences between the results of our analysis from 27 items compared to
28 items, we will only report results from the full sample (i.e., 2005-2010 cycles) that
included 27 items of DII.
3.3.3 Assessment of Outcome: Inflammation
NHANES provides participants’ CRP levels as a measure of the body’s response
to inflammation from chronic conditions, such as arthritis. CRP was used both as a
continuous variable in our mediation analysis, and a dichotomous variable (i.e., <3 mg/L
and ≥3 - <10 mg/L) in other analyses based on previous studies that consider CRP levels
above 3 mg/L indicative of high-risk for chronic disease (Shivappa et al., 2015).
3.3.4 Assessment of Outcome: Depression
NHANES uses the Patient Health Questionnaire (PHQ) to assess depressive
symptoms. The 9-item PHQ (PHQ-9) is used for diagnoses of probable depressive
disorders in primary care (Kroenke et al., 2001). PHQ-9 has been validated in two
studies, on a total of 6,000 patients in 15 different health clinics (Spitzer et al., 1999;
Spitzer et al., 2000). It has a diagnostic validity comparable to the clinician-administered
PRIME-MD (Kroenke & Spitzer, 2002). PHQ-9 has been validated and a score of >10
has a sensitivity of 88% and a specificity of 88% for diagnosing moderate-to-severe
depression (Kroenke et al., 2001).
PHQ-9 assesses the presence of symptoms over the past two weeks. Responses to
all nine items are coded on a four-point scale (Not at all: 0, Several days: 1, More than
half the days: 2, Nearly every day: 3). The score for all nine items are summed to create
the PHQ-9 Score, with the minimum and maximum total scores of 0 and 27, respectively,
and with higher scores representing more severe symptoms.
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We defined probable existence of major depression if five or more items were
present for at least “more than half the days” during the two-week period, with one of the
symptoms being depressed mood or anhedonia (i.e., reduced ability to experience
pleasure) (Gorwood, 2008; Kroenke et al., 2001). If the final item of PHQ-9 (i.e.,
suicidality) was present at all, even for “several days”, it was counted in the diagnosis as
part of the five items.
The total PHQ-9 score was used to categorize the severity of probable depression:
0-4 no depression, 5-9 mild depression, 10-14 moderate depression, 15-19 moderately
severe, and 20-27 severe depression. We combined the first two and the last three
categories to dichotomize depression severity into no-to-mild and moderate-to-severe
depression, using cut-points of <10, and >=10, respectively.
The somatic sub-score was calculated by summing the PHQ-9 items on sleep
disturbance, fatigue, appetite changes, and psychomotor retardation/agitation (Case &
Stewart, 2014). The cognitive sub-score was calculated by summing the remaining 5
items on the PHQ-9, including anhedonia (i.e., absence of enjoyment, motivation, and
interest), depressed mood, low self-esteem, concentration problems, and suicidal ideation
(Case & Stewart, 2014).
3.3.5 Assessment of Covariates
In our regression models, we controlled for variables that are either associated
with our dependent variables (i.e., depression or CRP) or are confounders in the
association of DII with depression or CRP. These variables included age, race/ethnicity
(dichotomized into White or other), BMI (categorized into underweight, normal weight,
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overweight, obese), waist circumference [WC] (dichotomized into <35 or ≥35 inches
based on disease risk for non-pregnant women [CDC]), physical activity, smoking status
(dichotomized into never- or ever-smokers), marital status (categorized into single, with
partner/married, or separated/divorced), education level, and poverty-to-income ratio.
Models that included CRP were further controlled for diabetes, as previous studies have
shown insulin resistance affecting cytokine levels (Sanchez-Villegas et al., 2015).
3.3.6 Statistical Analysis
We divided participants into quartiles of DII according to the distribution in our
population. The range of DII values in each quartile were as follows: Q1: -4.90 to -1.26,
Q2: -1.27 to 0.11, Q3: 0.12 to 1.46, Q4: 1.47 to 4.49. The range of PHQ-9 scores was 0 to
27, and the range of CRP levels was 0.1 to 9.9 in both groups.
We used histograms to assess the normality of distribution of exposure and
outcome variable, and scatter plots to assess the linearity of association between
covariates and our exposure and outcomes. Pairwise correlations and variance inflation
factors were used to test for possible multicollinearity between variables. For the
distribution of subject characteristics, t tests were used for continuous covariates across
categories of DII, CRP, and depression. For the categorical covariates, we used Chi2 test
for our dichotomous outcomes (i.e., CRP and depression) and one-way ANOVA to assess
whether there were differences in values of the outcome variables and covariates across
the DII quartiles.
Linear regression models were used for continuous outcomes: CRP, total
depression score, and somatic and cognitive depression. Logistic regression was used for
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dichotomous outcomes: CRP (cutoff at 3 mg/L), major depression, and depression
severity. We compared the predicted probability of our dichotomous outcomes (i.e., CRP,
major depression, moderate-to-severe depression) at different levels of DII. After
assessing the direct effect of DII on depression, we further explored the indirect (i.e.,
mediating) effect of inflammation on the association of DII and depression. This analysis
assessed how much of the relationship between DII and depression was explained by the
intervening effect of CRP and other inflammatory biomarkers. Structural equation
modeling (SEM) was used to perform the mediation analysis. Inflammatory biomarkers
and depression scores were entered in our analysis models as continuous variables and
DII was used as a continuous and categorical (i.e., quartiles) variable in separate models.
To compare whether the difference in coefficients resulted from linear regression
models were significant between pre- and post-menopausal groups, we calculated zscores. If the z-score was greater than 1.96 or less than -1.96, the difference was
considered significant (P<0.05).
We built three regression models for each outcome: Model 1 was age adjusted;
for Model 2 we used the likelihood ratio test to identify the most parsimonious model;
and in Model 3, all covariates were included. In this paper, we only report the results for
Model 1 and Model 3 because the results for Model 2 did not substantially differ from
Model 3.
All statistical analysis test were conducted using the STATA Statistical Software
(StataCorp. 2017. Stata Statistical Software: Release 16. College Station, TX: StataCorp
LLC).
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3.4

Results

3.4.1 Population Characteristics
Our sample included 2,512 pre-menopausal and 2,392 post-menopausal women
with the mean age and standard deviation (SD) of 35.94 ± 9.66 and 62.90 ± 9.96,
respectively. The mean DII score was +0.09 (SD ± 1.78) and +0.007 (SD ± 1.80), the
mean CRP was 2.50 (SD ± 2.39) and 2.85 (SD ± 2.33), and the mean PHQ-9 score was
3.62 (SD ± 4.42) and 3.56 (SD ±4.50) for pre- and post-menopausal, respectively.
Somatic depression scores in both groups ranged from 0 to 12, with a mean (SD) of 2.16
(2.43) and 2.16 (2.46) for pre- and post-menopausal women, respectively. Cognitive
depression scores in both groups ranged from 0 to 15, with a mean (SD) of 1.46 (2.36)
and 1.40 (2.43) for pre- and post-menopausal women, respectively.
For pre-menopausal women, compared with Q1, those in Q4 of DII were more
likely to be significantly younger, less physically active, poorer, have higher BMI and
WC, have higher total, somatic, and cognitive depression scores, and higher CRP levels
(Table 3.2). The same pattern existed for post-menopausal women; however, age was not
significantly different across the quartile groups (Table 3.3). In terms of categorical
variables, pre-menopausal women in Q4 were more likely to be Black, current or
previous smoker, overweight/obese, single or divorced/widowed/separated, belong to the
high risk waist circumference group, have diabetes and less than a college education. The
same pattern existed among post-menopausal women, but in terms of race, aside from
being Black, those in Q4 were also more likely to be Hispanic. For menopausal women,
only those with a high school degree or below high school degree were more likely to be
in Q4.
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3.4.2 Inflammation
Among pre-menopausal women in Model 1, there was a 0.64 mg/L increase in
CRP in Q4 compared to Q1 (95% CI, 0.35, 0.92; P-trend = 0.001). The results were no
longer significant in Model 2 or the fully adjusted model. Among post-menopausal
women, however, there was a 0.83. mg/L increase in CRP in Q4 compared to Q1 in
Model 1 (95% CI, 0.55, 1.10; P-trend < 0.001). The results remained significant in the
fully-adjusted model with a 0.33 mg/L increase in CRP levels in Q4 vs. Q1 (95% CI,
0.06, 0.60; P-trend = 0.009) (Table 3.4). The odds for risk of high CRP levels (i.e., >3
mg/L) was 1.48 among pre-menopausal women (95% CI, 1.13, 1.94; P-trend = 0.028)
and 1.74 (95% CI, 1.35, 2.25; P-trend < 0.001). In the fully adjusted model, the odds for
risk of high CRP levels was not significantly higher than Q1 across any of the quartiles of
DII among pre-menopausal women (P-trend = 0.659). Although, the odds among postmenopausal women was 1.20, the result was not significant (95% CI, 0.91, 1.59; P-trend
= 0.045) (Table 3.5).
In our fully adjusted linear models and with DII as a continuous measure, for each
unit increase in DII, CRP increased by 0.02 units (P=0.466) and 0.06 units (P=0.024) for
pre- and post-menopausal women, respectively. The z-score was 1.12, thus, making the
difference in coefficients between our two groups non-significant.
3.4.3 Depression
In the age-adjusted model, compared to Q1, depression symptoms score was 1.58
units higher in Q4 among pre-menopausal women (95% CI, 1.05, 2.11; P-trend = 0.001).
The score was 0.74 units higher in the fully-adjusted model (95% CI, 0.20, 1.27; P-trend
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= 0.008). Among post-menopausal women, in the age-adjusted model the depression
symptoms score was 1.70 units higher in Q4 compared to Q1 (95% CI, 1.19, 2.22; Ptrend < 0.001) and 0.67 units higher in the fully-adjusted model (95% CI, 0.14, 1.20; Ptrend = 0.008). The depression score in Q2 and Q3 in the fully adjusted model was not
significantly different than Q1 for either group (Table 3.6). We noticed similar patterns
for somatic symptoms of depression scores (Table 3.7). In the age-adjusted model, the
score was 0.76 units higher in Q4 among pre-menopausal women and 0.83 units among
post-menopausal women. In the fully-adjusted model, compared to Q1, the score was
0.31 units higher in Q4 (95% CI, 0.02, 0.61; P-trend = 0.050) among pre-menopausal
women. Among post-menopausal women, the score was 0.37 units higher in Q4
compared to Q1 (95% CI, 0.08, 0.67; P-trend = 0.010). Compared to Q1, cognitive
depression scores were significantly higher in Q4 for both pre- and post-menopausal
women in the age-adjusted and fully-adjusted models. Among pre-menopausal women,
cognitive symptoms of depression was 0.42 units higher in Q4 vs. Q1 (95% CI, 0.13,
0.71; P-trend = 0.003) and was 0.32 units higher among post-menopausal women (95%
CI 0.04-0.61, P-trend = 0.016) (Table 3.8).
Among pre-menopausal women in the age-adjusted model, the odds of having
probable major depression in Q2, Q3, and Q4 compared to referent (i.e., Q1) was 3.8, 6.6,
and 10.3, respectively (P-trend < 0.001). In the fully-adjusted model, the odds remained
high for all quartiles compared to referent, with OR of 3.2, 5.0, and 6.3 for Q2, Q3, and
Q4, respectively (P-trend < 0.001). The wide confidence interval among pre-menopausal
women suggests that our sample size may have been small to detect differences in
depression across DII quartiles (Table 3.9). Among post-menopausal women, in the age-

95

adjusted model the odds were significantly higher in Q3 and Q4 only the fourth quartile
had significantly higher odds of experiencing major depression compared to Q1 (OR =
2.1; 95% CI, 1.1, 4.3; P-trend = 0.026) (Table 3.9). There was not a significant difference
between the ORs for moderate or severe depression among pre- and post-menopausal
women in the age-adjusted or fully adjusted model (Table 3.10). The odds in the fullyadjusted model was 2.5 (95% CI, 1.4, 4.3; P-trend = 0.001) for pre-menopausal women
and 2.4 (95% CI, 1.3, 4.1; P-trend = 0.001) for post-menopausal women.
To test whether the OR for major depression was significantly different between
pre- and post-menopausal women, we ran a fully interactive model, where all the
variables in our fully adjusted models were entered in the model in interaction with
“menopausal status.” Because the interaction term between DII and menopausal status
was significant (P=0.001), we concluded that the difference in the ORs for major
depression differed significantly by menopausal status.
Examining depression scores as continuous variables, we ran linear regression
models, where DII was also entered as a continuous variable. Comparing the fully
adjusted models for pre- and post-menopausal women, the coefficients and significance
levels were the same. For each unit increase in DII, the depression score increased by
0.16 units (P=0.001) and 0.16 (P=0.002), for pre- and post-menopause, respectively. We
further calculated the z-score to assess whether there was a significant difference in the
results of the regression models for depression scores between the two groups. The zscore was 0.127; therefore we concluded that the difference was not significant.
We further ran linear regression models with continuous somatic and cognitive
depression scores as our outcome and DII as a continuous exposure. For each unit
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increase in DII, somatic depression increased by 0.07 units (95% CI, 0.02, 0.13; P =
0.005) among pre-menopausal women and 0.08 units (95% CI, 0.02, 0.13; P = 0.006)
among post-menopausal women. For each unit increase in DII, cognitive depression
increased by 0.09 units (95% CI, 0.03, 0.14; P = 0.001) among pre-menopausal women
and 0.08 units (95% CI, 0.02, 0.13; P = 0.004) among post-menopausal women. We
calculated z-scores for both somatic and cognitive depression outcomes and found no
significant difference between pre- and post-menopausal women in terms of the
association of DII and these outcome measures.
3.4.4 Predicted Probabilities
We assessed the predicted probability (PP) for our categorical outcomes (i.e., risk
of high CRP, probable major depression, probable moderate to severe depression) at
different levels of DII score (i.e., -5, 0, +4). The PP for risk of high CRP levels among
pre-menopausal women in the fully adjusted model was 31% at all three levels of DII.
Among post-menopausal women the PP was 32%, 36%, and 40%, respectively (Figure
3.2). Age-adjusted results are presented in Figure 3.1.
The PP of probable major depression in the fully adjusted model among premenopausal women was 1%, 4%, and 11%, and among post-menopausal women was 3%,
6%, and 9% for for DII of -5, 0, and +4, respectively (Figure 3.4). The age-adjusted
results are presented in Figure 3.3.
There were no differences in the predicted probability of probable moderate or
severe depression among pre- and post-menopausal women (Figures 3.5 and 3.6).
3.4.5 Mediation Analysis
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In the age-adjusted model, CRP explained only 4% of the effect of change in DII on
depression symptoms score among pre-menopausal women (P-trend = 0.024) and 5%
among post-menopausal women (P-trend = 0.006). There was no significant mediation
effect of CRP in the fully adjusted model (Table 3.11). Similar results were found for
somatic and cognitive symptoms of depression (Tables 3.12 and 3.13).
3.5

Discussion
In this cross-sectional study, we found significant associations between DII scores

and increase in CRP levels only among post-menopausal women. We found positive and
significant associations between DII and the odds of having major depression among premenopausal women, which was significantly different than post-menopausal women
based on a fully interactive model. However, predicted probabilities did not show
significant differences between the two groups. The association of DII with somatic and
cognitive depression was significant but not biologically meaningful. Further, there were
no differences between pre- and post-menopausal women in terms of these associations.
Some studies have noted an increased risk of depression in menopausal transition
(i.e., perimenopause) and a decreased likelihood of depression after the onset of
menopause (Freeman et al., 2004). Women in menopausal transition are two- to fourtimes more likely to experience major depressive disorder and depressive symptoms
(Gordon and Girdler, 2014). In our study, we were not able to differentiate between preand peri-menopause because that information is not available in the NHANES database.
It is possible that the stronger association we noticed between DII and major depression
could be partially explained by the presence of peri-menopausal women in our pre-
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menopausal group. Future studies using the menopausal classification system set by
Stages of Reproductive Aging Workshop (STRAW + 10) (Harlow et al., 2012) may be
helpful in better defining the menopausal status of women and minimizing
misclassifications.
Contrary to our hypothesis, we found the association of DII and major depression
to be stronger among pre-menopausal women than post-menopausal women. This
suggests that depression may be more strongly related to lifestyle habits among premenopausal women and that depression in post-menopause is mainly associated with
changes in hormonal balance. Not all studies agree that ovarian changes and hormonal
fluctuations are the cause of depression during menopause, and these inconsistencies
have contributed to design limitations, such as infrequent hormone measurements
(Gordon & Girdler, 2014).
Tabung and colleagues (2016) conducted the only study to date among postmenopausal women that examined the association of DII, as assessed by a FFQ, with
three inflammatory biomarkers (i.e., hs-CRP, IL-6, and TNFa-R2). Their study included
2,567 post-menopausal women between the ages of 50 and 79 years. They categorized
DII into quintiles. Comparing the fifth to the first quintile, the odds of hs-CRP >3 mg/L
was increased by 7% , however, the results were not significant (OR = 1.07; 95% CI,
0.95-1.20; P = 0.37). This was similar to our findings, as we did not find any significant
increase in the odds of having high CRP levels when comparing the fourth to first
quartile of DII. The odds of having high IL-6 and TNFa-R2 was significantly higher in
Q5 versus the Q1 of DII (ORIL-6 = 1.25; 95% CI, 1.15-1.38; P < 0.0001, and ORTNFa-R2 =
81.43; 95% CI, 19.15-143.71; P = 0.004). Overall, the findings of this study by Tabung et
99

al. (2016) were null, due to the non-significant results for CRP and wide confidence
intervals for TNFa-R2. This study was also one of the few that had included
inflammatory biomarkers other than CRP in their analyses. CRP is viewed as a
nonspecific biomarker for systemic inflammation (Jorgensen et al., 2018) and a surrogate
marker of cytokines, such as IL-6 and IL-1B (Ridker, 2016; Ruiz-Canela et al., 2016).
In a longitudinal study, Duval and colleagues (2014) recruited 94 women who
were pre-menopausal at baseline and followed them up over menopausal transition and
after the onset of menopause to assess the changes in their energy and macronutrient
intake. They found that women’s energy intake significantly decreases after menopause.
They also reported increase in protein intake, and decrease in fat and carbohydrate
intakes, with the change in carbohydrates being the only statistically significant change.
Lower caloric intake is typically associated with lower DII scores, due to a decreased
intake of beneficial nutrients, as higher intake of food may result in higher intake of
different types of micronutrients (Julia et al., 2017). Previous studies have shown proinflammatory properties and increased inflammatory biomarkers (e.g., CRP) concurrent
with higher intakes of calories, carbohydrates, total fat, saturated fat, high-fat dairy, red
and processed meat, and total sugars (Almeida-de-Souza et al., 2017; Boden et al., 2017;
Park et al., 2018).
During menopause the distribution of fat in the body changes and there is an
increase in abdominal adiposity, which may result in higher inflammation in the body
(Sites et al., 2002). Pro-inflammatory cytokines may affect mood and mental health
through changes in the metabolism of neurotransmitters (e.g., serotonin [5-HT]),
dopamine, noradrenaline, glutamate), basal ganglia function, neuroendocrine system, or
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synaptic plasticity (Adjibade et al., 2017; Derry et al., 2015; Miller et al., 2009). This is
the basis for the monoamine hypothesis that considers central synaptic deficiency of
serotonin and/or norepinephrine to be the cause of depression (Makhija & Karunakaran,
2013). Cytokines stimulate and increase serotonin reuptake from synapses. Increased
amounts of IL-6, IL-1, and TNF-a in cerebrospinal fluid also activates the mitogenactivated protein kinase pathway, which has been shown to upregulate the reuptake of
neurotransmitters, such as serotonin, dopamine, and norepinephrine in the hippocampus
(Makhija & Karunakaran, 2013).
Menopause is associated with an increase in CRP (Yanes & Reckelhoff, 2011)
and markers of oxidative stress (Castelao et al., 2008). However, menopausal stage did
not significantly modify the association between DII and CRP in our analysis. The results
of previous studies on the comparison of CRP levels among pre- and post-menopausal
women has been inconsistent. In a study by Sites and colleagues (2002) with the
objective of assessing the differences in inflammation markers by menopausal status,
they found that only TNF-alpha was significantly higher in post-menopausal women
compared to pre-menopausal women; whereas, IL-6 and CRP levels did not differ
between the two groups. In another study by Sponholtz and colleagues (2014), using the
Framingham Heart study they found CRP levels to be higher among post-menopausal
women (3.9 mg/L for those on HRT and 2.3 mg/L for those not on HRT) compared to
pre-menopausal women (1.4 mg/L). Similar to findings by Sponholtz et al. (2014) the
difference between CRP levels between the two groups in our study was significant [2.50
(SD ± 2.39) for pre-menopause and 2.85 (SD ± 2.33) for post-menopause]; however, the
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mean difference was not as great as the difference in that study. Further, HRT has been
shown to increase CRP concentrations (Ridker et al., 1999; Cushman et al., 1999).
It is important to note some of the limitations of our study. First, we did not have
information available on HRT among post-menopausal women. This treatment can often
alleviate depressive symptoms among peri-menopausal and early post-menopausal
women (Gordon and Girdler, 2014). Not controlling for HRT may have biased our results
towards the null. Further, HRT has been shown to affect CRP levels depending on the
mode of HRT delivery: oral administration increases CRP levels by twofold, but
transdermal administration either had no effect or decreased circulation CRP levels
(Casanova et al. 2015; Decensi et al., 2002; Sattar et al. 1999; Sproston & Ashworth,
2018; Vongpatanasin et al. 2003). In previous studies, CRP predicted negative health
outcomes among post-menopausal women, regardless of HRT use (Kurtz et al., 2010;
Rizzo et al., 2009). Therefore, we expect the effect of not controlling for HRT on our
results to have been minimal. Second, aside from the variables we controlled for in our
analysis that have been associated with increased depression in menopausal women (e.g.,
education, socioeconomic status, smoking, exercise, BMI, partner status), there are other
variables associated with depression in this population (Borkoles et al., 2015) that we did
not have the data to control for, such as social support, stressful life events, and hormonal
vulnerability (Borkoles et al., 2015). Third, it is possible that residual confounding may
have affected our estimates. Previous studies (Freeman et al., 2014; Gibbs & Kulkarni,
2013; Gordon & Girdler, 2014) have reported an increased risk for depression among
women who had a history of depression, regardless of menopausal status. Further, due to
the formatting of data on medications in NHANES, we were not able to control for anti-
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inflammatory medication use that may have had an impact on both inflammation and
depression. Furthermore, we did not have data on history of depression to control for
therefore, this may have been another source of bias in our results. Depression was not
diagnosed clinically in our study, which may have led to misclassification of the
population and outcome, biasing our results towards the null. However, the PHQ-9 used
in the NHANES database has been validated, with high sensitivity and specificity for
diagnosis of major depression. This may have helped minimize the possibility of
measurement error in biasing our results towards the null. Finally, due to the nature of
our study design, we were only able to assess recent dietary intake, CRP, and depression
levels. Depression and systemic inflammation are chronic conditions (Akbaraly et al.,
2016; Kunnumakkara et al., 2018; Lucas et al., 2014; Sanches-Villegas et al., 2015) and
diet may affect these conditions over a long period of time. Lastly, due to the crosssectional nature of our study design, we were not able to infer causality. It is possible that
the correlation of DII and depression may be explained by the association of depression
with unhealthy diet. Previous epidemiological studies have suggested a bidirectional
relationship between inflammation and depression (Sanchez-Villegas et al., 2015), which
further points to the complicated physiological mechanisms in the association of these
factors. Lifetime fluctuations in reproductive hormones (e.g., estrogens) has been
identified as one of the reasons for a high prevalence of mood disorders in women at
different stages of their lives (Derry et al., 2015), such as pregnancy and menopause. Our
sample did not include pregnant women; thus, our pre-menopausal sample may have
been less likely to have experienced hormonal fluctuations. Further, the wide confidence
interval seen in the association of DII with depression among pre-menopausal women
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may be an indication that our models were underpowered to detect modest associations.
Future studies in different populations are needed to confirm our findings. Inconsistencies
in findings of previous studies on depressive symptoms by menopausal status have been
partly due to methodological differences (Borkoles et al., 2015). For example,
epidemiological studies, such as ours, have typically found no increase in depression
during menopause; however, clinical studies have reported higher prevalence of
depression in menopause (Borkoles et al., 2015). The nature of our study was
epidemiological, which may have resulted in no detection of increase in depression
among our post-menopausal population. This may have ultimately resulted in not finding
significant differences in depression levels among pre- and post-menopausal women. It
should also be noted that the range of depression score in our sample was small and
similar in both groups. By categorizing our scores by depression severity, we were able to
look at the extreme ends of depression in our population. More clinical studies should be
done on the association of DII with depression, where a wider range of depression scores
are available. The NHANES database only included CRP as an inflammatory biomarker
that we could use. Although CRP is considered an acceptable marker for low-grade
inflammation and can be used as a predictor for several chronic diseases (Julia et al.,
2017), in the future, more studies should include other inflammatory biomarkers in their
analyses, as measuring multiple biomarkers is preferable to assessing inflammatory status
(Julia et al., 2017). A recent study showed that serum levels of CRP and proinflammatory cytokines are higher in healthy elderly (>65 years) compared to younger
individuals (Wyczalkowska-Tojmasik et al., 2016). With more information gathered on

104

this front, new normal ranges should be considered for older populations to better
compare inflammation among the young and the elderly.
There are also several strengths in our study. This was the first study to assess the
association of DII and depression among pre-menopausal women, and the first to assess
the mediation effect of inflammation, as assessed by CRP, on the association of DII and
depression among both pre- and post-menopausal women. This was also the first study to
compare these associations between the two groups to assess possible differences by
menopausal status. Second, for our analysis we used a large sample size, which provided
us with higher statistical power and allowed us to consider various possible confounders
in our models. Third, the population we used was a group of nationally representative
women, making our results generalizable to American women.
Our study did not confirm that the association of DII and depression is via CRPassociated immune function. One possible explanation is that the DII is not a strong
dietary assessment tool in evaluating the inflammatory potential of diets, which would
reflect the inflammatory biomarker levels. It is not clear what other pathway may mediate
the correlation between DII and depression. DII may be an indicator of an overall healthy
diet or other healthy habits that may be related to depression (e.g., physical activity,
social support). As mentioned above, due to the cross-sectional design of our study, it is
possible that depression may lead to unhealthy behaviors, such as unhealthy dietary
habits. Diet may be related to depression via other pathways, such as the neuroendocrine
pathways affecting neurotransmitters, neurohormones, and the HPA axis. For example,
the surplus of metabolites, such as QUIN, due to excessive breakdown of tryptophan can
lead to over-activity of the HPA-axis, which has been shown to influence the
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development of major depression (Adler et al., 2008; Allison et al., 2014). More studies
are needed to confirm these hypotheses.
In conclusion, the findings of our study do not suggest that the association of DII
and depression is mediated by inflammation. We did not find any significant differences
between pre- and post-menopausal women in terms of the associations of DII with
various depressive outcomes. However, our results indicate that the inflammatory
potential of diet may be more related to major depression in pre-menopausal women.
Future studies with greater statistical power and inclusion of other inflammatory
biomarkers need to be conducted to confirm our findings. Focusing on improving diet
may be recommended as part of the treatment plan and prevention for depression before
menopause.
3.6

Future Directions
Many studies have indicated an increase in depression among peri-menopausal

women. Indeed, Cohen and colleagues (2006) reported 9.5% and 16.6% of mood
disturbances among pre-menopausal and peri-menopausal women, respectively. We did
not assess the associations among peri-menopausal women, as the NHANES dataset did
not have that information, and using only age to define peri-menopause as a proxy
measure may have led to misclassification of menopausal status and produced a bias
towards the null. Future studies with clear definition of peri-menopause can assess the
association of DII and depression among this group of women. Based on the findings of
Tabung and colleagues (2016) regarding the significant associations of DII with IL-6,
TNFa-R2, and combined inflammatory biomarker score, future studies should assess the
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association of DII with various inflammatory biomarkers among pre- and postmenopausal women. It is important to use prospective studies to assess lifetime changes
in diet and its association with systemic inflammation and depression. The wide
confidence interval in our findings for probable major depression among pre-menopausal
women is an indication of a small sample size. Studies with larger sample sizes are
needed to confirm our findings in probable major depression.
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Table 3.1 Food parameters included in the dietary inflammatory index, inflammatory effect scores, and
global intake values, Shivappa et al. (2014)a, Continued onto Next Page
Food Parameter

Overall Inflammatory Effect Score

Global Daily Mean Intake

SD

-0.278

13.98

3.72

Vitamin B12 (ug)

0.106

5.15

2.7

Vitamin B6 (mg)

-0.365

1.47

0.74

Beta-Carotene (ug)

-0.584

3718

1720

Caffeine (g)

-0.11

8.05

6.67

Carbohydrate (g)

0.097

272.2

40

Cholesterol (mg)

0.11

279.4

51.2

Energy (kcal)

0.18

2056

338

0.298

71.4

19.4

-0.663

18.8

4.9

Folic acid (ug)

-0.19

273

70.7

Iron (mg)

0.032

13.35

3.71

Magnesium (mg)

-0.484

310.1

139.4

MUFA (g)

-0.009

27

6.1

Niacin (mg)

-0.246

25.9

11.77

n-3 Fatty acids (g)

-0.436

1.06

1.06

n-6 Fatty acids (g)

-0.159

10.8

7.5

Protein (g)

0.021

79.4

13.9

PUFA (g)

-0.337

13.88

3.76

Riboflavin (mg)

-0.068

1.7

0.79

Saturated fat (g)

0.373

28.6

8

Selenium (ug)

-0.191

67

25.1

Thiamin (mg)

-0.098

1.7

0.66

Vitamin A (RE)

-0.401

983.9

518.6

Vitamin C (mg)

-0.424

118.2

43.46

Vitamin D (ug) b

-0.446

6.26

2.21

Available in NHANES and Included in Analysis
Alcohol (g)

Total fat (g)
Fiber (g)
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Vitamin E (mg)

-0.419

8.73

1.49

Zinc (mg)

-0.313

9.84

2.19

Not Available in NHANES and Not Included in Analysis
Eugenol (mg)

-0.140

0.01

0.08

Garlic (g)

-0.412

4.35

2.90

Ginger (g)

-0.453

59.0

63.2

Green/black tea (g)

-0.536

1.69

1.53

Flavan-3-ol (mg)

-0.415

95.8

85.9

Flavones (mg)

-0.616

1.55

0.07

Flavonols (mg)

-0.467

17.7

6.79

-0.25

11.7

3.82

Anthocyanidins (mg)

-0.131

18.05

21.14

Isoflavones (mg)

-0.593

1.20

0.20

Onion (g)

-0.301

35.9

18.4

Pepper (g)

-0.131

10.00

7.07

Saffron (g)

-0.140

0.37

1.78

Thyme/oregano (mg)

-0.102

0.33

0.99

0.229

3.15

3.75

Turmeric (mg)

-0.785

533.6

754.3

Rosemary (mg)

-0.013

1.00

15.00

Flavonones (mg)

Trans fat (g)

a.

b.

Shivappa, N., Steck, S. E., Hurley, T. G., Hussey, J. R., & Hébert, J. R. (2014).
Designing and developing a literature-derived, population-based dietary inflammatory
index. Public health nutrition, 17(8), 1689-1696.
Vitamin D only available in 2009 and 2010 NHANES cycles
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Table 3.2 Subject characteristics by Dietary Inflammatory Index (DII) quartiles, among 2,512 Premenopausal Participants from the National Health and Nutrition Evaluation Study 2005-2010, Continued
onto Next Page
DII Quartiles
n (%)
Q1
670 (26.68)
Subject Characteristics

Q2
634 (25.25)

Q3

Q4

621 (24.73)

586 (23.34)

Mean (SD)

Mean (SD)

Mean (SD)

Mean (SD)

Age (y)

37.9 (9.5)

37.05 (9.6)

35.4 (9.4)

34.6 (9.7)

Physical Activity (MET-minutes) a

942 (1392)

759 (1277)

579 (1179)

648 (1400)

Poverty Income Ratio b

3.1 (1.7)

2.8 (1.6)

2.4 (1.6)

2.0 (1.5)

Dietary Inflammatory Index Scores

-2.5 (0.5)

-1.1 (0.3)

0.2 (0.4)

2.1 (0.8)

n (%)

n (%)

n (%)

n (%)

White

222 (55.2)

258 (44.8)

302 (42.6)

357 (43.2)

Hispanic

111 (27.6)

189 (32.8)

240 (33.9)

235 (28.4)

Black

42 (10.4)

97 (16.8)

125 (17.6)

194 (23.5)

Multiracial

27 (6.7)

32 (5.5)

41 (5.8)

40 (4.8)

Never smoker

277 (68.9)

411 (71.3)

484 (68.4)

451 (54.6)

Ever smoker

125 (31.1)

165 (28.7)

224 (31.6)

375 (45.4)

Married/Partner

257 (63.9)

379 (65.8)

429 (60.6)

457 (55.3)

Divorced/Widowed/Sep

52 (12.9)

81 (14.0)

96 (13.5)

119 (14.4)

Single (Never married)

93 (23.1)

116 (20.1)

183 (25.8)

250 (30.2)

Underweight & Normal
Weight

200 (49.7)

220 (38.1)

280 (39.6)

307 (37.1)

Overweight & Obese

202 (50.3)

356 (61.9)

428 (60.4)

519 (62.9)

Low Risk

225 (55.9)

253 (43.9)

320 (45.2)

358 (43.4)

High Risk

177 (44.1)

323 (56.1)

388 (54.8)

468 (56.6)

Below HS

47 (11.7)

97 (16.8)

165 (23.3)

240 (29.0)

HS Degree

56 (13.9)

90 (15.6)

153 (21.6)

214 (25.9)

Subject Characteristics
Race

Smoking

Marital Status

BMI

WC

Education Level
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Quartiles of PIR

Quartiles of PA

Diabetes

Some College/AA

122 (30.3)

205 (35.6)

233 (32.9)

272 (32.9)

College Grad & Higher

177 (44.0)

184 (31.9)

157 (22.2)

100 (12.1)

1

80 (19.9)

136 (23.6)

199 (28.1)

295 (35.7)

2

68 (16.9)

115 (19.9)

163 (23.0)

208 (25.1)

3

89 (22.1)

142 (24.6)

173 (24.4)

177 (21.4)

4

141 (35.0)

144 (25.0)

130 (18.3)

98 (11.8)

5 (Missing)

24 (5.9)

39 (6.7)

43 (6.0)

48 (5.8)

1

94 (23.3)

190 (33.0)

275 (38.8)

311 (37.6)

2

49 (12.2)

85 (14.7)

89 (12.5)

108 (13.0)

3

100 (24.8)

121 (21.0)

157 (22.1)

163 (19.7)

4

137 (34.0)

138 (23.9)

131 (18.5)

155 (18.7)

5 (Missing)

22 (5.4)

42 (7.3)

56 (7.9)

89 (10.7)

Not Present

394 (98.0)

555 (96.4)

678 (95.7)

782 (94.6)

8 (2.0)

21 (3.6)

30 (4.3)

44 (5.4)

Borderline/Diabetic

3.6.1
P values from ANOVA and chi-square tests <0.05 for all comparisons
N for Physical activity = 2,303
N for Poverty-to-Income Ratio = 2,358
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Table 3.3 Subject characteristics by Dietary Inflammatory Index (DII) quartiles, among 2,392 Postmenopausal Participants from the National Health and Nutrition Evaluation Study 2005-2010, Continued
onto Next Page
DII Quartiles
n (%)
Q1

Q2

Q3

Q4

641 (26.75)

605 (25.25)

592 (24.71)

558 (23.29)

Mean (SD)

Mean (SD)

Mean (SD)

Mean (SD)

Age (y)

64.0 (9.3)

62.5 (9.8)

62.8 (9.7)

62.5 (10.5)

Physical Activity (MET-minutes) *

653 (1069)

457 (768)

384 (830)

270 (609)

Poverty Income Ratio *

3.2 (1.5)

2.9 (1.5)

2.6 (1.5)

2.1 (1.4)

Dietary Inflammatory Index Scores

-2.6 (0.5)

-1.1 (0.3)

0.2 (0.4)

2.1 (0.8)

n (%)

n (%)

n (%)

n (%)

White

302 (69.4)

309 (57.8)

327 (49.7)

356 (46.5)

Hispanic

65 (14.9)

133 (24.9)

170 (25.8)

218 (28.5)

Black

49 (11.2)

78 (14.6)

146 (22.2)

173 (22.6)

Multiracial

19 (4.3)

14 (2.6)

15 (2.2)

18 (2.3)

259 (59.6)

317 (59.4)

391 (59.4)

396 (51.7)

217 (40.6)

267 (40.6)

369 (48.3)

Subject Characteristics

Subject Characteristics
Race

Smoking

Never smoker
Ever smoker

Marital Status

BMI

WC

Education Level

176 (40.4)

Married/Partner

253 (58.1)

313 (58.6)

362 (55.0)

402 (52.5)

Divorced/Widowed/Sep

153 (35.1)

194 (36.3)

256 (38.9)

318 (41.5)

Single (Never married)

29 (6.6)

27 (5.0)

40 (6.0)

45 (5.8)

Underweight & Normal
Weight

153 (35.1)

143 (26.7)

146 (22.2)

183 (23.9)

Overweight & Obese

282 (64.9)

391 (73.3)

512 (77.8)

582 (76.1)

Low Risk

147 (33.8)

122 (22.8)

140 (21.2)

171 (22.3)

High Risk

288 (66.2)

412 (77.1)

518 (78.7)

594 (77.6)

Below HS

70 (16.1)

111 (20.8)

200 (30.4)

319 (41.7)

HS Degree

98 (22.5)

143 (26.8)

170 (25.8)

214 (27.9)
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Quartiles of PIR

Some College/AA

123 (28.3)

163 (30.5)

191 (29.0)

169 (22.1)

College Grad & Higher

144 (33.1)

117 (21.9)

97 (14.7)

63 (8.2)

1

47 (10.8)

92 (17.2)

131 (19.9)

250 (32.6)

2

98 (22.5)

118 (22.1)

176 (26.7)

214 (27.9)

3

95 (21.8)

138 (25.8)

148 (22.5)

144 (18.8)

4

154 (35.4)

152 (28.4)

142 (21.5)

102 (13.3)

41 (9.4)

34 (6.3)

61 (9.2)

55 (7.2)

1

141 (32.4)

212 (39.7)

319 (48.4)

392 (51.2)

2

43 (9.9)

62 (11.6)

65 (9.8)

82 (10.7)

3

122 (28.0)

115 (21.5)

116 (17.6)

125 (16.3)

4

100 (23.0)

87 (16.3)

82 (12.4)

51 (6.6)

5 (Missing)

29 (6.6)

58 (10.8)

76 (11.5)

115 (15.0)

Not Present

376 (86.4)

425 (79.6)

516 (78.4)

589 (77.0)

Borderline/Diabetic

59 (13.6)

109 (20.4)

142 (21.6)

176 (23.0)

5 (Missing)
Quartiles of PA

Diabetes

P values from ANOVA and chi-square tests <0.01 for all comparisons, except for age (0.077) and marital
status (0.267)
* N for Physical Activity = 2,114
* N for Poverty-to-Income Ratio = 2,201
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Table 3.4 Estimated Beta Coefficient and Standard Errors for the Association of Dietary Inflammatory
Index Quartiles and Continuous CRP Levels (mg/L), among Pre- and Post-menopausal Participants from
the National Health and Nutrition Evaluation Study 2005-2010
Model 1a

Model 2b

Beta (SE)

95% CI

Beta (SE)

95% CI

Quartile 1

Referent

-

Referent

-

Quartile 2

0.61 (0.15)

0.31-0.91

0.28 (0.13)

Quartile 3

0.47 (0.15)

0.18-0.77

Quartile 4

0.64 (0.14)

0.35-0.92

Model 3c
Beta (SE)

95% CI

Pre-menopause
(N=2,512)

P-trend

Referent

-

0.01-0.55

0.28 (0.13)

0.01-0.56

0.15 (0.13)

-0.11-0.41

0.15 (0.13)

-0.11-0.41

0.20 (0.13)

-0.06-0.46

0.19 (0.13)

-0.07-0.46

0.001

0.421

0.469

Post-menopause
(N=2,392)
Quartile 1

Referent

-

Quartile 2

0.37 (0.15)

Quartile 3
Quartile 4
P-trend

Referent

-

0.07-0.66

0.11 (0.14)

0.67 (0.14)

0.39-0.96

0.83 (0.14)

0.55-1.10
<0.001

a.
b.

c.

Referent

-

-0.01-0.39

0.09 (0.14)

-0.18-0.37

0.29 (0.13)

0.03-0.56

0.25 (0.13)

-0.01-0.52

0.37 (0.13)

0.11-0.64

0.33 (0.13)

0.06-0.60

0.002

0.009

Model 1: Adjusted for age
Model 2 (Pre-menopause): Adjusted for age, BMI (underweight, normal weight,
overweight, obese), WC (low risk, high risk), smoking (never smoker, ever smoker),
diabetes (None diabetic, borderline/diabetic), PA (quartiles)
Model 2 (Post-menopause): Adjusted for age, BMI (underweight, normal weight,
overweight, obese), WC (low risk, high risk), smoking (never smoker, ever smoker), PIR
(quartiles), PA (quartiles)
Model 3: Adjusted for age, race (White, Hispanic, Black, Multiracial), BMI
(underweight, normal weight, overweight, obese), WC (low risk, high risk), marital status
(Married/Partner, Divorced/Widowed/Separated, Never married), education (Below high
school, high school degree, some college/AA, college grad and higher), diabetes (None
diabetic, borderline/diabetic), smoking (never smoker, ever smoker), PIR (quartiles), PA
(quartiles)
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Table 3.5 Estimated Odds Ratio for the Association of Dietary Inflammatory Index Quartiles and Risk of
High CRP Levels (>3 mg/L)* among Pre- and Post-menopausal Participants from the National Health and
Nutrition Evaluation Study 2005-2010
Model 1a

Model 2b

Odds Ratio

95% CI

Quartile 1

1

-

Quartile 2

1.48

Quartile 3
Quartile 4

Odds
Ratio

95% CI

Model 3c
Odds Ratio

95% CI

Pre-menopause
(N=2,512)
1

-

1.11-1.96

1.14

1.38

1.05-1.82

1.48

1.13-1.94

P-trend

1

-

0.83-1.56

1.16

0.85-1.58

1.05

0.77-1.42

1.03

0.76-1.40

1.02

0.76-1.38

1.01

0.74-1.37

0.028

0.798

0.659

Post-menopause
(N=2,392)
Quartile 1

1

-

Quartile 2

1.13

Quartile 3
Quartile 4
P-trend

1

-

0.85-1.49

0.89

1.66

1.28-2.15

1.74

1.35-2.25
<0.001

1

-

0.66-1.20

0.90

0.67-1.21

1.19

0.90-1.59

1.22

0.92-1.62

1.17

0.88-1.56

1.20

0.91-1.59

0.067

0.045

* Those with CRP above 10 mg/L have been excluded.
a. Model 1: Adjusted for age
b. Model 2 (Pre-menopause): Adjusted for age, BMI (underweight, normal weight, overweight,
obese), WC (low risk, high risk), diabetes (None diabetic, borderline/diabetic), smoking (never
smoker, ever smoker), PA (quartiles)
Model 2 (Post-menopause): Adjusted for age, race (White, Hispanic, Black, Multiracial), BMI
(underweight, normal weight, overweight, obese), WC (low risk, high risk), PIR (quartiles), PA
(quartiles)
c. Model 3: Adjusted for age, race (White, Hispanic, Black, Multiracial), BMI (underweight, normal
weight, overweight, obese), WC (low risk, high risk), marital status (Married/Partner,
Divorced/Widowed/Separated, Never married), education (Below high school, high school degree,
some college/AA, college grad and higher), diabetes (None diabetic, borderline/diabetic), smoking
(never smoker, ever smoker), PIR (quartiles), PA (quartiles)
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Table 3.6 Estimated Beta and Standard Errors for the Effects of Dietary Inflammatory Index Quartiles and
Depression Symptoms Score, among Pre- and Post-menopausal Participants from the National Health and
Nutrition Evaluation Study 2005-2010
Model 1a

Model 2b

Beta (SE)

95% CI

Beta (SE)

95% CI

Quartile 1

Referent

-

Referent

-

Quartile 2

0.64 (0.28)

0.08-1.20

0.38 (0.28)

Quartile 3

1.00 (0.27)

0.46-1.54

Quartile 4

1.58 (0.27)

1.05-2.11

Model 3c
Beta (SE)

95% CI

Pre-menopause
(N=2,512)

P-trend

Referent

-

-0.16-0.93

0.36 (0.28)

-0.01-0.91

0.52 (0.27)

-0.007-1.06

0.50 (0.27)

-0.03-1.03

0.77 (0.27)

0.24-1.31

0.74 (0.27)

0.20-1.27

0.001

0.004

0.008

Post-menopause
(N=2,392)
Quartile 1

Referent

-

Referent

-

Quartile 2

0.47 (0.28)

Quartile 3
Quartile 4

-0.08-1.03

0.14 (0.27)

0.76 (0.27)

0.23-1.30

1.70 (0.26)

1.19-2.22

P-trend

<0.001

Referent

-

-0.39-0.68

0.14 (0.27)

-0.39-0.68

0.13 (0.26)

-0.38-0.65

0.11 (0.26)

-0.41-0.64

0.71 (0.26)

0.18-1.23

0.67 (0.27)

0.14-1.20

0.005

0.008

* Range of Score: 0-27
a.
b.

c.

Model 1: Adjusted for age
Model 2 (Pre-menopause): Adjusted for age, BMI (underweight, normal weight, overweight,
obese), marital status (Married/Partner, Divorced/Widowed/Separated, Never married), education
(Below high school, high school degree, some college/AA, college grad and higher), diabetes
(None diabetic, borderline/diabetic), smoking (never smoker, ever smoker), PIR (quartiles), PA
(quartiles)
Model 2 (Post-menopause): Adjusted for age, race (White, Hispanic, Black, Multiracial), BMI
(underweight, normal weight, overweight, obese), marital status (Married/Partner,
Divorced/Widowed/Separated, Never married), diabetes (None diabetic, borderline/diabetic),
smoking (never smoker, ever smoker), PIR (quartiles), PA (quartiles)
Model 3: Adjusted for age, race (White, Hispanic, Black, Multiracial), BMI (underweight, normal
weight, overweight, obese), WC (low risk, high risk), marital status (Married/Partner,
Divorced/Widowed/Separated, Never married), education (Below high school, high school degree,
some college/AA, college grad and higher), diabetes (None diabetic, borderline/diabetic), smoking
(never smoker, ever smoker), PIR (quartiles), PA (quartiles)
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Table 3.7 Estimated Beta and Standard Errors for the Effects of Dietary Inflammatory Index Quartiles and
Score for Somatic Symptoms of Depression* among Pre- and Post-menopausal Participants from the
National Health and Nutrition Evaluation Study 2005-2010, Continued onto Next Page
Model 1a

Model 2b

Beta (SE)

95% CI

Beta (SE)

95% CI

Quartile 1

Referent

-

Referent

-

Quartile 2

0.33 (0.15)

0.02-0.64

0.19 (0.15)

Quartile 3

0.46 (0.15)

0.16-0.76

Quartile 4

0.76 (0.14)

0.47-1.05

Model 3c
Beta (SE)

95% CI

Pre-menopause
(N=2,512)

P-trend

Referent

-

-0.10-0.49

0.19 (0.15)

-0.10-0.49

0.22 (0.14)

-0.06-0.52

0.20 (0.15)

-0.09-0.49

0.35 (0.14)

0.06-0.64

0.31 (0.15)

0.02-0.61

<0.001

0.020

0.050

Post-menopause
(N=2,392)
Quartile 1

Referent

-

Quartile 2

0.26 (0.15)

Quartile 3
Quartile 4
P-trend

a.
b.

c.

Referent

-

-0.04-0.56

0.10 (0.15)

0.39 (0.15)

0.09-0.68

0.83 (0.14)

0.54-1.11
<0.001

Referent

-

-0.19-0.40

0.10 (0.15)

-0.19-0.40

0.08 (0.14)

-0.20-0.37

0.09 (0.15)

-0.20-0.38

0.37 (0.14)

0.07-0.66

0.37 (0.15)

0.08-0.67

0.010

0.010

Range of Score: 0-12
Model 1: Adjusted for age
Model 2 (Pre-menopause): Adjusted for BMI (underweight, normal weight, overweight, obese),
marital status (Married/Partner, Divorced/Widowed/Separated, Never married), diabetes (None
diabetic, borderline/diabetic), smoking (never smoker, ever smoker), PIR (quartiles), PA
(quartiles)
Model 2 (Post-menopause): Adjusted for age, race (White, Hispanic, Black, Multiracial), BMI
(underweight, normal weight, overweight, obese), marital status (Married/Partner,
Divorced/Widowed/Separated, Never married), diabetes (None diabetic, borderline/diabetic),
smoking (never smoker, ever smoker), PIR (quartiles), PA (quartiles)
Model 3: Adjusted for age, race (White, Hispanic, Black, Multiracial), BMI (underweight, normal
weight, overweight, obese), WC (low risk, high risk), marital status (Married/Partner,
Divorced/Widowed/Separated, Never married), education (Below high school, high school degree,
some college/AA, college grad and higher), diabetes (None diabetic, borderline/diabetic), smoking
(never smoker, ever smoker), PIR (quartiles), PA (quartiles)
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Table 3.8 Estimated Beta and Standard Errors for the Effects of Dietary Inflammatory Index Quartiles and
Score for Cognitive Symptoms of Depression* among Pre- and Post-menopausal Participants from the
National Health and Nutrition Evaluation Study 2005-2010
Model 1a

Model 2b

Beta (SE)

95% CI

Beta (SE)

95% CI

Quartile 1

Referent

-

Referent

-

Quartile 2

0.31 (0.15)

0.01-0.61

0.20 (0.15)

Quartile 3

0.53 (0.14)

0.25-0.82

Quartile 4

0.81 (0.14)

0.53-1.09

Model 3c
Beta (SE)

95% CI

Pre-menopause
(N=2,512)

P-trend

Referent

-

-0.09-0.50

0.18 (0.15)

-0.10-0.48

0.32 (0.14)

0.04-0.61

0.29 (0.14)

0.007-0.58

0.47 (0.14)

0.18-0.75

0.42 (0.14)

0.13-0.71

<0.001

0.001

0.003

Post-menopause
(N=2,392)
Quartile 1

Referent

-

Quartile 2

0.21 (0.15)

Quartile 3
Quartile 4
P-trend

a.
b.

c.

Referent

-

-0.08-0.51

0.05 (0.15)

0.37 (0.14)

0.09-0.66

0.87 (0.14)

0.59-1.15
<0.001

Referent

-

-0.24-0.34

0.05 (0.15)

-0.24-0.34

0.02 (0.14)

-0.26-0.30

0.04 (0.14)

-0.24-0.33

0.30 (0.14)

0.01-0.59

0.32 (0.14)

0.04-0.61

0.024

0.016

* Range of Score: 0-15
Model 1: Adjusted for age
Model 2 (Pre-menopause): Adjusted for age, WC (low risk, high risk), marital status
(Married/Partner, Divorced/Widowed/Separated, Never married), diabetes (None diabetic,
borderline/diabetic), smoking (never smoker, ever smoker), PIR (quartiles), PA (quartiles)
Model 2 (Post-menopause): Adjusted for age, BMI (underweight, normal weight, overweight,
obese), marital status (Married/Partner, Divorced/Widowed/Separated, Never married), education
(Below high school, high school degree, some college/AA, college grad and higher), diabetes
(None diabetic, borderline/diabetic), smoking (never smoker, ever smoker), PIR (quartiles), PA
(quartiles)
Model 3: Adjusted for age, race (White, Hispanic, Black, Multiracial), BMI (underweight, normal
weight, overweight, obese), WC (low risk, high risk), marital status (Married/Partner,
Divorced/Widowed/Separated, Never married), education (Below high school, high school degree,
some college/AA, college grad and higher), diabetes (None diabetic, borderline/diabetic), smoking
(never smoker, ever smoker), PIR (quartiles), PA (quartiles)
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Table 3.9 Estimated Odds Ratio for the Association of Dietary Inflammatory Index Quartiles and Risk of
Probably Major Depression, among Pre- and Post-menopausal Participants from the National Health and
Nutrition Evaluation Study 2005-2010
Model 1a

Model 2b

Odds Ratio

95% CI

Quartile 1

1

-

Quartile 2

3.8

Quartile 3
Quartile 4

Odds
Ratio

Model 3c

95% CI

Odds
Ratio

95% CI

Pre-menopause
(N=2,512)
1

-

1.3-11.3

3.4

6.6

2.4-18.7

10.3

3.7-28.4

P-trend

1

-

1.1-10.0

3.2

1.1-9.7

5.1

1.8-14.6

5.0

1.7-14.3

6.9

2.5-19.4

6.3

2.2-17.9

<0.001

<0.001

<0.001

Post-menopause
(N=2,392)
Quartile 1

1

-

Quartile 2

1.8

Quartile 3
Quartile 4
P-trend

1

-

0.8-3.7

1.6

2.4

1.2-4.8

3.7

1.9-7.2
<0.001

a.
b.

c.

1

-

0.8-3.5

1.6

0.8-3.5

1.7

0.8-3.5

1.7

0.8-3.4

2.1

1.1-4.2

2.1

1.1-4.3

0.024

0.026

Model 1: Adjusted for age
Model 2 (Pre-menopause): Adjusted for age, smoking (never smoker, ever smoker), PIR
(quartiles), PA (quartiles)
Model 2 (Post-menopause): Adjusted for age, BMI (underweight/normal weight,
overweight/obese), marital status (Married/Partner, Divorced/Widowed/Separated, Never
married), smoking (never smoker, ever smoker), PIR (quartiles), PA (quartiles)
Model 3: Adjusted for age, race (White, Hispanic, Black, Multiracial), BMI
(underweight/normal weight, overweight/obese), WC (low risk, high risk), marital status
(Married/Partner, Divorced/Widowed/Separated, Never married), education (Below high
school, high school degree, some college/AA, college grad and higher), smoking (never
smoker, ever smoker), PIR (quartiles), PA (quartiles)
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Table 3.10 Estimated Odds Ratio for the Association of Dietary Inflammatory Index Quartiles and Risk of
Probably Moderate or Severe Depression, among Pre- and Post-menopausal Participants from the National
Health and Nutrition Evaluation Study 2005-2010
Model 1a

Model 2b

Crude
OR

95% CI

Quartile 1

1

-

Quartile 2

2.3

Quartile 3
Quartile 4

Adjusted
OR

Model 3c
95% CI

Adjusted
OR

95% CI

Pre-menopause
(N=2,512)
1

-

1.3-4.0

1.9

2.8

1.6-4.8

4.1

2.4-6.9

P-trend

1

-

1.1-3.5

1.9

1.0-3.4

2.1

1.2-3.7

2.0

1.1-3.6

2.7

1.5-4.6

2.5

1.4-4.3

<0.001

<0.001

0.001

Post-menopause
(N=2,392)
Quartile 1

1

-

Quartile 2

1.8

Quartile 3
Quartile 4
P-trend

a.
b.

c.

1

-

1.0-3.2

1.6

2.9

1.7-5.0

4.1

2.4-7.0
<0.001

1

-

0.8-2.9

1.5

0.8-2.8

2.1

1.2-3.7

2.0

1.1-3.6

2.5

1.4-4.3

2.4

1.3-4.1

<0.001

0.001

Model 1: Adjusted for age
Model 2 (Pre-menopause): Adjusted for BMI (underweight/normal weight, overweight/obese),
marital status (Married/Partner, Divorced/Widowed/Separated, Never married), smoking (never
smoker, ever smoker), PIR (quartiles), PA (quartiles)
Model 2 (Post-menopause): Adjusted for age, BMI (underweight/normal weight,
overweight/obese), smoking (never smoker, ever smoker), PIR (quartiles), PA (quartiles)
Model 3: Adjusted for age, race (White, Hispanic, Black, Multiracial), BMI (underweight/normal
weight, overweight/obese), WC (low risk, high risk), marital status (Married/Partner,
Divorced/Widowed/Separated, Never married), education (Below high school, high school degree,
some college/AA, college grad and higher), smoking (never smoker, ever smoker), PIR (quartiles),
PA (quartiles)
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Table 3.11 Mediation Results Examining CRP as a Mediator of the Relationship between Dietary Inflammatory Index (DII) Quartiles and Depression Symptom
Score Using Structural Equation Modeling (SEM), among Participants from the National Health and Nutrition Evaluation Survey 2005-2010, Continued onto
Next Page
DII
Quartiles

Total effect
coefficient (SE)

95% CI

Direct effect
coefficient (SE)

95% CI

Indirect effect
coefficient (SE)
[CRP]

95% CI

Indirect/Total
Effect

Pre-menopause (N=2,512)
Adjusted for age
1 (referent)
2

0.64 (0.22)

0.20-1.09

0.58 (0.22)

0.13-1.02

0.06 (0.02)

0.01-0.12

0.09

3

0.99 (0.23)

0.54-1.45

0.94 (0.23)

0.49-1.40

0.05 (0.02)

0.006-0.09

0.05

4

1.58 (0.24)

1.11-2.06

1.51 (0.24)

1.04-1.99

0.07 (0.02)

0.01-0.12

0.04

P-trend

<0.001

<0.001

0.024

Fully Adjusted *
1 (referent)
2

0.37 (0.22)

-0.06-0.80

0.36 (0.22)

-0.07-0.80

0.005 (0.01)

-0.02-0.03

0.01

3

0.46 (0.22)

0.02-0.91

0.46 (0.22)

0.02-0.91

0.003 (0.007)

-0.01-0.01

0.006

4

0.70 (0.24)

0.22-1.18

0.69 (0.24)

0.21-1.17

0.003 (0.009)

-0.01-0.02

0.004

P-trend

0.010

0.010

Post-menopause (N=2,392)
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0.684

Adjusted for age
1 (referent)
2

0.48 (0.23)

0.02-0.94

0.43 (0.23)

-0.02-0.89

0.04 (0.02)

0.0003-0.09

0.08

3

0.77 (0.22)

0.33-1.21

0.68 (0.22)

0.24-1.13

0.08 (0.03)

0.02-0.15

0.10

4

1.70 (0.23)

1.24-2.17

1.60 (0.23)

1.13-2.07

0.10 (0.04)

0.03-0.18

0.05

P-trend

<0.001

<0.001

0.006

Fully Adjusted *
1 (referent)
2

0.15 (0.22)

-0.28-0.59

0.14 (0.22)

-0.29-0.58

0.004 (0.007)

-0.01-0.02

0.02

3

0.23 (0.24)

-0.21-0.66

0.21 (0.22)

-0.22-0.66

0.01 (0.01)

-0.01-0.04

0.04

4

0.86 (0.24)

0.39-1.34

0.85 (0.24)

0.37-1.32

0.01 (0.02)

-0.02-0.05

0.01

P-trend

<0.001

<0.001

0.468

* Adjusted for age, sex, CRP, race (White, Hispanic, Black, Multiracial), BMI (underweight, normal weight, overweight, obese), WC (low risk, high risk),
marital status (Married/Partner, Divorced/Widowed/Separated, Never married), education (Below high school, high school degree, some college/AA, college
grad and higher), smoking (never smoker, ever smoker), PIR (quartiles), PA (quartiles)
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Table 3.12 Mediation Results Examining CRP as a Mediator of the Relationship between Dietary Inflammatory Index (DII) Quartiles and Score for Somatic
Symptoms of Depression Using Structural Equation Modeling (SEM), among Participants from the National Health and Nutrition Evaluation Survey 2005-2010,
Continued onto Next Page
DII
Quartiles

Total effect
coefficient (SE)

95% CI

Direct effect
coefficient (SE)

95% CI

Indirect effect
coefficient (SE)
[CRP]

95% CI

Indirect/Total
Effect

Pre-menopause (N=2,512)
Adjusted for age
1 (referent)
2

0.33 (0.13)

0.07-0.59

0.29 (0.13)

0.03-0.55

0.04 (0.01)

0.008-0.07

0.12

3

0.46 (0.13)

0.20-0.72

0.43 (0.13)

0.17-0.69

0.03 (0.01)

0.005-0.05

0.06

4

0.76 (0.13)

0.50-1.03

0.72 (0.13)

0.46-0.99

0.04 (0.01)

0.01-0.07

0.05

P-trend

<0.001

<0.001

0.016

Fully Adjusted *
1 (referent)
2

0.19 (0.13)

-0.06-0.44

0.18 (0.13)

-0.07-0.44

0.004 (0.007)

-0.009-0.01

0.02

3

0.19 (0.13)

-0.06-0.44

0.18 (0.13)

-0.06-0.44

0.002 (0.004)

-0.006-0.01

0.01

4

0.30 (0.13)

0.03-0.57

0.30 (0.13)

0.03-0.57

0.003 (0.005)

-0.007-0.01

0.01

P-trend

0.053

0.054

Post-menopause (N=2,392)
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0.593

Adjusted for age
1 (referent)
2

0.26 (0.13)

-0.005-0.52

0.23 (0.13)

-0.02-0.50

0.02 (0.01)

0.0002-0.05

0.07

3

0.39 (0.13)

0.14-0.65

0.35 (0.13)

0.09-0.60

0.04 (0.01)

0.01-0.08

0.10

4

0.83 (0.13)

0.56-1.09

0.77 (0.13)

0.51-1.03

0.05 (0.02)

0.01-0.10

0.06

P-trend

<0.001

<0.001

0.006

Fully Adjusted *
1 (referent)
2

0.10 (0.13)

-0.15-0.36

0.10 (0.13)

-0.15-0.36

0.002 (0.004)

-0.005-0.01

0.02

3

0.14 (0.13)

-0.11-0.40

0.13 (0.13)

-0.12-0.39

0.006 (0.008)

-0.009-0.02

0.04

4

0.46 (0.13)

0.19-0.72

0.45 (0.13)

0.18-0.72

0.008 (0.01)

-0.01-0.03

0.01

P-trend

0.001

0.001

0.419

* Adjusted for age, sex, CRP, race (White, Hispanic, Black, Multiracial), BMI (underweight, normal weight, overweight, obese), WC (low risk, high risk),
marital status (Married/Partner, Divorced/Widowed/Separated, Never married), education (Below high school, high school degree, some college/AA, college
grad and higher), smoking (never smoker, ever smoker), PIR (quartiles), PA (quartiles)
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Table 3.13 Mediation Results Examining CRP as a Mediator of the Relationship between Dietary Inflammatory Index (DII) Quartiles and Score for Cognitive
Symptoms of Depression Using Structural Equation Modeling (SEM), among 10,022 Participants from the National Health and Nutrition Survey 2005-2010,
Continued onto Next Page
DII
Quartiles

Total effect
coefficient (SE)

95% CI

Direct effect
coefficient (SE)

95% CI

Indirect effect
coefficient (SE)
[CRP]

95% CI

Indirect/Total
Effect

Pre-menopause (N=2,512)
Adjusted for age
1 (referent)
2

0.31 (0.12)

0.07-0.54

0.28 (0.12)

0.05-0.52

0.02 (0.01)

-0.001-0.05

0.06

3

0.53 (0.12)

0.29-0.78

0.51 (0.12)

0.27-0.76

0.02 (0.01)

-0.001-0.04

0.03

4

0.81 (0.13)

0.56-1.07

0.79 (0.13)

0.53-1.04

0.02 (0.01)

-0.0006-0.05

0.02

P-trend

<0.001

<0.001

0.069

Fully Adjusted *
1 (referent)
2

0.18 (0.12)

-0.05-0.41

0.18 (0.12)

-0.05-0.41

0.001 (0.006)

-0.01-0.01

0.005

3

0.27 (0.12)

0.03-0.52

0.27 (0.12)

0.03-0.52

0.0006 (0.003)

-0.006-0.008

0.002

4

0.39 (0.13)

0.13-0.65

0.39 (0.13)

0.13-0.65

0.0007 (0.004)

-0.008-0.01

0.001

P-trend

0.005

0.005

Post-menopause (N=2,392)
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0.863

Adjusted for age
1 (referent)
2

0.22 (0.12)

-0.02-0.47

0.20 (0.12)

-0.04-0.44

0.02 (0.01)

-0.001-0.04

0.09

3

0.38 (0.12)

0.14-0.61

0.33 (0.12)

0.09-0.58

0.04 (0.01)

0.006-0.07

0.10

4

0.87 (0.12)

0.62-1.12

0.82 (0.12)

0.57-1.08

0.05 (0.02)

0.008-0.09

0.05

P-trend

<0.001

<0.001

0.018

Fully Adjusted *
1 (referent)
2

0.04 (0.12)

-0.19-0.28

0.04 (0.12)

-0.19-0.27

0.001 (0.003)

-0.005-0.009

0.02

3

0.08 (0.13)

-0.15-0.32

0.08 (0.12)

-0.15-0.31

0.004 (0.008)

-0.01-0.02

0.05

4

0.40 (0.13)

0.14-0.66

0.40 (0.13)

0.14-0.65

0.005 (0.01)

-0.01-0.02

0.01

P-trend

0.001

0.002

0.594

* Adjusted for age, sex, CRP, race (White, Hispanic, Black, Multiracial), BMI (underweight, normal weight, overweight, obese), WC (low risk, high risk),
marital status (Married/Partner, Divorced/Widowed/Separated, Never married), education (Below high school, high school degree, some college/AA, college
grad and higher), smoking (never smoker, ever smoker), PIR (quartiles), PA (quartiles)
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Figure 3.1 Predicted Probability of High CRP (>3 mg/L) among Pre- and Post-menopausal Participants of
NHANES 2005-2010, Age-Adjusted.
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Figure 3.2 Predicted Probability of High CRP (>3 mg/L) among Pre- and Post-menopausal Participants of
NHANES 2005-2010, Multivariable-Adjusted.
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Figure 3.3 Predicted Probability of Major Depression among Pre- and Post-menopausal Participants of
NHANES 2005-2010, Age-Adjusted
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Figure 3.4 Predicted Probability of Major Depression among Pre- and Post-menopausal Participants of
NHANES 2005-2010, Multivariable*-Adjusted.
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Figure 3.5 Predicted Probability of Depression Severity among Pre- and Post-menopausal Participants of
NHANES 2005-2010, Age-Adjusted.
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Figure 3.6 Predicted Probability of Depression Severity among Pre- and Post-menopausal Participants of
NHANES 2005-2010, Multivariable*-Adjusted.
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